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ABSTRACT
ON THE NEUROENDOCRINE REGULATION OF REPRODUCTION: 
FUNCTIONAL CHARACTERIZATION AND KINETIC STUDIES OF THE 
LAMRPEY GONADOTROPIN-RELEASING HORMONE RECEPTOR
AND
CLONING AND ANALYSIS OF THE cDNA ENCODING LAMPREY 
GONADOTROPIN-RELEASING HORMONE-III
by
Matthew R. Silver 
University of New Hampshire, December, 2005
The vertebrate hypothalamic-pituitary-gonadal (HPG) axis is regulated by gonadotropin- 
releasing hormone (GnRH), a decapeptide that is produced and released from the 
hypothalamus. At the anterior pituitary, GnRH action is mediated through high affinity 
binding with the GnRH receptor, a rhodopsin-like seven transmembrane G-protein 
coupled receptor (GPCR). Interest in the evolution of reproductive physiology has led 
scientists to study the lamprey, a member of the oldest extant class of vertebrates, the 
agnathans. The studies presented herein contribute to the field of reproductive 
neuroendocrinology through developing our understanding of ancestral, or ancestral-like 
characteristics and mechanisms of the HPG axis. This dissertation is divided into two
xii
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major components: (1) functional characterization and kinetic studies of the lamprey 
GnRH receptor (chapters II and III), and (2) an analysis of the lamprey GnRH-III cDNA 
(chapter IV).
A type II lamprey GnRH receptor was recently identified via cDNA cloning, 
BLAST analysis and in situ hybridization, however the classification by these homology 
and expression studies was insufficient. Demonstration of function, through binding 
capacity or efficacy is a vital and required component of receptor characterization. To 
this end, a heterologous expression system was developed using COS7 cells transiently 
transfected with the lamprey GnRH receptor. The lamprey GnRH receptor was shown to 
be functional as well as lamprey GnRH-III selective based on a series of efficacy and 
kinetic studies. Ligand dependant internalization was characterized, which was 
dependant on a motif within the first forty amino acids of the C-terminal tail. Further 
function and kinetics studies were performed using C-terminal tail truncation mutants.
The objective of the second component of this dissertation was to clone and 
characterize the cDNA encoding lamprey GnRH-III from eight species of lamprey, which 
were analyzed by phylogenetics methodology to address the molecular evolution of the 
GnRH family and the lamprey lineage. The lamprey GnRH-III sequences formed three 
groups, supporting the current view of the lamprey lineage at the family level. 
Phylogenetic analysis of these sequences together with 64 previously described GnRH 
sequences suggested that the lamprey GnRHs are unique, as they group together 
separately from the three previously described paralogous lineages of the GnRH family.
xiii
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CHAPTER I
BACKGROUND AND SIGNIFICANCE
Reproductive physiology is a fundamental component of life, evolution and medicine. 
Efficient and robust regulation of the mechanisms that control the reproductive system, 
from neural function to steroid synthesis, is essential for a species to survive and flourish, 
and therefore is subject to the unwavering scrutiny of selective pressure. In this light, the 
field of reproductive biology spills across disciplines and has been the focus of intense, 
multidisciplinary research which has been fed by the desire for basic scientific progress 
as well as the high pressure pursuit of pharmaceutical development. Like all other 
physiological systems, proper reproductive function relies on a highly organized 
mechanism of communication; hormones and their receptors provide this link between 
distantly located tissues that are coordinated in operation. This biochemical 
communication is governed by the hypothalamus, a region within the diencephalon 
(which sits at the base of the cerebral cortex), where integration and coordination of 
internal and environmental information occurs. In the control of the reproductive system, 
the hypothalamus produces the gonadotropin-releasing hormone (GnRH), which acts at 
the pituitary causing the synthesis and secretion of the gonadotropins, which in turn 
regulate gonadal function, which in turn feedback information, via gonadal hormones 
(steroid and protein) to the hypothalamus and pituitary. Consummate maintenance and 
regulation of this cycle is necessary and essential for proper reproductive function, and
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
therefore lies at the heart of fitness, selection and evolution as well as medicinal therapy 
development for the treatment of fertility disorders, reproductive abnormalities and sex 
steroid driven cancers.
In no field is the importance of comparative analysis as great as it is in 
reproductive biology, where the analysis of species across the vertebrate lineage has led 
to a more developed understanding through the description of systematic change through 
evolution. It is in this spirit that this dissertation intends to address and contribute to the 
field of molecular neuroendocrinology of reproduction through analysis o f an ancestral 
model, the sea lamprey, which is one of the oldest living vertebrates, in order to better 
our understanding of more derived species.
Gonadotropin-Releasing Hormone
The gonadotropin-releasing hormone (GnRH-previously referred to as LRF or LHRH) is 
a ten amino acid peptide hormone that is produced in the hypothalamus and is the central 
regulator of the reproductive axis in all vertebrates. Since its discovery in the early 
1970’s (Burgus et al., 1972; Matsuo et al., 1971) GnRH has been the focus o f intense 
research which has lead to a rapid advancement of this field. Released from the 
hypothalamus, GnRH stimulates the synthesis and secretion of the gonadotropins, 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which travel via the 
circulation system to the gonads where they stimulate gonadal steroidogenesis (i.e. 
testosterone or estradiol production) and gametogenesis (i.e. spermatogenesis or 
oogenesis) (See Figure 1). To date, twenty-four forms of GnRH have been identified,
2
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Figure 1. Schematic Representation o f the Neuroendocrine Regulation o f Reproduction. In all
vertebrates, GnRH is the primary regulatory o f the hypothalamic-pituitary-gonadal (HPG) axis, and 
therefore reproduction. GnRH is released from the hypothalamus and stimulates the synthesis and 
secretion o f the gonadotropins (LH and FSH) from pituitary gonadotrope cells. The gonadotropins in turn 
control steoidogenesis and gametogenesis at the level o f the gonads.
fourteen forms from vertebrates and ten from invertebrates, which have been named after 
the species they were identified (see Figure 2) (Gorbman and Sower, 2003).
After the isolation of mammalian GnRH in the early 1970’s, two forms of GnRH 
were identified in the chicken in the early 1980’s (Miyamoto et al., 1982; Miyamoto et al.,
1984), at which time it was believed that only one form of GnRH was expressed within 
any given species, with a few exceptions that where accounted for as they arose, such as 
the lamprey (Sherwood et al., 1986; Sower et al., 1993) and certain teleosts (Bogerd et al., 
1994; White and Femald, 1998; White et al., 1995); which generally were thought of as 
unique non-mammalian variants. In time and in light of developing research powered by 
molecular biology, numerous sequences were cloned, most notably the cDNA encoding
3
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Vertebrate 1 2 3 4 5 £ 7 8 9 10
Mammal pGlu His T ip Ser Tvr Q v Leu A ig Pro d v N ffi
Guinea Pig pGlu Tsr T ip Ser Tvr Glv Viil Arg Pro dvNH2
Chicken - 1 pGlu His T ip Ser Tvr cav Leu d l l Pro dvNHZ
Ran a pGlu His T ip Ser Tvr Glv Leu T ip Pro dvNH2
Seabream p d u His T ip Ser Tvr Glv Leu Ser Pro dvNH2
Salmon pGlu His T ip Ser Tvr Glv T*? Leu Pro dvNH2
Medaka pGlu His T ip Ser Phe Glv Leu Sei Pro dvNH2
Catfish pGlu His T ip Ser Hi* Glv Leu Asn Pro dvNH2
Herring pGlu His T ip Ser Ms Glv Len Ser Pro dvNH2
Chicken -II pGlu His T ip Ser Ms Glv T rP Tyr Pro dvNH2
Dogfish pGlu His T ip Ser His Glv T ip Leu Pro dvNH2
Lamprey - III pGlu IDs T ip Ser Ms Asp Tip Lvs Pro dvNH2
Lamprey - 1 pGlu m s 1 st Ser d u Trp Lvs Pro dvNH2
Wliitefish pGlu m s T ip Ser Tvr d v Met As li Pro dvNH2
Invertebrate 1 2 3 4 5 6 - 8 I 10
Octopus PGlu A s n Tvr m s Phe Ser As n d v Tl? m s Pro dyNH2
Tunicate - 1 pGlu m s T ip Ser Asp Tvr Phe Lvs Pro dvNH2
Tunicate - II pGlu m s T ip Ser Leu ( u m s .Ala Pro dvNH2
Tmiicate-III pGlu m s T ip Ser Tvr d u Phe Met Pro dvNH2
Tunica te lV pGlu m s T ip Ser A m i d n Leu Tlir Pro dvNH2
Timicate-V pGlu m s T ip Ser Tvr i i i Tit Met Pro dvNH2
Tiuucate-'VT p d u m s T ip Ser Lvs d v T>t Her Pro dvNH2
Timieate-VH p d u m s T ip Ser Tvr Ala Leu Ser Pro dvNH2
Tunicate-VHI p d u m s T ip Ser Leu Ala Leu Ser Pro dvNH2
Tunicate-K p d u m s Trp Ser A m i I.SS Leu Ala Pro dvNH2
Figure 2. GnRH Family o f Peptides. To date, 24 different forms o f GnRH have been identified, which 
are named after the species from which they were first discovered. 14 Forms have been identified from 
vertebrates, and 10 from invertebrates. Highlighted residues indicated variation relative to mammalian 
GnRH. All forms, except from the octopus, are decapeptides with highly conserved N- and C-termini and 
Ser4. Image design by Scott I. Kavanaugh.
chicken GnRH-II from shrew, human and monkey (Kasten et al., 1996; Urbanski et al., 
1999; White et al., 1998), which led to the general conclusion that species expressing 
multiple forms of brain GnRH is common, with few exceptions (i.e. rat and mouse only 
express mammalian GnRH) (Silver et al., 2004). Within these multiple-GnRH 
expressing species, typically one form is hypothalamic and regulates the pituitary- 
gonadal axis, while the others are non-hypothalamic in expression and operate in some 
neuromodulatory function.
4
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The hypothalamic form of GnRH is expressed in the preoptic-anterior 
hypothalamic region of the diencephalon (mammalian GnRH in all tetrapods except 
guinea pig (guinea pig GnRH) and bullfrog (rana GnRH); variable forms in fish including 
mammalian GnRH, sea bream GnRH, herring GnRH, whitefish GnRH, medaka GnRH, 
salmon GnRH and dogfish GnRH; and lamprey GnRH-I and -III in lamprey) (Femald 
and White, 1999; Parhar, 2002). In tetrapods, these GnRH expressing neurons have 
axons that extend caudally and impinge and synapse on the median eminence, a neural- 
hemal organ, which is a portal blood vessel that is fed by the superior hypophysial artery 
and runs from the hypothalamus to the adenohypophysis (anterior pituitary). At the level 
of the adenohypophysis, GnRH diffuses through fenestrations in the capillary bed and 
interacts with gonadotropes via a specific 7-transmembrane G-protein coupled receptor 
(which is described in detail bellow) (Millar et al., 2004; Sealfon et al., 1997). This 
delivery system and hypothalamic GnRH distribution pattern [at a superficial level] has 
remained conserved within the tetrapod lineage (Nozaki et al., 1994). The Agnathan 
(lamprey and hagfish) and teleost (a radiation of the osteichthyes) hypothalamic GnRH 
system is highly conserved, however their mechanisms of delivery to the 
adenohypophysis are unique since neither group has a median eminence. Teleost have 
adapted to the lack o f the portal system via neurohypophysial axon extension and 
penetration of the pituitary, creating a direct intervention (Kah et al., 1986; Peter et al.,
1990). In lamprey, GnRH is released from the hypothalamus and diffuses through a thin 
layer of epithelial glandular cells, to the pituitary (Nozaki et al., 1994).
The second form of GnRH, chicken GnRH-II, is the most ubiquitously expressed 
form, which has been identified in all classes of vertebrates except Agnatha (Femald and
5
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White, 1999; Parhar, 2002). The sequence of chicken GnRH-II has remained unchanged 
throughout vertebrate evolution from cartilaginous fish through mammals, which would 
suggest a strong selective pressure, however its function is, to this date, rather ambiguous 
(Millar et al., 2004). The expression pattern of chicken GnRH-II varies drastically from 
species to species, but generally is expressed in the midbrain and numerous peripheral 
tissues (Parhar, 2002). For example, chicken GnRH-II is only expressed in the midbrain 
and testis of Haplochromis burtoni (White and Fernald, 1998), while it is expressed in the 
brain, testi, gonad, kidney, liver, pancreas, stomach, intestine, heart, lung, parathyroid, 
thymus and spleen of the leopard gecko (Ikemoto and Park, 2003). The function of 
chicken GnRH-II in peripheral tissues is largely unknown, but is thought to function in a 
paracrine/autocrine fashion. As a neuromodulator, chicken GnRH-II has been shown to 
be involved in behavior and possibly as a link between energy state and reproduction.
For example, in poecilid (live bearing) fish, neurons that regulate sperm duct and oviduct 
contraction are impinged on by chicken GnRH-II immunoreactive cells located in the 
midbrain (Miller and Kriebel, 1986), and in newts, during courtship activity, chicken 
GnRH-II immunoreactivity relocates from midbrain soma to their axons (Kasten et al., 
1996; Muske and Lancaster, 1993). In a few cases chicken GnRH-II has been detected 
in the median eminence, which suggests that, in these species, it may have some 
pituitary-gonadal axis regulatory function. In the goldfish, chicken GnRH-II 
immunoreactivity was detected in the median eminence and pituitary (Rosenblum et al., 
1994), while in the chicken and quail immunoreactivity in the median eminence was 
detected, and sequence verification was performed by peptide sequencing using mass 
spectrometry (Clerens et al., 2003; van Gils et al., 1993). Interestingly, in mammals,
6
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chicken GnRH-II has been cloned from the tree-shrew (Kasten et al., 1996), monkey 
(Urbanski et al., 1999), and human (White et al., 1998), but has not been identified in the 
rat or mouse. Additionally, the chimp chicken GnRH-II gene is considered a pseudogene 
due to a premature stop codon, and the human chicken GnRH-II gene polyadenylation 
sequence lies in-frame prior to the stop codon, which suggests the possibility of an 
unstable mRNA population (Morgan and Millar, 2004). Taken together, these data could 
be used to infer an optimization of the GnRH system has occurred, whereas the function 
of chicken GnRH-II may no longer be useful in more derived tetrapods (Morgan and 
Millar, 2004).
A third population of GnRH neurons exists in the teleost radiation of the 
osteichthyes, which in all species identified to date is salmon GnRH (Femald and White, 
1999; Parhar, 2002). Like chicken GnRH-II, salmon GnRH is generally extra- 
hypothalamic and is neuromodulatory in function. Although salmon GnRH is expressed 
in the hypothalamus and regulates the pituitary-gonadal axis in goldfish (Parhar, 2002), in 
most cases it is expressed in the ventral telencephalon/terminal nerve region of the brain 
(Femald and White, 1999; Parhar, 2002). The extrahypothalamic function of salmon 
GnRH is not understood, however it is believed, like chicken GnRH-II, to function in 
reproductive behavior (for example nest building). Since salmon GnRH is only found in 
teleosts, it is thought to be lineage specific, although whether its gene arose prior to the 
teleosts or early in the teleost lineage is unknown (Okubo and Aida, 2001; Okubo et al., 
1999).
7
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GnRH Development: Embryonic Origin and Cellular Migration
The development of the GnRH system in vertebrates from fish to mammals has remained 
highly conserved (Muske, 1993; Parhar, 2002; Tobet et al., 2001). As to be expected 
based on the three different GnRH populations described above, there are three different 
major embryonic origins and migratory pathways that are seen in vertebrates. The 
migration of the hypothalamic GnRH producing neurons begins in the olfactory placode 
in the nasal cavity, migrates through the cribiform plate and finally rests in the preoptic 
anterior hypothalamus, where axons extend to the median eminence (Muske and Moore, 
1988; Schwanzel-Fukuda and Pfaff, 1989; Tobet et al., 2001; Wray et al., 1989). As a 
note, the olfactory placode is a thickening of the ectoderm that develops as a result of cell 
division during the formation of the neural tube. The olfactory placodes develop into the 
primarily sensory neurons, support cells and basal cells of the olfactory system (Whitlock, 
2004). The cues involved in this migration of the hypothalamic GnRH producing 
neurons have been investigated in many different species, however the exact nature of 
this process has not been fully described due to the complexity of the system, which is a 
result of the appearance of subsets of populations that results from differences in cell 
surface molecule expression (Tobet et al., 2001). The factors involved in this migration 
can be divided into two main categories, including components that interact at the cell 
surface (for example neural cell adhesion molecules (NCAM) and nasal embryonic 
luteinizing hormone-releasing hormone factor (NELF)) and informational molecules 
(GABA, peptide hormones) (Dellovade et al., 2001; Tobet et al., 2001; Wray, 2002). The 
olfactory placodal origin of the hypothalamic GnRH producing neurons was initially 
described based on ICC studies of mice (Schwanzel-Fukuda and Pfaff, 1989; Wray et al.,
8
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1989) and amphibians (Muske and Moore, 1988) during embryonic development. When 
the olfactory placode is removed from the axolotl (amphibian) embryo for example, the 
adult does not produce hypothalamic GnRH, as examined by immunocytochemical 
analysis (Northcutt and Muske, 1994). Additional support of the olfactory origin of 
hypothalamic GnRH neurons hypothesis came from Kallmann syndrome research, which 
is characterized by anosmia and hypogonadotropic-hypogonadism (Rugarli, 1999; 
Schwanzel-Fukuda et al., 1989). Kallmann syndrome is caused by a genetic mutation in 
the Kal-1 gene, which encodes the extracellular matrix protein anosmin-1 (Legouis et al.,
1991), and is necessary for olfactory bulb development (MacColl et al., 2002; 
Schwanzel-Fukuda et al., 1989). This link between olfactory function and GnRH 
ontogeny in Kallmann syndrome is considered a hallmark discovery and a proof of 
principle, however there is emerging data indicating alternative developmental schemes 
in certain vertebrates (Parhar, 2002; Parhar et al., 1998; Whitlock et al., 2003). First, the 
hypothalamic GnRH producing neurons in zebra fish were shown to originate in the 
adenohypophyseal regions of the anterior neural plate, which is flanked by the olfactory 
placode (Whitlock et al., 2003). Secondly, the origin of the hypothalamic GnRH 
producing neurons in seabream and medaka lies in the basal diencephalon, which notably 
is similar to the origin of the cells producing the hypothalamic GnRHs in the lamprey, 
which arise from the proliferative zones of the diencephalon (Tobet et al., 1995; Tobet et 
al., 1997). Additional investigation into the origin and migration of hypothalamic GnRH 
producing neurons from basal vertebrates, such as hagfish, and more derived vertebrates, 
such as mice, is needed in order to accurately describe this developmental process.
9
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The development and migration of the cells producing the neuromodulatory 
GnRHs, chicken GnRH-II in the midbrain and salmon GnRH in the ventral telencephalon 
of the advanced teleosts, have been investigated, however the mechanisms regulating 
these processes are not as well understood compared to their hypothalamic GnRH neuron 
counterpart. Chicken GnRH-II producing neurons originate in the midbrain, not the 
olfactory placode, which was demonstrated in the aforementioned study by Northcutt and 
Muske. The ablation of the olfactory placode in axolotl abolished hypothalamic GnRH 
expression, but had no effect on chicken GnRH-II expression in the midbrain (Northcutt 
and Muske, 1994). In advanced teleosts, such as the seabream and medaka, the nucleus 
olfactoretinalis, which lies at the olfactory bulb/telencephalon junction, expression of 
salmon GnRH, which is distinct from the hypothalamic GnRH producing neurons, arises 
in the olfactory placode during early development (Parhar, 2002; Parhar et al., 1998). 
These two GnRH populations, as inferred based on the work of Whitlock’s group, likely 
ultimately arose from the cranial neural crest.
Phytogeny of the GnRH Family
A proposed relationship of the GnRH family was recently described based on 
phylogenetic analysis, location of expression within the brain and general associated 
function (Femald and White, 1999) (Figure 3). In this model, the GnRH family was 
divided into three paralogous lineages. GnRH-I (also known as mammalian GnRH and 
its orthologs) is expressed in the hypothalamus and is the central regulator of the pituitary 
gonadal axis. GnRH-II (also known as chicken GnRH-II) is expressed in the midbrain 
and is generally considered to have a neuromodulatory function
10
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The Four Lineages of GnRH
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Figure 3. The Lineages of GnRH. The GnRH family is divided into four paralgous lineages based on 
phylogenetic analysis, location o f expression within the brain and function. Modified from Gorbman and 
Sower,2003 and Silver et al., 2004.
(Femald and White, 1999; Parhar, 2002). Finally, GnRH-III (or salmon GnRH), which is 
only found in the teleosts, is expressed in the telencephalon and is also believed to have a 
neuromodulatory function (Femald and White, 1999; Parhar, 2002). Parhar recently 
modified this scheme by the addition of a fourth family that consists of medaka and 
seabream GnRH, which formerly would have been considered GnRH-I (Parhar, 2002). 
This modification is supported by the fact that the cells producing medaka and seabream 
GnRH do not share the same developmental origin as the other hypothalamic forms,
11
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although they do function in a similar manner and group together phylogenetically.
These models that describe the molecular phylogeny of the GnRH family are incomplete 
since only a limited number of the known GnRH sequences were used in these analyses. 
Based on my thesis research (Chapter II; (Silver et al., 2004)), we have proposed a new 
scheme, in which our phylogenetic analysis confirms Femald and White’s division of the 
GnRH family, but shows the medaka and seabream forms of GnRH grouping with the 
type I GnRHs, which conflicts with Parhar’s model. Additionally the lamprey GnRH 
forms group together separately from the three previously described lineages o f GnRH, 
and as such we suggest that they, and not medaka and seabream GnRH, form the 4th 
lineage of GnRH (See Table 3). Our assertion is based directly on our phylogenetic 
analysis, which is supported by immunocytochemical and functional data on lamprey 
GnRH (Deragon et ah, 1994; Nozaki et ah, 2000). These schemes will ultimately need to 
be revised when additional sequence, function and expression data are available.
GnRH: From Mature Peptide to Gene
Consistent with other neuropeptides, GnRH is synthesized as part of a larger protein 
precursor, prepro-GnRH, which upon post-translational modification yields the mature 
decapeptide (Klungland et ah, 1992). Prepro-GnRH consists of a tripartite structure, 
including a N-terminal hydrophobic signal domain, followed by the mature decapeptide 
sequence and the Gly-Lys-Arg dibasic cleavage site, and finally the C-terminal GnRH 
associated peptide (GAP) (Figure 4). The functional significance of the tripartite 
structure relates to intracellular trafficking and processing. The signal peptide is essential 
for entry of the prepro-hormone into the endoplasmic reticulum (ER) during the
12
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Figure 4. GnRH Gene and cDNA Structures. The conserved GnRH gene configuration consists o f  4 
exons and 3 introns. Exon 1 encodes the 5’ UTR, exon 2 encodes the signal peptide, mature decapeptide 
and N-terminal end o f the GAP, Exon 3 encodes the central region o f the GAP while Exon 4 encodes the 
C-terminal end o f the GAP and the 3’ UTR.
translational process via its interaction with the signal recognition particle (SRP). The 
SRP then docks to the surface of the ER and the prepro-hormone is funneled into the 
lumen. The significance of the GAP region is less well understood, and may simply exist 
to provide the necessary length to bridge the space between the SRP and the ER surface, 
which was shown to require a minimum of 50 amino acids (Dores et al., 1996; Wolin and 
Walter, 1993). The extremely low amino acid sequence conservation of the GAP across 
vertebrates would suggest that there are no specific functional constraints, however it has 
been shown to be released with the mature GnRH decapeptide and to have some LH,
FSH and prolactin regulatory properties in rat pituitary cell cultures (Nikolics et al.,
1985).
In vertebrates, the conserved GnRH gene structure is composed of four exons, 
with three introns, which produces a mature mRNA that encodes the prepro-GnRH (see
13
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Figure 4) (Femald and White, 1999). The first exon encodes the 5’-untranslated region 
(UTR), the second exon encodes the signal peptide, GnRH decapeptide with dibasic 
cleavage site and the N-terminal portion of the GAP. The third exon encodes the middle 
potion of the GAP while the fourth exon encodes the C-terminal portion of the GAP and 
the 3’-UTR. The major difference seen between different GnRH genes lies within the 
size of the introns, which can range from between a few hundred bases to a few thousand 
bases (Femald and White, 1999). Based on the high level of conservation of the GnRH 
gene organization, which has been described across vertebrates from lamprey (Suzuki et 
al., 2000) to humans (Adelman et al., 1986; Hayflick et al., 1989) it is likely that this 
organization represents the ancestral structure.
The upstream regulatory elements o f the GnRH gene have been identified in a 
limited number of species, and have been characterized in the greatest detail in human 
(Belsham and Mellon, 2000; Kepa et al., 1996; Wolfe et al., 2002b), mouse (Givens et al., 
2004; Lawson et al., 2002), and rat (Whyte et al., 1995). The GnRH gene has been 
shown to be regulated through both a promoter region, -173 to +1, and enhancer region - 
1863 to -1571 (Lawson et al., 2002), while more recently, using a phylogenetic 
footprinting analysis, Givens et. al. identified a conserved enhancer region, at ~3500 bp 
upstream of the transcriptional start site (Givens et al., 2004). This upstream enhancer 
was shown to contain nine Octamer-binding transcription factor 1 (Oct-1) binding sites as 
well as nuclear factor 1 (NF-1) binding sites, both of which have been previously shown 
to regulate GnRH expression (Belsham and Mellon, 2000; Wolfe et al., 2002b). Analysis 
of mature GnRH cells (GT1) transfected with luciferase reporter constructs containing 
variations of the mouse 5’ GnRH gene regulatory sequence indicated that the promoter,
14
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enhancer and upstream enhancer are all required for efficient GnRH expression, and that 
Oct-1 and NF1 interaction is also necessary for activation of transcription (Givens et al., 
2004). The human GnRH gene regulatory region has also been shown to contain Bm-2 
binding sites, in addition to Oct-1 binding sites, within a promoter region located -992 to 
-795 bases upstream of the transcriptional start site, which are necessary for GnRH 
neuron specific expression, as demonstrated using transgenic mouse lines (Wolfe et al., 
2002a). Additional information is needed in order to identify, with more detail, all of the 
promoter/enhancer regions involved in GnRH transcriptional regulation, which would 
require sequencing and analysis of 5’ sequences from representatives of all classes of 
vertebrates.
GnRH Neuron Regulation
Numerous internal and external factors are involved in the control o f GnRH synthesis and 
secretion, which operate at all levels of cellular function including gene expression, 
transcript processing, prepro-peptide metabolism, vesicular packaging and release 
(Givens et al., 2004; Lawson et al., 2002; Martinez de la Escalera and Clapp, 2001; 
Wetsel et al., 1991; Wolfe et al., 2002b) (see Figure 5). Both in vivo (examples such as 
fish, rat and rabbit) and in vitro (immortalized cell lines such as GT1 (Mellon et al.,
1990)) systems have been developed in order to probe these mechanisms. These 
experimental systems have provided invaluable insight into the physiology of GnRH 
neurons, despite their respective shortcomings. GnRH neurons receive input from a 
variety of sources, including amines, peptide hormones and gonadal steroids, which are 
thought to, in part, lead to the pulsatile nature of GnRH release (Martinez de la Escalera
15
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F ig u re  5. G n R H  N eu ro n  R egu la tion . GnRH neurons are regulated by several factors. The nature o f  the 
input for each  com ponent is variable betw een different reproductive states and species. NPY, neuropeptide 
Y; G A BA , y-am inobutyric acid; E2, 17-p estradiol; DA, dopam ine; NE, norepinephrine; T, testosterone; 
G lu, glutam ate.
and Clapp, 2001). The exact nature of the effect of the aforementioned signals is fairly 
well described (i.e. functioning through an inhibitory or excitatory post-synaptic potential 
(IPSP or EPSP), or through cellular modulation), however due to the complexity of these 
systems and the variations seen between different species, a single overriding model has 
yet to be established.
Regulation of GnRH neurons by amino acid or amine derivative neurotransmitters 
such gamma-amino butyric acid (GABA), glutamate (GLU), norepinephrine (NE), and 
dopamine (DA) has been well documented (Jennes and Conn, 2002; Levine, 1997). 
GABA, the primary inhibitory neurotransmitter of the central nervous system, has been 
shown to regulate the HPG axis in representative species across the vertebrate line
16
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(Anglade et al., 1999; Root et al., 2004). The exact nature of the effect of GABAergic 
innervation is still in question as GABA has been shown to act primarily as a GnRH 
neuron inhibitor (Herbison and Dyer, 1991; Jarry et al., 1995; Terasawa et al., 1999), 
however GABA has been shown to elicit a stimulatory response in the rat embryonic 
(Kusano et al., 1995) and neonatal (Feleder et al., 1996) hypothalamus, in seabream 
preoptic-anterior hypothalamic tissue slices (Senthilkumaran et al., 2001), and in the GT- 
1 cell line (Martinez de la Escalera et al., 1992b; Martinez de la Escalera and Clapp, 
2001). More recently GABA has been shown to increase brain GnRH content in the sea 
lamprey (Root et al., 2004). Similarly, DA and NE have been shown to regulate GnRH 
neurons directly, through the dopamine receptor and a/(3-adrenergic receptor, receptively, 
leading to a variety of experimental results showing both a stimulatory or inhibitory 
response, based on species, laboratory and preparative differences (Kordon et al., 1994; 
Martinez de la Escalera et al., 1992a; Martinez de la Escalera et al., 1992c). Glutamate, 
on the other hand has been definitively shown to stimulate both GnRH secretion and 
increase plasma LH levels (Brann and Mahesh, 1997; Martinez de la Escalera and Clapp, 
2 0 0 1 ), however these effects are thought to be partially indirect due to the apparent 
absence or low level of expression of glutamate receptors in GnRH neurons (Mahesh et 
al., 1999; Martinez de la Escalera and Clapp, 2001). At this time there is no evidence to 
support the idea that one neurotransmitter is the primary regulator of GnRH neurons, but 
rather it is thought that a redundant, multi-neuromodulatory network is in place to 
regulate not only these neurons directly, but also to facilitate modulation through 
coordination of signals from other systems (Jennes and Conn, 2002).
17
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An ever growing number o f peptides have been shown to directly and indirectly 
regulate GnRH neurons, forming the link between reproduction and other physiological 
systems such as stress, energy balance, appetite, and the immune system. The most 
relevant of these peptides include neuropeptide Y (NPY), the opiates, interleukin-1 (IL1) 
and vasoactive intestinal polypeptide (VIP) (Jennes and Conn, 2002; Levine, 1997; Pau 
and Spies, 1997; Plant and Shahab, 2002). The role of NPY on GnRH regulation has 
been investigated extensively, and has been shown to stimulate or inhibit GnRH neurons 
in a wide range of vertebrates, depending on the particular network that is activated, i.e. 
innervating GnRH neurons directly (axo-somal or axo-axonal) or indirectly (through 
GABAergic neurons) and which NPY receptor subtype is involved (Y1-Y5) (Ichimaru et 
al., 2001; Knauf et al., 2001; Sainsbury et al., 2002; Senthilkumaran et al., 2001). In 
primates, intracerebroventricular (ICV) injection of NPY has been shown to suppress 
GnRH release in adults (Kaynard et al., 1990; Plant, 2001), while NPY mRNA levels 
were shown to be inversely related to GnRH synthesis and secretion during the juvenile- 
pubertal transition (El Majdoubi et al., 2000). In goats, ICV injection of NPY was also 
shown to decrease GnRH neurons pulsatility (Ichimaru et al., 2001). Furthermore, it has 
been well established that during periods of starvation, the hypothalamus-pituitary- 
gonadal axis is down regulated, primarily through NPY mediated inhibition of GnRH 
neurons (Wade and Jones, 2004). However, NPY has been shown to stimulate GnRH 
mediate LH release in rats (Crowley et al., 1987), and GnRH release in seabream 
hypothalamic tissue sections (Senthilkumaran et al., 2001), while arcuate nucleus NPY 
mRNA levels have been shown to increase just prior to the LH surge (Jennes and Conn, 
2002; Sahu et al., 1994), illustrating a possible stimulatory effect on the GnRH system.
18
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What is unknown, and therefore confounding, is in which of these studies NPY is acting 
directly or indirectly and through which receptor. It is likely that NPY acts through a 
variety of different mechanisms, which impart this differential response. For example 
NPY may act via inhibition of GABAergic neurons that innervate GnRH neurons, 
thereby inhibiting an inhibitor, and stimulating a response. Alternatively, NPY may 
deliver an IPSP through Yx receptors at an axon terminal of a GnRH neuron (Knauf et al., 
2001; Sainsbury et al., 2002). During these times it is clearly beneficial to the individual 
to focus energy on survival, and therefore shut down non-essential systems, such as 
reproduction. The hormones involved in these systems, interleukin-1 and the opiates 
(endorphins and enkephalins) have been shown to inhibit GnRH production and release 
both directly and indirectly (Jennes and Conn, 2002).
Not surprisingly, the role of sex steroids on GnRH neurons depends on species 
dependant physiological variations and the temporally dependent hormonal milieu 
(Hrabovszky et al., 2000; Moenter et al., 2003; Skynner et al., 1999). For example, 17P- 
estradiol (E2) is known to have an inhibitory effect on both the pituitary and 
hypothalamus, however it is also the trigger driving the pre-ovulatory GnRH, and hence 
LH, surge, which drives ovulation (Shirley et al., 1968). The failure of early attempts to 
identify estrogen receptors within GnRH neurons (Herbison and Theodosis, 1992; Navas 
et al., 1995) led to the hypothesis that E2 regulation of GnRH neurons occurs indirectly, 
for example through modulation of GABAergic or dopaminergic pathways. Recently, 
through mRNA cloning and immunocytochemistry, estrogen receptors have been 
identified in mouse and rat GnRH neurons (Hrabovszky et al., 2000; Skynner et al., 1999) 
and in GT1 cells (Butler et al., 1999; Roy et al., 1999), indicating E2 may assert its
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function, in part, directly. E2 has been shown to function through a variety of 
mechanisms, including pulse frequency alteration, transcriptional activation/inhibition, 
sensitization and ion flux (Kelly et al., 2003; Moenter et al., 2003; Temple et al., 2004). 
Progesterone has also been shown to influence GnRH neuron activity directly in some 
cases, however less is known about the mechanisms involved, and progesterone receptors 
have only been seen in a limited number of GnRH neurons (King et al., 1995; Skinner et 
al., 2001). Androgens and glucocorticoids have been shown to regulate GnRH neurons, 
however far less attention has been given to the description of these mechanisms. In vitro 
analysis has shown that both testosterone and glucocorticoids decrease GnRH 
transcription and secretion in GT1 cells (Attardi et al., 1997; Belsham et al., 1998; 
Chandran et al., 1994). In teleosts, treatment with testosterone in a variety of species 
including salmonids and cichlids has been shown to both increase and decrease brain 
GnRH immunoreactivity (Francis et al., 1993; Grober et al., 1991), which is difficult to 
interpret, as it suggests either an inhibitory or stimulatory response. Steroid hormone 
regulation of GnRH neurons is heavily intertwined with other neuromodulatory systems 
and is therefore a complicated system to model, however recent research has led to the 
dissection of this system including the isolation and description of these vastly different 
mechanisms of action, from the traditional theory of steroid action through modulation of 
gene expression to the more recent observations o f fast acting membrane associated 
steroid receptors.
Clearly GnRH neurons are highly regulated through a diverse set of pathways, 
which reflects the importance of proper interaction between the hypothalamus, pituitary 
and gonads. It is no surprise considering the central location of reproduction in selective
20
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
pressure and evolution; a species will be unfit despite any advantage, given a faulty 
reproductive axis. Proper maintenance of GnRH neuron function and coordination with 
the other physiological systems is absolutely necessary for a species to reproduce, and 
therefore propagate.
Clinical Application of GnRH and its Analogs
The clinical application of GnRH analogs as therapeutic drugs generates over 2 billion 
dollars per year in sales, most notably in the treatment of sex steroid driven cancers such 
as certain prostate and breast cancers; hence there is considerable interest in the function 
of each residue in the GnRH so that analogs can be designed with maximum efficiency as 
agonists or antagonists to the GnRH receptor to be used as drugs (Millar et al., 2000).
The structure of the functional conformation of the GnRH decapeptide was first described 
as a p-tum using NMR in the 1970’s (Deslauriers et al., 1975; Smith et al., 1973), and 
later using knowledge based computer modeling (Gupta et al., 1993). In order to 
determine the function of the ten residues in GnRH, thousands of analogs have been 
constructed and tested for pharmacological divergence (Karten and Rivier, 1986; Sealfon 
et al., 1997). This information has been used to construct a knowledge base to identify 
functional characteristics of each residue with respect to the mammalian GnRH 
decapeptides interaction with its receptor. It is understood that there are a number of 
complicating factors involved in trying to apply the results from the analogs 
pharmacological profiles to describe the function of the ten residues in the GnRH 
(Sealfon et al., 1997). For example, it is difficult to determine whether an altered residue 
is affecting the binding of the analog or its ability to activate the receptor. Furthermore, 
the change could alter the structure of the peptide thereby changing the three dimensional
21
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orientation of functional groups from other residues that are involved in receptor 
interaction, although, the altered conformation could possibly facilitate new contact sites 
that could compensate and mask the effect of the altered residue. With these drawbacks 
in mind, Sealfon et al. in 1997 described the role of each residue of the GnRH 
decapeptide (see Figure 6 ). The general conclusions that they made were that there was 
no single amino acid that is critical for GnRH activity, although the amino and carboxyl 
terminal domains are predominantly involved in receptor binding, and the amino terminal 
residues function in the activation of the receptor. The 6 th position is important in the 
folding of the peptide, while the function of the 8 th position is most likely to confer 
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F ig u re  6. F u n c tio n  o f  M a m m a lia n  G n R H  R esidues. The function o f  each residue o f  m G nR H  has been  
analyzed using analogs and com puter modeling. This figure w as adapted from  Sealfon et al., 1997.
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Gonadotropin-Releasing Hormone Receptor
The GnRH receptor is a member of the class A, or rhodopsin-like subfamily of the 7- 
transmembrane G-protein coupled receptor (GPCR) super family (Millar et al., 2004; 
Sealfon et al., 1997). The three families of GPCRs: the class A receptors, metatropic 
glutamate receptors and secretin-calcitonin-PTH receptors, are all seven transmembrane 
proteins, however they do not share an apparent global sequence identity (Sealfon et al., 
1997). The basic GPCR structure consists of seven hydrophobic a-helical 
transmembrane domains, which are connected by intra- and extracellular loops with an 
extracellular N-terminal domain and an intracellular C-terminal tail (See Figure 7). 
Members of the class A family of GPCRs, such as the GnRH receptor family, are 
identified through several conserved amino acid motifs within the transmembrane 
domains, including an N in position 21 of transmembrane I, a D in position 11 in 
transmembrane II, a DRY motif in the basal region of transmembrane III, a W in position 
12 of transmembrane IV, a P in position 16 in transmembrane V, a CWXP motif in the 
middle of transmembrane VI and an NPXXY motif in the basal portion of 
transmembrane VII (Millar et al., 2004; Sealfon et al., 1997). The GnRH receptors have 
several unique variations relative to other Class A GPCRs; most notably, the type I 
GnRH receptors, found in certain mammals, lack a C-terminal tail, which is found in all 
other known GPCRs (the human genome encodes approximately 1000 GPCRs 
(Fredriksson et al., 2003)). The functional significance of this “natural mutation” is 
relevant to both GPCR evolution and reproductive medicine since the C-terminal tail 
plays an important role in cell signaling, ligand dependant internalization 
(desensitization) and cell surface expression (Blomenrohr et al., 1999; Heding et al.,
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1998; Heding et al., 2000; Hislop et al., 2001; Lin et al., 1998; McArdle et al., 2002; 
Pawson et al., 1998; Pawson et al., 2003; Vrecl et al., 2000; Willars et al., 2001). Also of 
importance are the conserved D in transmembrane II and N in transmembrane VII, which 
are thought to interact in the membrane and are necessary for receptor function. These 
regions have undergone a reciprocal mutation in the type I GnRH receptors, however 
they are both D’s in type II GnRH receptors (Sealfon et al., 1997).
The first GnRH receptor was cloned from a mouse cDNA library (Reinhart et al., 
1992; Tsutsumi et al., 1992), shortly after which the human GnRH receptor was cloned 
(Chi et al., 1993; Kakar et al., 1992), both of which lacked a C-terminal tail (referred to 
as tail-less). GnRH receptors from rat (Eidne et al., 1992), sheep (Campion et al., 1996; 
Illing et al., 1993) and pig (Weesner and Matteri, 1994), which are also tail-less, were 
cloned over the next several years, giving rise to the belief that all GnRH receptors lack
24
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C-terminal tails. In 1997 the first non-mammalian GnRH receptor was cloned from the 
catfish, which encoded a protein with the conserved GPCR structure including a C- 
terminal tail (Tensen et al., 1997). Since this time, over 36 GnRH receptors have been 
cloned, from which only 11 forms, all mammalian, lack the C-terminal tail (Millar et al., 
2004).
Based simply on the gross structural distinction of tailed or tail-less, the GnRH 
receptors can be divided into two basic sub-groups: the type I receptors, which lack C- 
terminal tails and have only been found in mammals, and the type II receptors, which 
contain C-terminal tails and have been found across vertebrates (mammal and non­
mammal species). An analysis o f the phylogeny of the GnRH receptor family by Troskie 
et al in 1998 was performed based on conserved structural motifs in the third 
extracellular loop (Troskie et al., 1998). GnRH receptors with the conserved 
PXML/IXXXXE/D sequence motif, including the mammalian tail-less receptors and 
some teleost tailed receptors, were classified as subtypes la and lb. Alternatively, 
receptors with the conserved PEMLTXXVRRXLSHIL sequence motif in extracellular 
loop 3 were classified as type II (Troskie et al., 1998). A more robust analysis was 
presented by Okubo et al., in which the full amino acid sequence of the known GnRH 
receptors and intron structure o f the type I and type II division was suggested to correlate 
with the presence or absence of the C-terminal tail (Okubo et al., 2001). Later, Millar et 
al,. suggested yet another classification based on the phylogenetic analysis of the full 
length receptor sequences, in which the family was divided into 3 groups, which mixed 
tailed and tail-less receptors together (Millar et al., 2004). More recently, a phylogenetic 
analysis of nearly all known GnRH receptor amino acid sequences, including
25
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
representation from the agnathans, produced trees divided into three major clades, which 
represent two main groupings divided based on the presence or absence of a C-terminal 
tail (Silver et al., 2005), which agrees well with Troskie et al., and Okubo et al.. 
Ultimately, this naming and grouping system has become overly complicated, and likely 
inaccurate, and therefore, until more sequence information is available the most 
reasonable classification would likely come from the simple division based on 
phylogenetic analysis and the presence or absence of the C-terminal tail.
Vertebrates Express multiple GnRH receptors
Like the GnRH peptide system, it has now been established that most vertebrate species 
express multiple GnRH receptors. This concept was first confirmed by the identification 
of two GnRH receptors from the goldfish, termed goldfish GnRH receptor-a and GnRH 
receptor-b (Illing et al., 1999). Both receptors were shown to have a similar 
pharmacological profile, and were both shown to be expressed in the pituitary and brain, 
while only GnRH receptor-a was expressed in the ovary and liver. In 2001, Wang et al., 
described the cloning of three distinct GnRH receptors in the bullfrog, o f which only 
bullfrog GnRH receptor-1 was shown to be expressed in the pituitary, while bullfrog 
GnRH receptor-2 and -3 were expressed in the brain (Wang et al., 2001). To date, 
multiple GnRH receptors have been identified in numerous species, including, as 
examples, two forms in the catfish (Bogerd et al., 2002; Tensen et al., 1997), three forms 
in the medaka (Okubo et al., 2003; Okubo et al., 2001), five forms in the salmon (Jodo et 
al., 2003), European sea bass (Moncaut et al., 2005), while only two forms have been
26
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
identified in monkey (Neill et al., 2001; Santra et al., 2000) and human (Chi et al., 1993; 
Millar etal., 1999).
The location of expression of the GnRH receptors varies widely among receptor 
subtypes and species. Unlike the GnRH peptide family, the GnRH receptors cannot be to 
this date divided neatly based on phylogenetic grouping, function or location of 
expression. The GnRH receptor is primarily expressed in the pituitary, where it functions 
in the regulation of the reproductive axis. Extra-pituitary GnRH receptor expression is 
typical, however to what extent and for what function varies from species to species, and 
is not currently well understood (Millar et al., 2004). However, it is thought that the type 
II GnRH receptors are more widely expressed than the type I receptors. For example, in 
primates, using a human tissue array, human type II GnRH receptor RNA was shown to 
be expressed in 2 1  different tissues, including the brain, pituitary, heart, stomach, spleen, 
ovary and testis (Neill et al., 2001) [NOTE the function of the human type II GnRH 
receptor is still in debate (Faurholm et al., 2001; Morgan and Millar, 2004)]. Conversely, 
the human type I GnRH receptor is expressed in the pituitary, liver, heart and kidney 
(Kakar and Jennes, 1995), while the guinea pig type I GnRH receptor was only shown to 
be expressed in the pituitary with no detectable transcript in the brain, spinal cord, heart, 
liver, kidney, adrenal gland, spleen, lung, thyroid gland, epididymis or ovary (Fujii et al.,
2004). Less data has been collected in reptiles, where transcriptional analysis using RT- 
PCR in Xenopus indicates expression of the type II GnRH receptor is confined to the 
pituitary and hind brain, however no expression was detected in the forebrain, kidney, 
liver, heart or testis (Troskie et al., 2000). Bullfrogs express three distinct GnRH receptor 
subtypes; using RT-PCR bullfrog GnRH receptor-1 expression was detected in the
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pituitary and bullfrog GnRH receptor-2 and -3 were detected in the brain (Wang et al., 
2001). In contrast, the type II GnRH receptor from the leopard gecko was shown to be 
expressed in all tissues examine, including the pituitary, brain, eye, male reproductive 
components, female reproductive components, kidney, adrenal gland and liver, based on 
RT-PCR analysis (Ikemoto et al., 2004). There is a wealth of expression data from 
teleost fishes, from which only a few examples will be drawn. In the goldfish, the two 
GnRH receptors that have been identified, goldfish GnRH receptor-a and -b, have both 
been shown to be expressed in the pituitary and brain using in situ hybridization, but only 
goldfish GnRH receptor-a was shown to be expressed in ovary and liver (Illing et al., 
1999). Catfish express two type II GnRH receptors, catfish GnRH receptor-1 and -2, 
which share a similar trend in expression compared to mammals. Catfish GnRH 
receptor-1 , the primary pituitary form, is only expressed outside the pituitary in low 
levels in the brain. Conversely, the primary brain form, catfish GnRH receptor-2 is more 
widely expressed, including testes and ovaries. Five GnRH receptors have been 
identified in the masu salmon (Jodo et al., 2003) and European sea bass (Moncaut et al.,
2005), however no activity data were reported to distinguish the functional receptors 
from possible pseudogenes. In the salmon, all five GnRH receptors are expressed in the 
brain and only three of these receptors were shown to be expressed in the pituitary. 
Additional, GnRH receptors were detected in the kidney, ovary and testis, but not muscle, 
heart, gill or liver. A similar trend was seen in the sea bass. On the other hand, the 
GnRH receptor from the Japanese eel was only shown to be expressed in the brain, 
pituitary and testis (Okubo et al., 2000). Lastly, in the most ancient vertebrates, the 
agnathans, the sea lamprey GnRH receptor is expressed in both the pituitary and testes
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using RT-PCR, while in situ hybridization showed expression and localization of the 
transcript in the proximal pars distalis of the pituitary (Silver et al., 2005). The question 
is what, if anything, does all this expression data mean? Clearly the GnRH receptor is 
functional in a wide variety of tissues, likely regulating various paracrine / autocrine 
functions. The exact nature of these systems has yet to be described in a global sense, or 
in most cases even in each individual local environment. One outstanding interest that 
comes from these observations is that GnRH receptors are expressed in various cancers, 
such as prostate (Limonta et al., 1999), ovary (Emons et al., 1993) and breast (Eidne et al., 
1985) cancers. A better description of how the GnRH receptor functions in extra- 
pituitary environments may provide clues to better understand these cancers and may 
shed light onto new approaches to develop novel therapeutics.
Structure and Regulation of the GnRH Receptor Gene
One potential means to organize the GnRH receptors into subdivisions could be based, in 
part, on gene structure. There have been several different GnRH receptor gene structures 
reported to date, from which several conserved introns have been reported, with several 
unique variations. The typical, perhaps basal gene structure consists of three exons 
divided by two introns located in transmembrane-4 and intracellular loop-3 (See Figure 
8 ) (Millar et al., 2004). GnRH receptor genes with this structure have been identified in 
several vertebrates including human (Fan et al., 1994), mouse (Zhou and Sealfon, 1994), 
sheep (Campion et al., 1996), rat (Reinhart et al., 1997), dog (Cui et al., 2000), Japanese 
eel (Okubo et al., 2000) and medaka (receptor-1) (Okubo et al., 2001). A third intron is 
present in both the medaka GnRH receptor-2 gene and chicken GnRH receptor gene,
29
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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F ig u re  8. G n R H  R ecep to r G ene S tru c tu re . The conserved G nRH  receptor gene structure consists o f  
th ree  exons and tw o introns, located w ithin the coding sequence o f  the 4th transm em brane domain and 3rd 
intracellular loop. Unique intron locations in the N-term inus o f  the coding sequence (*) or within the 5 ’ 
U T R  (**) are demarcated. Region encoding the C-term inal tail is dashed as it is not present in all GnRH 
receptors.
located in the very N-terminus of the open reading frame (Okubo et al., 2001; Sun et al., 
2001), while a similar intron is also located in the -3 or -1 position relative to the start 
codon in Xenopus (Troskie et al., 2000) and trout (Madigou et al., 2002), respectively. 
Recently, the gene structure of the type II GnRH receptor from the gecko was described, 
which contained the conserved introns located in transmembrane-4 and intracellular loop- 
3, however two introns are located in the 5’ untranslated region (Ikemoto et al., 2004). 
The applicability of this information to the description of the molecular evolution of the 
GnRH receptor family has promise, however there is not enough gene sequence data at 
this time to construct a full, robust description. Based on the available information, the 
presence of the third intron may be useful in distinguishing the subdivision of the tailed 
type II GnRH receptors, which may help delineate the difference in function of the multi­
type II GnRH receptor expressing systems.
The cA-acting regulatory elements of the GnRH receptor gene have been 
characterized primarily using the mouse GnRH receptor gene as a model (Albarracin et 
al., 1994; Duval et al., 1997a; Duval et al., 1997b; Kam et al., 2005; McGillivray et al., 
2005; Norwitz et al., 1999a; Norwitz et al., 1999b) (see Figure 9). The 1.2 kb flanking 
region of the GnRH receptor gene was initially shown to contain regulatory elements that 
were involved in gonadotrope specific expression (Albarracin et al., 1994). The 1.2 kb
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AAATTACT TCATTAAG ATATTATG GAATTAGA
\ - /  \  / \  /  \ /
GRAS SURG1 SURG2/AP1 SF1
F ig u re  9. G n R H  R e ce p to r  G ene 5 ’ R eg u la to ry  E le m en ts . Several regulatory elem ents have been 
identified in the G nRH  receptor gene, as show n in this schem atic from the m ouse (M cGillivray et al., 2005). 
GRAS, GnRH receptor activating sequence; SURG, sequence underlying responsiveness to  GnRH; A P I, 
activator protein-1; SF1, steroidogenic factor-1.
promoter region of the GnRH receptor gene was shown to be transcriptionaly active, and 
to have several conserved regulatory elements, including an activator protein 1 (API) 
response element at -274 to -267 relative to the start codon, and a GnRH response 
element like sequence from position -354 to -335 (Albarracin et al., 1994). The region in 
between -492 to -235 of the GnRH receptor gene was shown to be sufficient to confer full 
basal activity, and was shown to not only contain the previously described AP-1 element, 
but an SF-1 binding site and a unique GnRH receptor activating sequence (GRAS) were 
identified between -393 and -330 (Duval et al., 1997b). In 1999, the promoter region was 
re-characterized and was described relative to two sequences underlying responsiveness 
to GnRH, or SURG elements, which were shown to be regulated via PKC and the 
activation of the cFos/cJun heterodimer family (API) (Norwitz et al., 1999a; Norwitz et 
al., 1999b). SURG-2, which contains the AP-1 binding site, is located at -276- to -269,
31
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
while SURG-1, which interacts with nuclear factor Y and Oct-1 is located between -292 
to -285 (Kam et al., 2005; Norwitz et al., 1999a; Norwitz et al., 1999b). Further studies, 
especially using non-mammalian species, will provide insight into the exact mechanisms 
involved in tissue specific expression of the GnRH receptor.
GnRH Receptor Structure
Three dimensional structural information is key to the understanding of receptor function 
as it provides invaluable insight into the mechanisms of ligand interaction and receptor 
activation, however little information is available about GPCR structure to date. The 
seven transmembrane motif was first identified in bacteriorhodopsin using electron 
microscopy (Henderson and Unwin, 1975; Unwin and Henderson, 1975), while more 
recently the crystal structure for rhodopsin was resolved (Palczewski et al., 2000) (See 
Figure 10). Several studies have been performed to determine the relationship between 
structure and function of the GnRH receptor based on sequence conservation analysis, 
and biochemical and biophysical studies (Sealfon et al., 1997); however the actual three 
dimensional structure of the GnRH receptor has not been resolved. A model of the 
mammalian type I GnRH receptor has been proposed based on these studies and the 
projection map of the electron density of rhodopsin (Millar et al., 1999; Sealfon et al., 
1997; Zhou and Sealfon, 1994).
Additional structural elements within the GnRH receptors include glycosylation, 
phosphorylation and disulfide bridging sites (Sealfon et al., 1997). The human, cow, 
sheep and pig GnRH receptors contain two putative glycosylation sites, one in the N- 
terminal domain and one in the first extracellular domain, while the mouse and rat GnRH
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F ig u re  10. B ov ine R hodopsin  C ry s ta l S tru c tu re . Crystal structure o f bovine rhodopsin , looking laterally 
along the m em brane (left) and dow nw ard tow ard the m em brane from the extracellular s id e  (Palczewski et 
al., 2000).
receptors have an additional site in the N-terminal domain (Sealfon et al., 1997). Of 
these sites, the GnRH receptors have only been shown to be glycosylated on the N- 
terminal domain, which is thought to be involved in receptor expression and has been 
shown not to effect the affinity of ligand binding (Hazum and Keinan, 1984; Schvartz 
and Hazum, 1985). Many GPCRs are regulated through phosphorylation o f intracellular 
serine and threonine residues, most particularly located in the C-terminal tail. GnRH 
receptors contain several putative phosphorylation sites, however due to the lack of a C- 
terminal tail in the type I receptors, there is a marked reduction in rapid internalization, 
which is seen in the tailed type II receptors (See below). A conserved disulfide bridge 
between the first and second extracellular loops has been shown to be required for 
receptor stability and ligand binding (Sealfon et al., 1997). The mouse GnRH receptor 
was shown to contain this conserved disulfide bridge, as demonstrated using mutation 
analysis, while the human GnRH receptor may have a second disulfide bridge between 
the N-terminal tail and the second extracellular loop (Sealfon et al., 1997).
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GPCR Activation
Activation of GPCR signaling systems is a complex cascade of events that starts with 
ligand binding to its receptor, which leads to a conformational change that stabilizes the 
interaction between the receptor and a heterotrimeric G-protein. The exact changes in 
GPCR conformation and its mechanism of interaction with G-proteins are still not well 
understood due to the lack of structural data. However, based on the rhodopsin model, it 
is believed that receptor activation may cause a shift in transmembranes 3 and 6 , which 
may result in the proper intracellular conformation for G-protein activation (Sealfon et al.,
1997). The initial theory of receptor activation, referred to as the ternary complex model 
(De Lean et al., 1980) described a system where an agonist was required to activate a 
receptor, which would lead to the activation of a G-protein. Alternatively, as described 
by the two-state model (Samama et al., 1993), the receptor would naturally be in a state 
of equilibrium between the inactive state (R) and active state (R*), and G-proteins could 
only interact with R*. Based on this model, the function of an agonist could be described 
as having a higher affinity for R*, and therefore agonist stabilize the R* conformation, 
and effectively shift the equilibrium to a higher proportion of R* (Samama et al., 1993). 
Receptor activation is likely more complicated and may actually result in multiple active 
state conformations depending on the agonist, which is described by the three-state model 
(Leff et al., 1997). The three state model describes the receptor function as being in the R 
and R* states as well as a possible R** state, which describes how a receptor could 
activate different signaling systems when treated with different agonists, as seen in 
numerous systems, including the pituitary adenylate cyclase-
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Models o f GPCR Activation
Ternary complex model (DeLean et al.. 1980)
CAMP
Two-state model (Samama et al.. 1993)
Three-state model ILeff et al.. 19971
A T P  cAMP
F ig u re  11. M odels o f  G P C R  A ctivation . T hese  schematics represent the three models o f  G PC R 
activation, including the ternary com plex, tw o-state and three-state m odels. R , inactive receptor; R* 
receptor in active state; R** receptor in  alternative active state; AC, adenylate cyclase; PLC, phospholipase 
C.
activating polypeptide receptor (Spengler et al., 1993) and serotonin receptor (Berg et al.,
1998) (See Figure 11).
After GPCR activation, system specific signaling occurs through the activation of 
specific G-proteins. G-proteins are heterotrimeric, consisting of a Ga subunit and a GPy 
subunit. There are 16 different G a subunits, which are grouped into four families: G as, 
which activates adenylate cyclase; Gai, which inhibits adenylate cyclase; G aq, which
35
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
activates phospholipase C; and Gan/13, which activates RhoA, a member of the Ras 
homology family o f small GTPases. Additionally there are five G(3 subunits and 12 Gy 
subunits (Bockaert et al., 2003). Exactly how system specific signaling occurs with such 
a limited number o f G-proteins is currently a topic of intense research. In addition to 
stimulating second messenger production (such as cyclic adenosine monophosphate 
(cAMP) through adenylate cyclase (AC) or idenosine-1,4,5-triphosphate (IP3 ) through 
phospholipase C (PLC)), GPCR and G-protein activation initiates the mitogen activated 
protein kinase (MAP kinase) signaling system as well (Kraus et al., 2001). The MAP 
kinase family consists of four subgroups, including extracellular signal-regulated kinase 
(ERK), Jun N-terminal kinase (JNK), P38 and Big MAP kinase (BMK) (Kraus et al., 
2001). GPCR activation results in MAP kinase activation through several mechanisms. 
For example, activation of Gas leading to cAMP accumulation results in the activation of 
the cAMP dependant protein kinase (PKA), which ultimately results in ERK activation 
(Bimbaumer, 1992). Alternatively, Gaq activation results in the conversion of 
phosphotidyl inositide-4,5-bisphosphate (PIP2) to IP3 and diacyl glycerol (DAG), which 
can link to the MAP kinase cascade in several ways, one of which is through the 
activation of protein kinase C by DAG, which activates pyk2, which in turn leads to the 
activation of ERK (Kraus et al., 2001). This multiplicity of GPCR signaling leads to a 
diverse response ranging from simple signal propagation and hormone release to mRNA 
transcription and translation as well (Nguyen et al., 2004).
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Signaling Systems of the GnRH Receptor
Pituitary GnRH receptors are thought to primarily signal through Gaql 1, resulting in the 
stimulation of the IP3 second messenger system, however Gs activation and cAMP 
signaling has been reported as well (Grosse et al., 2000; Stanislaus et al., 1998). In aT3- 
1 cells, a mouse gonadotrope cell line, the GnRH receptor was shown to exclusively 
couple to Gaq (Grosse et al., 2000), while in L|3T-2 cells, a related cell line, both Gaq 
and GaS coupling was reported (Liu et al., 2002). Furthermore, functional distinction 
has been made between the signaling systems involved in the activation of type I and 
type II receptors, as in the case of the latter, Gas coupling has been well documented (Oh 
et al., 2005). The presence or absence of the C-Terminal tail in the type II and type I 
GnRH receptors could possibly explain the signaling disparity between the two groups. 
Recently, the three bullfrog type II GnRH receptors were shown to activate both IP3 and 
cAMP systems (Oh et al., 2005). The tail-less mutant forms of the three receptors 
showed no significant reduction in IP3 signaling after activation of receptor-1 and 
receptor-3, however all three of the tail-less mutant forms had a significant decrease in 
cAMP signaling, which was brought to near basal levels in the case of receptor-1 and 
receptor-2. An HFRK motif in the membrane proximal region of the C-terminal tail was 
shown to confer cAMP signaling capability in type II GnRH receptors. Addition of this 
motif to the rat type I GnRH receptor drastically increased the level of cAMP signaling, 
which suggests this HFRK motif may be responsible for the differential signaling 
between type I and type II GnRH receptors (Oh et al., 2005).
GnRH receptor signaling through the MAP kinase cascade leading to the 
regulation of several gonadotrope specific transcripts, such as LH, FSH and the GnRH
37
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
receptor itself, has been well documented (Naor et al., 2000). Studies investigating the 
link between the GnRH receptor, MAP kinase signaling and transcriptional activation 
have been predominately performed using pituitary cell lines from the mouse (aT3-l and 
LPT2), from which it has been shown that GnRH receptor signaling involves all four of 
the MAP kinase groups, however ERK and JNK activation was most significant (Gur et 
al., 2001; Levi et al., 1998; Reiss et al., 1997; Sim et al., 1993). In general, the cascade 
leading to ERK activation begins with Gaq, PLC and PKC, which lead to the activation 
of RAF, which in turn activates the MAP Kinase-ERK kinase (MEK) which ultimately 
leads to the activation of ERK (Naor et al., 2000). This cascade of events has been 
probed using various GnRH independent stimulants or inhibitors, such as tetradecanoyl 
phorbol acetate (TP A), an activator of PKC, which was shown to mimic GnRH 
stimulation, the effects of which, however were shown to be blocked by GF 109203X, a 
PKC inhibitor (Reiss et al., 1997). Furthermore, the MEK inhibitor PD-98059 was 
shown to eliminate ERK activation in GnRH stimulated aT3-l cells (Week et al., 1998). 
Similar results have been reported using tilapia pituitary cells, where GnRH stimulation 
of glycoprotein-a and LHp expression was shown to be inhibited by both PD-98059 and 
GF 109203X (Gur et al., 2001). These studies indicate that MAP kinase signaling is an 
important mechanism of gonadotrope functioning that has been conserved across 
vertebrates.
An alternative mechanism linking the activation of the GnRH receptor to 
gonadotropin synthesis through a direct link to translational machinery has recently been 
reported (Nguyen et al., 2004). This mechanism is commonly seen in receptor tyrosine 
kinase systems, such as in the case of insulin (Mendez et al., 1996), however it has only
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F ig u re  12. G n R H  R ecep to r S ignaling . GnRH receptor activation has been shown to lead to  the 
activation o f  both IP3 and cA M P as well as the M A PK  signaling systems. (Source: Protein Lounge).
been reported in a handful o f GPCR systems, including the p-opiod receptor, endothelin 
and angiotensin receptors (Polakiewicz et al., 1998; Wang and Proud, 2002). Stimulation 
of LPT2 cells with GnRH in the presence of either actinomycin D, an inhibitor of 
transcription, or cyclohexamide, an inhibitor of translation, revealed a strong
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transcriptionally-independent stimulation of LH(3 synthesis. GnRH treatment led to a 
time and dose dependant activation of 4E-binding protein 1, eukaryotic initiation factor 
4E and eukaryotic initiation factor 4G, all of which are involved in ribosome assembly 
during the translational process. This response, however, was abolished by PD-98059, 
indicating the role of MEK and ERK in this alternative GnRH receptor signaling system 
(Nguyen et al., 2004).
To summarize, as shown in Figure 12, GnRH receptors predominantly couple 
with Gaq/ii, leading to the activation of PLC and subsequently IP3 and DAG production 
(Grosse et al., 2000). Gas coupling to GnRH receptors occurs in many instances as well, 
resulting in AC activation and cAMP production. In addition to second messenger driven 
GTH release, GnRH receptor activation has been shown to lead to MAP kinase signaling 
resulting in both translational and transcriptional modulation (Nguyen et al., 2004).
GnRH receptor signaling is clearly a multifaceted cascade of events that leads to a 
diverse level of cellular regulation likely to reflect the various reproductive strategies 
found across vertebrates.
Regulation of the GnRH Receptor: Functional Significance of the C-Terminal Tail 
The regulation of GPCR activity is a critical check point in cellular function that involves 
multiple levels of control. Unchecked, as demonstrated by both naturally occurring and 
laboratory constructed mutants, constitutively active GPCRs can lead to a variety of 
cellular abnormalities, ranging from apoptosis to cancer (Bockaert et al., 2003; Lefkowitz, 
2004). Early studies described receptor desensitization (defined as a waning of 
responsiveness in response to continuous stimulation) by monitoring cellular signaling
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events, such as second messenger activation in treated tissues over time, or signal output 
response, such as hormone release over time (Belchetz et al., 1978; Heding et al., 1998).
It wasn’t until the first GPCRs were cloned, including the a and (3-adrenergic receptors 
(Dixon et al., 1986; Kobilka et al., 1987), muscerinic receptors (Fukuda et al., 1987) and 
NK1 tachykinin receptor (Masu et al., 1987) in the mid 1980’s, and subsequent 
mutational analysis studies that elucidated several key mechanisms that lead to 
desensitization of activated GPCRs through covalent modification, complex formation 
resulting in steric hindrance and finally receptor relocation. It should be noted that other 
non-GPCR related mechanisms are involved in the overall desensitization of cellular 
response, including alteration of transcription and/or translation, degradation, cellular 
transport and storage, however these pathways lay beyond the scope of this dissertation 
(Bockaert et al., 2003; Lefkowitz, 2004).
Receptor desensitization (Figure 13) begins through phosphorylation of specific 
Ser/Thr residues, typically in the C-terminal tail, by either a member of the G-protein 
coupled receptor kinases (GRK) or a second messenger dependant protein kinase, such as 
protein kinase A (PKA), protein kinase C (PKC) or casein II. Arrestins (arrestinl -  
rhodopsin specific; arrestin 2 (P-arrestinl) and arrestin 3 (P-arrestin2) -general) bind the 
phosphorylated GPCR, which interferes with association of G-proteins through steric 
hindrance, leading to a first level of down regulation (McArdle et al., 2002). Furthermore, 
P-arrestin acts as a scaffold linking the phosphorylated active receptor/p-arrestin complex 
to clathrin coated pits, which are internalized in a dynamin dependant manor (McArdle et 
al., 2002). This internalization furthers the level of desensitization through relocation of 
the receptor, which can no longer interact with extracellular ligands nor can it activate
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Lysosome
F ig u re  13. G P C R  In te rn a liza tio n . G P C R  activation leads to  phosphorylation by G -protein coupled 
receptor kinase (GRK), w hich stabilizes (3-arrestin/GPCR com plex formation. This com plex is targeted for 
internalization v ia dynam in dependant clathrin  coated vesicles. W hen internalized, the receptor com plex is 
either degraded or recycled back to  the p lasm a membrane.
additional G-proteins. Simultaneously, the signaling cascade is deactivated through 
regulators of G-protein signaling (RGS), which enhances Got GTPase activity, while 
second messengers are metabolized, for example through the activity of cAMP specific 
phosphodiesterases, which convert cAMP to 5’ AMP (McArdle et al., 2002; Millar et al., 
2004). This rapid (minutes) orchestration of events is an absolutely critical regulatory 
process, which is still far from being fully understood. It should be noted that there are a 
number of internalization mechanisms that are currently trying to be elucidated. Simply, 
these mechanisms can include internalization through p-arrestin independent mechanisms,
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or can be p-arresting dependent but dynamin independent or through non-clathrin coated 
vesicles, such as caveolae (Claing et al., 2000). Numerous studies have been performed 
identifying these different means of internalization using inhibitors, mutagenesis and 
dominant negative co-transfections, however the exact mechanisms or molecular markers 
driving these processes are yet to be established (Claing et al., 2000; Hislop et al., 2005; 
Ronacher et al., 2004). As a final note, it is important to recognize the potential for 
receptor internalization through P-arrestin to be a signaling switch, where G-protein 
mediated second messenger signaling is down regulated however MAPK signaling is 
activated. The internalized GPCR is linked to the MAPK cascade through the multi­
protein complex associated with p-arrestin, which includes a SRC homology domain, 
kinases and adapter protein 2 (McArdle et al., 2002).
Activation of type II GnRH receptors has been extensively shown to lead to rapid 
internalization that can be P-arrestin dependent or independent, dynamin dependent or 
independent and through either clathrin coated or caveolae (Acharjee et al., 2002; Hislop 
et al., 2005; Pawson et al., 2003; Ronacher et al., 2004). Type I GnRH receptors have 
been shown to be internalized, however at a significantly slower rate and to a lesser 
extent when compared to type II GnRH receptors (Hislop et al., 2005; Pawson et al., 
1998; Willars et al., 1999). Addition of the C-terminal tail from the type II catfish GnRH 
receptor to the rat GnRH receptor was shown to result in several functional aberrations, 
most notably induction of rapid ligand dependant internalization, which was shown to be 
reversible through C-terminal tail truncations (Lin et al., 1998). Furthermore, removal 
of the C-terminal tail from the type II chicken GnRH receptor was shown to result in an 
internalization profile similar to the naturally tail-less human type I GnRH receptor
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(Pawson et al., 1998). These studies provided the impetus to further define the motifs 
involved in this rapid internalization, leading to a series o f studies indicating specific 
Ser/Thr moieties located in both the membrane proximal or distal regions of the C- 
terminal tail (Blomenrohr et al., 1999; Millar et al., 2004; Pawson et al., 2003; Ronacher 
et al., 2004). For example, Ser3 6 3  of the catfish GnRH receptor is a major ligand induced 
phosphoaccepter, which, through site directed mutagenesis (S363A), was shown to be
369 370 • •required for rapid internalization. Mutation of a Thr doubled (Thr Thr ) in the distal 
region of the chicken GnRH receptor C-terminal tail led to a 70% reduction in ligand 
dependent internalization compared to wild-type, which was shown to internalize in a P- 
arrestin independent, dynamin dependant manner through caveolae (Pawson et al., 2003).
338 339More recently, Ronacher et al., identified a Ser doublet (Ser Ser ) in the membranes 
proximal region of the human type II GnRH receptor, which when mutated to Ala led to a 
75% reduction in internalization compared to wild-type, which was also shown to require 
both GRK and dynamin, but not p-arrestin, and to proceed through both clathrin coated 
pits and caveolae (Ronacher et al., 2004).
To summarize, rapid ligand dependant internalization is a critical distinguishing 
characteristic between the regulation of tailed type II GnRH receptors and tail-less type I 
GnRH receptors. Activated type II GnRH receptors can be phosphorylated at Ser/Thr 
residues within the C-terminal tail, which leads to an interaction with p-arrestin. p- 
arrestin can block G-protein coupling, link the receptor to G-protein independent 
signaling mechanisms and also lead to dynamin dependant or independent internalization 
through clathrin coated vesicles. The lack of rapid internalization of the type I GnRH 
receptors may reflect the various actions of GnRH in controlling pituitary gonadotropins 
through diverse regulatory mechanisms.
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Agnathans
Lamprey (Petromyzoniformes) and hagfish (Myxiniformes) are the only living 
representatives of the agnathans, the oldest class of vertebrates, which diverged from the 
main line of vertebrate evolution approximately 500-550 million years ago (Janvier,
1981). The relationship between lamprey and hagfish is unclear, particularly whether 
their divergence is monophyletic (lamprey and hagfish form a natural group) or 
paraphyletic (lamprey being more closely related to the gnathostome (jawed vertebrates) 
(Forey, 1984; Forey and Janvier, 1993). Lamprey and hagfish have many similarities 
including the lack of a jaw, internal ossification, scales and paired fins, and each has a 
single nostril, pore like gill openings, and multicuspid lingual lamina (Forey, 1984; Forey 
and Janvier, 1993; Hubbs and Potter, 1971). These traits may represent a close relation 
or rather could be the product of convergent evolution. On the other hand, there are many 
differences between lamprey and hagfish. For example hagfish are exclusively marine 
fish, where as lampreys are anadromous. There are also anatomical and physiological 
differences as well, as shown in Table 1, which is a summarization from Hubbs and 
Potter, 1971. Using morphology and physiology as a bases for construction of the early 
vertebrate phylogeny is difficult because o f the uncertainty as to which traits are ancestral, 
and therefore uninformative, and which are derived (Stock and Whitt, 1992). Molecular 
analysis has shed light onto the problem, where initial studies investigated the molecular 
evolution of 18S and 28S ribosomal RNA (rRNA), indicating lamprey and hagfish form a 
monophyletic group, separate from the gnathstomes (Mallatt and Sullivan, 1998; Stock 
and Whitt, 1992). Furthermore, analysis o f protein tyrosine kinase cDNAs (Suga et al., 
1999), mitochondrial DNA (Delarbre et al., 2002) and a reconcile tree
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Trait Lamnrev Hagfish
Dorsal Fin One or Two None
Eyes Moderately developed Very Degenerate
Lingual Lamina One transverse and two longitudinal Two longitudinal pairs
Oculomotor Muscles Yes No
Teeth On oral disc and tongue Tongue and palate
Nasohypophysial opening On top o f the head In front o f the head
Number o f Gills 7 5 to 14
Skull Mostly cartilaginous Membranous
Eggs Small and unkeratinized Large karatinized
Table 1. Distinguishing Characteristics of Lamprey and Hagfish. Examples of differences between the 
morphology and physiology o f  the adult lamprey and hagfish, adapted from Pottter et al., 1971.
analysis of 118 gene families (Page, 2000) supports the monophyletic divergence of the 
agnathans.
Petromvzoniformes
The phylogeny of Petromyzoniforms is less controversial than that of the agnathans as a 
whole, however a considerable amount of further research in the area would be warranted. 
The lamprey lineage is divided into three families: the Petromyzonidae, or Northern 
Hemisphere lamprey, also referred to as the Holarctic species, and the two Southern 
Hemisphere families, Geotriidae and Mordaciidae (Hubbs and Potter, 1971; Potter, 1980; 
Potter and Hilliard, 1987), although there are some taxonomists that believe that the 
Geotria and Mordacia belong to a single family (Eigenman, 1928; McCulloch, 1929; 
Scott, 1962). The lamprey lineage will be discussed here forth using this tripartite 
division, as it is the consensus view in the field.
The Petromyzonidae consists of 6  genera: Ichthyomyzon, Petromyzon, 
Caspiomyzon, Eudontomyzon, Tetrapleurodon, and Lampetra, which is further divided
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Diagram and key to the terminology used to 
describe the phylogeny o f the lamprey 
lineage. This is a picture o f Ichthyomyzon 
bdellium. This figure has been adapted from 
Hubbs and Potter, 1971.
Lingual Lamina-multicuspid teeth of the 
tongue. Consists o f the lingual lamina (LT) 
and longitudinal lingual laminae (LL)______
Supraoral (SQl-anterior tooth to the front edge 
o f the oesophageal opening-directly behind the 
anterior circumorals
Infraoral (IO )-tooth distal to the posterior edge 
o f the oesophageal opening
Circumoral row-the row o f teeth, continuous or 
not, around the oesophageal opening not 
including the IO o f SO. Consisting of the 
anterior (AC), lateral (LC), and posterior (PC) 
circumorals
Intermediate Disc Teeth (IT)-teeth between the 
circumorals and the marginals_______________
Median Anterior Tooth Row (MA)-the row of  
teeth extending from the suproral on the 
midline o f the disc. The first tooth is referred 
to as the anteromedian circumoral (AC)______
Anterior Field (AF)-the anterior portion o f the 
oral disc, not including the supraoral.
Lateral Field (LFVteeth within the area o f the 
oral disc that between the anterior and posterior 
field
Posterior Field fPFV the posterior portion of 
the oral disc, not including the infraoral.
Marginals (MG)-all teeth adjacent to the 
periphery o f an alate rows
into the three sub-genera Entosphenus, Lethenteron, and Lampetra (Hubbs and Potter, 
1971). The Geotriidae and Mordaciidae each consist of only one genus, Geotria and 
Mordacia respectively. This phylogeny of the lamprey lineage is based primarily on 
dentition (see Figure 14 for dental terminology) and is justified by other shared 
anatomical traits, such as the proportional measurements of body parts, size of the adult, 
snout shape, eyes and dorsal fins (Hubbs and Trautman, 1937; Vladykov and Follett, 
1967). The Ichthyomyzon are thought to be the most ancient of the lamprey because their 
simple teeth arrangement into rows throughout the entire oral disc. Of the Ichthyomyzon 
species, the I. Unicuspis had been considered the most primitive, (Hubbs and Potter, 
1971; Hubbs and Trautman, 1937) based on dentition, having mostly undifferentiated
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teeth in the anterior, lateral, and posterior field o f the circumoral row (Hubbs and Potter, 
1971). The Petromyzon and Caspiomyzon have a similar pattern of undifferentiated teeth 
in the circumoral row and a small supraoral lamina, but both have slightly more 
differentiated lateral circumoral teeth. The remaining three genera, all having a larger 
supraoral lamina and lacking complete alate rows of teeth, are thought to have evolved 
along two different lines, although both are more similar to the Petromyzon then to the 
Caspiomyzon (Hubbs and Potter, 1971; Potter, 1980; Potter and Hilliard, 1987). The 
Tetrapleurodon and Eudontomyzon are distinguished from the ancestral stock by their 
increased number of teeth, although much smaller in size, and number of rows of teeth 
(Hubbs and Potter, 1971; Potter, 1980). The Lampetra are separated from the 
Tetrapleurodon and Eudontomyzon as they have much fewer, but larger, teeth and more 
differentiated teeth in the circumoral row (Hubbs and Potter, 1971; Potter, 1980).
The dentition of the Southern Hemisphere lampreys is considerably different from 
that of the Holarctic genera and to themselves. The supraoral lamina of the Geotria is a 
wide pronged tooth with four points and that o f the Mordacia consists of two tricuspids, 
both markedly different then any of the Holarctic species (Hubbs and Potter, 1971; Potter, 
1980). Their retention of the alate rows of teeth in the anterior, lateral, and posterior field 
suggests an ancient divergence of the Southern Hemisphere lamprey (see Figure 15).
This system describing the lamprey phylogeny is unconvincing as it is based entirely on 
assumptions concerning what dentition patterns represent derived states.
This overall division into three families is supported by sequence analysis of the 
primary structure of insulin, where the M. mordax sequence is more similar to that of the 
holarctic sequences than to the G. australis sequence (Conlon, 2001; Conlon et al., 2001).
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Figure 15. Lamprey Phylogeny Based on 
Dentition. The lamprey lineage has 
previously been described based on dentition. 
The scheme divides the lamprey into three 
families, including the Petromyzonidae, 
Geotriidae and Mordaciidae (Potter and 
Hilliard, 1987).
One of the divisions of lampreys has since been supported by an analysis of 
mitochondrial genes exclusively within the Lampetra, reconfirming the species 
designation within this family (Docker et al., 1999), however, further analysis of other 
characters is needed to better our understanding of the lamprey phylogeny.
Lamprey Ecology
The three families of lampreys are distributed antitropically (at latitudes greater than 
30°N/S), except for the tetrapleurodon, which are found in high altitude lakes of Mexico 
(Hardisty and Potter, 1971). Prior to metamorphosis, all lamprey live in a fresh water 
environment, after which they divide into three classes: fresh water non-parasitic, fresh 
water parasitic, and anadromous parasitic. The holarctic Petromyzon marinus and
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Lampetra tridentatus are anadromous parasitic lamprey of vast distribution. The P. 
marinus can be found along the entire eastern coast of the United States and part of 
Canada, as well as the coastal region of Western Europe, while the L. tridentatus is 
distributed along the western coast of North America, from Alaska to California. Of the 
two southern hemisphere species the M. mordax is the most restricted in distribution, 
found only in southeast Australia and Tasmania. The G. australis is of considerably 
larger distribution, being found around western and southern Australia, Victoria, 
Tasmania, New Zealand, Chile, and Argentina (Hubbs and Potter, 1971). The life cycle 
of anadromous parasitic lamprey begins as a blind, filter-feeding larva, called an 
ammocoete, burrowed in the sands of fresh water streams. The ammocoete remains 
burrowed in the stream for three to five years until undergoing metamorphosis to a 
sexually immature parasitic stage, where eyes begin to develop. The parasitic lamprey 
migrates to the ocean, where they latch onto, and feed off of, host fish. The parasitic 
stage lasts up to two years, during this period the lamprey begins sexual maturation. 
Finally, the lamprey returns to freshwater streams where they become fully mature, 
spawn, and die (Hardisty and Potter, 1971; Hubbs and Potter, 1971).
Lamprey GnRH
Two primary amino acid forms of GnRH have been identified in the sea lamprey, 
lamprey GnRH-I and lamprey GnRH-III, both of which were first discovered through 
protein purification (Sherwood et al., 1986; Sower et al., 1993). In addition, the cDNA 
and partial gene encoding lamprey GnRH-I (Suzuki et al., 2000) and cDNA encoding 
lamprey GnRH-III have been cloned (Silver et al., 2004). The amino acid sequence of
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the mature lamprey GnRH-I (PGlu-His-Tyr-Ser-Leu-Glu-Trp-Lys-Pro-Gly-NH2) and 
lamprey GnRH-III (PGlu-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2) decapeptides
thshare the highly conserved N-terminus, C-terminus and Ser in the 4 position, when 
compared to other vertebrate forms. Interestingly, lamprey GnRH-I and lamprey GnRH- 
III have a Glu or Asp, respectively, in the 6 th position, which is unique among all other 
vertebrate forms. In general, positions 5-8 are thought to be involved in a (3-tum (Sealfon 
et al., 1997), which is interrupted by the 6 th position substitutions in the lamprey GnRH 
forms, leading to an alteration in their three dimensional structure and therefore function 
(Sealfon et al., 1997). Indeed, when lamprey GnRH-I is cyclized thereby forming a (3- 
turn conformation, it shows a reduced capacity to stimulate plasma estradiol levels 
compared to lamprey GnRH-I (Sower et al., 1995a).
Lamprey are the earliest evolved vertebrates for which two forms of GnRH have 
been clearly demonstrated as functional neurohormones mediating the pituitary-gonadal 
axis (Sower and Kawauchi, 2001). Both lamprey GnRH-I and lamprey GnRH-III were 
shown to be expressed in the preoptic anterior hypothalamus and the posterior 
hypothalamus of the adult sea lamprey using immunocytochemistry (Nozaki et al., 2000). 
Recently, using in situ hybridization, both lamprey GnRH-I and lamprey GnRH-III 
mRNAs were detected in the preoptic anterior hypothalamus, and furthermore, 
colocalization was observed in adult lamprey using a dual-label in situ approach (Root et 
al., 2005). Lamprey GnRH-III is considered the most active form during sea lamprey 
maturation based on the relative number of lamprey GnRH-III producing neurons which 
is larger than lamprey GnRH-I producing neurons during the larval and adult stages 
(Nozaki et al., 2000; Tobet et al., 1995) and that lamprey GnRH-III was more potent
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compared to lamprey GnRH-I in inducing spermiation in male sea lamprey (Deragon and 
Sower, 1994; Sower, 2003). Neither lamprey GnRH-I or lamprey GnRH-III peptides 
have been isolated from any other species of lamprey, although both forms have been 
detected in the brain and hypothalamus using immunocytochemistry and HPLC coupled 
with radioimmunoassay or immunocytochemistry in the pouched lamprey (Geotria 
australis), Australian lamprey (Mordacia mordax), silver lamprey (Ichthyomyzon 
unicuspis) and western brook lamprey (L. richardsoni) (Eisthen and Northcutt, 1996; 
Sower et al., 2000) and the cDNA encoding lamprey GnRH-III has been cloned from 
Petromyzon marinus, Lampetra tridentatus, Lampetra richardsoni, Lampetra appendix, 
Ichthyomyzon unicuspis, Ichthyomyzon fossor, Mordacia mordax and Geotria australis, 
see chapter IV (Silver et al., 2004).
Sea Lamprey GnRH Receptor
The lamprey GnRH receptor was first described by means of quantitative in vitro 
autoradiography using 1 2 5I-DAla6Pro9NEt mammalian GnRH (Knox et al., 1994). Two
19 Qhigh affinity binding sites (Kd 1.5x10' M and 5x10" M) were identified using the 
Rosenthal analysis, which were shown to be located predominantly in the proximal pars 
distalis and to a lesser extent in the rostral pars distalis of the pituitary. These binding 
sites were shown to be saturable, reversible, tissue specific and time and temperature 
dependant (Knox et al., 1994). Moreover, lamprey GnRH-I, lamprey GnRH-III, 
mammalian GnRH, salmon GnRH, chicken GnRH-I, chicken GnRH-II and DPhe2 ,6Pro3 
lamprey GnRH were able to compete for binding, while DAla6 Pro9-OH lamprey GnRH 
and TRH were not (Knox et al., 1994). Two high affinity GnRH binding sites in the
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pituitary were characterized during the reproductive development of the lamprey 
(Mateme et al., 1997). GnRH binding capacity at both sites increased during the 
development of the lamprey and correlated with gonadal maturation and brain GnRH 
content (Mateme et al., 1997). Extra-pituitary GnRH binding has been demonstrated as 
well; one high affinity GnRH binding site was characterized in both the testes and ovary 
(Gazourian et al., 1997; Materne et al., 1997) and GnRH binding has been shown in 
choroid plexus within the lamprey brain (Rosen and Sower 1996, unpublished). The 
presence of a high affinity lamprey GnRH binding site and lack of GnRH in circulation 
suggests the gonad may produce a GnRH-like factor which serves as an 
autocrine/paracrine regulator (Gazourian et al., 1997). Finally, the GnRH binding sites in 
the choroids plexus provides evidence of GnRH action in the brain or alternative 
transportation mechanisms, where GnRH may be transported throughout the brain by 
means of the ventricular system (Rosen and Sower 1996, unpublished). Most recently, a 
cDNA encoding a type II GnRH receptor with a lengthy C-terminal tail was cloned from 
the sea lamprey (Silver et al., 2005). Lamprey GnRH receptor transcript was detected in 
the proximal pars distalis using in situ hybridization, which correlated well with the 
previously described high affinity binding sites (Knox et al., 1994), while expression was 
detected in the testes using RT-PCR (Silver et al., 2005). The functional characterization 
and binding kinetics o f this receptor constitutes the majority of this dissertation, and will 
be described in detail in subsequent chapters.
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Opening the Black Box: Initial Isolation of lamprey GTHP
The years of exhaustive attempts to isolate GTH from lamprey, however unsuccessful, 
bore unexpected fruit. Through a series of biochemical, immunological and molecular 
experiments, numerous lamprey pituitary hormones have been discovered, including 
adrenocorticotropin (ACTH) (Takahashi et al., 1995), melanotropin (MSH-A and MSH- 
B) (Takahashi et al., 1995), nasohypophysial factor (NHF) (Sower et al., 1995b), AVT 
(Lane et al., 1988; Suzuki et al., 1995), proopiocortin (POC) (Heinig et al., 1995), 
proopiomelanotropin (POM) (Takahashi et al., 1995), and growth hormone (Kawauchi et 
al., 2002). Histological analysis revealed GTHp-like cells in the proximal pars distalis of 
the sea lamprey pituitary (Nozaki et al., 1999), which overlapped with previously 
described GnRH binding sites (Knox et al., 1994). Screening was performed using a 
variety of antisera to gonadotropins from various species, however the strongest 
immunoreactivity was detected using the anti-ovine LH antisera (Nozaki et al., 1999). 
Using lectin screening, glycoconjugates were detected in the same cell population as 
GTHP-immunoreactive cells (Nozaki et al., 1999). Recently, a large scale EST analysis 
was performed, in which 2208 clones were sequenced, yielding 3 encoding GTHp (Sower 
et al., submitted). The lamprey GTHp cDNA encodes the 134 amino acid mature GTHp 
along with a 16 amino acid signal peptide. Lamprey GTHp contains the conserved 12 
Cys residues and 2 putative N-glycosylations sites common to LHp and FSHp. Based on 
phylogenetic analysis, where the lamprey GTHp was a clear out-group, it was proposed 
to be closely related to the glycoprotein hormone ancestor (Sower et al., submitted). The 
existence of a GTHa is still in debate, however preliminary data indicate a GTHa in the 
lamprey genome (Scott Kavanaugh, personal communication).
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Objectives
GnRH and the GnRH receptor are critical components of the vertebrate hypothalamic- 
pituitary-gonadal axis and hence reproduction. Significant research efforts have been 
applied to the understanding of how reproductive regulation has evolved across 
vertebrates, at a physiological and molecular level. The objectives of this dissertation are 
to address these very issues through the characterization of both the recently cloned 
lamprey GnRH receptor and lamprey GnRH-III cDNA. Initial characterization of cell 
culture and activity assays using COS7 cells and the pcDNA3.1 control vector is first 
described. Using these techniques, the lamprey GnRH receptor was used in a series of 
functional and binding kinetics studies using the wild-type and C-terminal tail mutants 
(80 amino acids, 40 amino acids and 0 amino acids). These constructs were used to 
characterize the lamprey GnRH receptor in regards to second messenger activation (IP3 
and cAMP), binding kinetics (Kd and BMax), pharmacological profile and internalization.
To address the phylogeny of both the GnRH family of peptides and the 
Petromyzoniform lineage, the cDNA encoding the lamprey GnRH-III was cloned from 
eight species of lamprey, representing the Petromyzonidae, Mordaciidae and Geotriidae. 
These sequences were used in a phylogenetic analysis with all known GnRH sequences, 
providing a more robust analysis of the GnRH family lineage. Analysis of the lamprey 
GnRH-III cDNAs on their own was used to describe the relationship of the three families 
of lamprey.
55
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER II
LAMPREY GnRH RECEPTOR FUNCTIONAL ASSAY DEVELOPMENT AND
INITIAL CHARACTERIZATION
Introduction
The gonadotropin-releasing hormone (GnRH) is the central regulator of reproductive 
function in all vertebrates. The GnRH decapeptide is produced and released from the 
preoptic anterior-hypothalamic region of the diencephalon and stimulates the pituitary 
through its interaction with the gonadotropin-releasing hormone receptor. The GnRH 
receptor is a member of the class A, rhodopsin like family of 7-transmembrane G-protein 
coupled receptors (GPCRs), consisting of a core 7 hydrophobic a-helical transmembrane 
domains connected by three intra and extracellular loops. Activation of the GnRH-R has 
been shown to be linked to both Gq/n and Gs signaling, which lead to the synthesis and 
secretion of the gonadotropins, luteinizing hormone (LH) and follicle-stimulating 
hormone (FSH).
The first GnRH-R was cloned from a mouse pituitary cDNA library in 1992, 
which was shortly followed by the cloning of a human GnRH-R (Kakar et al., 1992; 
Tsutsumi et al., 1992). Strikingly, both receptors lacked intracellular C-terminal tails, 
which is a unique feature among GPCRs. These tail-less receptors were of interest as the 
C-terminal tail is thought to have numerous functional roles, including coupling with
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intracellular signaling components as well as desensitization and internalization pathways 
(McArdle et al., 2002). It was believed that all GnRH-Rs were tail-less until 1997 when 
a GnRH-R with a C-terminal tail was cloned from the catfish (Tensen et al., 1997). Since 
then, 40 more GnRH receptors have been cloned, including 11 tail-less receptors and 29 
tailed receptors (Millar et al., 2004). Based on structural features (i.e. tailed or not) and 
phylogenetic analysis, it has been proposed that the GnRH receptors form two separate 
major groups, the type I receptors, which are tail-less and have only been identified in 
mammals, and the type II receptors, which have tails and have been identified in 
vertebrates from Osteichthyes to mammals. Insight into the relationship of the GnRH 
receptors could be gained through the analysis of an ancestral model, such as the sea 
lamprey, which could provide clues to better describe the evolutionarily conserved motifs.
The sea lamprey, Petromyzon marinus, whose lineage dates back approximately 
550 million years, are members of the oldest lineage of vertebrates, the agnathans 
(Janvier, 1981). Two forms of GnRH have been identified in the sea lamprey, lamprey 
GnRH-I (Sherwood et al., 1986; Suzuki et al., 2000) and lamprey GnRH-III (Sower et al., 
1993; Silver et al., 2004), both of which have been shown to be involved in regulation of 
the reproductive axis (Deragon and Sower, 1994; Sower, 2003). Two specific GnRH 
binding sites were demonstrated in the sea lamprey pituitary (Knox et al., 1994), which 
suggested the lamprey express one, if not two GnRH receptors. Recently, a cDNA was 
cloned that encoded a protein with seven hydrophobic domains which was identified as a 
GnRH receptor via homology search (Silver et al., 2005). The cloned sequence was 
shown to be expressed in the pituitary and testes using RT-PCR, while in situ 
hybridization localized the pituitary expression to the proximal pars distalis, the same
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region previous GnRH binding sites where characterized by Knox et al. (Knox et al., 
1994).
The aforementioned data suggest the putative lamprey GnRH receptor clone 
encodes a functional GnRH receptor, however, analysis in a heterologous expression 
system is absolutely necessary in order to fully describe and classify receptor encoding 
clones. The objective of this research is to develop and characterize the methodologies to 
specifically test the function of the cloned putative GnRH receptor, and then to use this 
heterologous expression system to characterize the response of the lamprey GnRH 
receptor through second messenger accumulation assays. Using these techniques, the 
cloned lamprey GnRH receptor was shown to be functional, and to respond to both 
lamprey GnRH-I and lamprey GnRH-III in a dose dependant manner.
Materials and Methods
Cells, Solutions and Reagents
COS7 cells were provided by Dr. Aniko Fejes-Toth (Dartmouth Medical School), or 
where purchased from American Type Culture Collection (ATCC). Cells from Dr. Fejes- 
Toth were used for technical development, while the ATCC cells were used for the 
functional assay. Cell cultures were maintained using fetal bovine serum (FBS) and 
Dulbecco’s Modified Eagle’s Medium, and were passaged using IX Trypsin-EDTA, all 
of which were purchased from Invitrogen. Lamprey GnRH-I and lamprey GnRH-III 
were purchased from American Peptide, and were dissolved in MQ H2 O in a final 
concentration of 5 mg/ml (4.07 mM lamprey GnRH-I and 3.97 mM lamprey GnRH-III).
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Cell line origination and maintenance
Prior to seeding, stocks were removed from cryo-storage and were quickly thawed in a 
room temperature water bath. Stocks were then centrifuged for 5 minutes at low rpm, 
and medium containing DMSO was aspirated. Cells were then resuspended in 5 mL in 
10% FBS in DMEM. Two T7 5 culture flasks were seeded with 2.5 mL of diluted cells 
and 12.5 mL of 10% FBS in DMEM. All culture incubations were carried out at 37°C in 
5% CO2 . At approximately 90% confluence, cells were passed to new culture flasks or 
were thinned out via treatment with IX trypsin-EDTA. Cultures were first washed one 
time with 10 mL of phosphate buffered saline (PBS), pH 7.4, followed by application of 
trypsin-EDTA [in a container dependant volume] and were incubated at 37°C for 10 
minutes. Cells were collected in 50 mL falcon tubes, and then redistributed into culture 
plates/flasks and filled to appropriate volume with 10% FBS in DMEM.
Lamprey GnRH receptor construct development
The coding region of the wild type and mutant lamprey GnRH-R was inserted into the 
pcDNA3.1 mammalian expression vector (Invitrogen) via topo cloning. The lamprey 
GnRH-R open reading frames were amplified via PCR using the Advantage2 PCR 
system (CLONTECH) with the LGnRH-R ORF 5’ (5’-CAC CAT GGA ACC CAT CAA 
CAT GAA CAT GAC-3’) combined with either the LGnRH-R ORF 3’ (to produce the 
wild type ORF: 5’-TCA GAT GCAGCA GCT TTC AGG ACA TAC GAG AG-3’), 
LGnRH-R 80aa 3’ (to produce the LGnRH-R with an 80aa C-terminal tail: TCA-TGC- 
CGC-TCT-GTT-CAC-GGG-GAC), LGnRH-R 40aa 3’ (to produce the LGnRH-R with a 
40aa C-terminal tail: TCA-ACT-CCG-CAC-GGA-CGA-GGC-CGA), or the LGnRH-R
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Oaa 3’ (to produce the tail-less LGnRH-R: TCA-CGC-CGC-GAA-CAC-GCC-GTA- 
GAT), using the following cycling parameters: a 95°C initial denaturing step for 1 minute 
followed by 25 cycles of 95°C 15 sec, 62°C 1 minute and 72°C 1 min, followed by a final 
5 minute 72°C extension and 10°C hold. 4 pL of PCR product was used in the topo 
cloning reaction, which was then used to transform ToplO E. coli cells (Invitrogen). 
Clones were screened by sequencing at the HSC Core Research Facility at the University 
of Utah in at least 3X coverage in order to identify the correct clone. Finally, the clone 
containing the proper sequence was used to inoculate 100 mL of LB, which was grown 
overnight prior to plasmid purification using the EndoFree MaxiPrep Plasmid 
Purification system (Qiagen).
Transfection Optimization
Transfection was performed using the Lipofectamine transfection reagent (Invitrogen) in 
60 millimeter culture plates, which was optimized using a pcDNA3.1 vector containing 
the lacZ gene. Efficiency of transfection was monitored using the P-Gal Histochemical 
Staining Kit (Invitrogen). Optimization was performed by varying mass of vector used 
(2.5 pg-15 pg), volume of Lipofectamine (5 pL-15 pL), ratio of vector to Lipofectamine, 
and finally cell seed number (5xl0 5 -  lxlO6). Efficiency of transfection was estimated 
by comparing the number of blue cells (transfected) to clear cells (non-transfected) after 
P-Gal staining.
Inositol Phosphate Assay
The inositol phosphate (IP) stimulation and extraction protocol used was adapted from
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previous studies (Berg et al., 1994; Ikemoto and Park, 2003; Okubo et al., 2001). Briefly, 
24 hours after transfection, cells were trypsinized, and seeded in 12-well plates at 
approximately 1.5x10s cells/well. At hour 72 cells were washed in PBS and incubated in
■j t t
1 mL of 2% dialyzed fetal bovine serum and 2 pCi/mL myo[2- HJinositol (Amersham) 
in medium 199 (Invitrogen). At hour 96 cells were washed 2 times with IP buffer (20 
mM HEPES, 20 mM LiCl in IX HBSS), and were pre-incubated in IP buffer for 15 
minutes at 37 °C, followed by stimulation with either lamprey GnRH-I (American 
Peptide Company, Sunnyvale, CA) or lamprey GnRH-III (American Peptide Company) 
in IP buffer (concentrations ranging from 10‘6M to 10' 11 M for dose response analysis or 
10"6M for the C-terminal tail functional analysis), for 1 hour at 37 °C with gentle shaking. 
The reactions were stopped with the addition of 0.2 mL of pre-chilled 20% perchloric 
acid, and the plates were placed on ice for 30 minutes. The wells were scraped and the 
extracts were transferred to sterile 1.5 mL tubes and neutralized with 5M KOH, followed 
by a 1 hour incubation at 4°C. Tubes were centrifuged at 5,000 rpm at 4°C for 15 
minutes, and 1.2 mL of supernatant was transferred to a new sterile 1.5 mL tube. IPs (IP, 
IP2  and IP3) were isolated by ion exchange chromatography using AG 1X8-200 resin 
(Bio-Rad) in formate form. IPs were eluted with 1 M ammonium formate / 0.1 M formic 
acid, samples were counted by liquid scintillation and data were analyzed using Prism 
(GraphPad). Treatments were performed in triplicate in three independent experiments, 
and cells transfected with blank vector and non-transfected cells were used as negative 
controls.
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Results
Construct Development
The wild type and mutant lamprey GnRH receptor open reading frames were amplified 
via PCR, and were verified by both gel electrophoresis (see Figure 16) and sequence 
analysis (see Figure 17). Restriction digest indicated the vectors contained an insert of 
appropriate size, however PCR confirmed that there was no trace level of contamination. 
Sequence analysis was ultimately used in order to verify that there were no errors 
introduced into the sequences during amplification steps. Vectors were confirmed to 
contain the appropriate ORF prior to use.
120aa Vector SOaa Vector 4 0 aa  Vector Oaa Vector^  s/-----A  ^ f--- --A----------- A----
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s  = I s 1 1
120 80 40 0 $  «  ~  >  m
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Figure 16. Mutant Construct Analysis. Both PCR and restriction digests were used to verify the 
lamprey GnRH receptor constructs. Each vector, containing the wild type (120 aa), 80aa, 40aa, Oaa (tail­
less) or blank (control) was used as template for PCR using primers specific to each transcript (as noted at 
the bottom o f each lane. Results from the restriction digest are shown in the bottom right of the gel, where 
each lane contains a digest o f  a different vector, as denoted in each lane.
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LGnRH-R F u l l  
LGnRH-R 88 da T a il 
LGnRH-R 48 aa T a i l  
LGrtRH-R 8 act T a i l
HEPXNMNMTPRAAFLNNVTGPPNAI>HTGDE0LTN8SINSDIRLPA'r0FRVISTFALFIFAAISNLTVLCT------------ 1 1 ■ ■"! ■*---------- 1------------ 1 -I------------ r
10 20 3 0 46 50 60 20
MEPINMNMT^RAAFLNNVTCPPNASHTCDEOLTNSSINSDIRLPATOFRVISTFAl FIFAAISNITVLCT 70 
MEPINMNMTF'RAAFLNKVTGPPNASHTGDEQLTNSSINSDIRLPATOFRVISTFAl FIFAAISNLTVLCT 70  
MEPINA'NMTPRAAFLNNVTGPPNASHTGDEQLTNSSIRSDIRLPATQFRVISTFALFIFAAISNLmCT 70  
KEPINVNMTPR.AAFLNKVTGPPNASHTGDEOLTNSSINSDlRLPATdFRVISTFALc IFAAISNLTVLCT 70
LGnRH-R F u l l  
LGnRH-R 80 aa T a il 
LGnRH-R 48 aa T a i l  
LGnRH-R 0 aa T a i l
ISHNHRKTKSHVRILIVNLTTADLLITFiyMPLDAVftHITTQWYAGEFACRLLMFLRLLAMYSSAFITVV 
80 il0 100 U 0  120 130 148
ISHNHRKTKSHVRILIVNITTADLLITFIVHPLOAVWHITTOKYAGEFACRLLMFLRLLAMYSSAFITVV 140  
ISHNHRKTKSHVRILIVNLTTADLLITFIVMPLDAVWHITTQWYAGEFACRLLMFLRLLAMYSSAFITVV 140  
ISHMHRKTKSHVRILIVNLTTADLLITFIVMPLOAVWHITTdWYAGEFACRLLMFLRLLAMYSSAFITVV 140  
ISHNMRKTKSHVRILIVNLTTADLLITFIVMPLDAVWHITTQltYACEFACRllMFlRLlAMYSSAFITVV 140
LGnRH-R F u l l  
LGnRH-R 88 aa T a i l  
LGnRH-R. 48 aa T a i l  
LGnRH-R 8 act T a il
I5LDRHSAILNPLGIGKAKAKNKTMLSVAWVLSVLLAVP0LFLFHVK1F 1 [ FVQLVTHGNFVEOliHH 
150 160 170 180 190 200 210
ISLORHSAILNPLGIGKAKAKNKTMLSVAWVLSVLLAVPQLFLFHVK F FVQCV'THGNFVEQWHH 21 0
IS  L D R H S A IL  N P L GI G K A K A KNKTMLSV A W V L S V L L A ¥ PQ L F L F H'V K s P <, < N f FVQtVTMGNFVEQWHH 2 1 0  
IS l DRHSAILNPLGIGKAKAKNKTMLSVAWVLSVLLAVPOLFLFHVKSF N \ l FV0 CVTHGNFVEQ1VHH 210  
ISLDRHSAILNPLGIGKAKAKNKT M L SVAUiVLSVLLAVPQLFLFMVK Pi N \t FVQCVTHGNFVEQKMM 2 1 0
HLYYMFTFVFLFlLPLFIM IFCYCRIiLEISKRMREGSISSKEXRLRRSNNNIPKARMRTLKMSIAIVSS
220
LGnRH-R F u l l  
LGnRH-R 88 aa T a il 
LGnRH-R 48 aa T a i l  
LGnRH-R 0 aa  T a i l
230 240 250 260 270 280
NLYYMFTFVFLFILPLFIMIFCYCRILLEISKRMREGSISSKEIRLRRSNNNIPKARMRTLKMSIAIVSS 28 0  
NLYYMFTFVFLFILPLFIMIFCYCRIILEISKRMREGSISSKEIRLRRSNNNIPKARMRTLKMS1AIVSS 280  
NLYYMFTFVFLFILPLFIMIFCYCRIILEISKRMREGSISSKEIRLRRSNNNIPKARMRTLKMSIAIVSS 280  
NLYYMFTFVFLFILPLFmiFCYCRXLLEISKRMREGSISSKEIRLRRSNNNIPRARMRTLKMSIAIVSS 28 0
LGnRH-R F u l l  
LGnRH-R 80 aa T a i l  
LGnRH-R 40 aa T a it  
LGnRH-R 0 o.a T a i l
FVVCWTPYYyLGIWYWFDRSlV'SRKVVPHFVEEMSLTFGL LNACLEPVXYGVFAAHVRREVRRC CRWPRT 
290 300 310 320 330 340 350
FVVCWTPYYVLGHSIYWFDRSIV5RKVVPHFVEEHSLTFGLLNACLDPVIYGVFAAHVRREVRRCCRWPRT 350  
FVVCWTPYYVLGIKYftFDRSIVSRKVVPHFVEEMSLTFGLLNACLDPVIYGVFAAHVRREVRRCCRWPRT 350  
FVVCWTPYYVLGIWY*FDRSIVSRKVVPHFVEEMSLTFGLLNACLDPVIY6VFAAHVRREVRRCCR*PRT 350 
FVVCWTPYYVLGIWYWFDRSIVSRKVVPHFVEEMSLTFGLLNACLDPVIYGVFAA 335
L6nRH-R F u l l  
LGnRH-R 88 aa T a i l  
LGnRH-R 48 aa T a i l  
LGnRH-R 0 aa T a il
AAHDRDSSSTPVTGSFRYSAS5VRSRRVOFACGEOPEATGAHPTPATRLLORGCLVAGVPVKRAA--------------------- 1------------ ,------------ !------3------!--------------  1--------------r
360 370 380 390 408 410 420
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Figure 17. Lamprey GnRH Receptor C-Terminal Tail Truncations. Alignment o f the lamprey GnRH 
receptor mutants.
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Transfection Optimization
Transfection of COS7 cells with 5 jag of the pcDNA3.1 vector containing the lacZ gene 
using 15 pL of Lipofectamine was determined to be optimal. Increasing seed number 
from lx l  0 5 to lxlO8 was shown to increase the number of transfected cells, however the 
efficiency of transfection dramatically decreased (Figure 18).
Lamprey GnRH receptor Functional Analysis
Both lamprey GnRH-I and lamprey GnRH-III stimulated a significant response in IP 
accumulation, in a dose dependant manner, in COS7 cells that were transiently 
transfected with the lamprey GnRH receptor (Figure 19). The LogECso (represented as 
mean ± SEM; n=3) of lamprey GnRH-III (-9.37 ± 0.243) was significantly (P < 0.0002) 
lower then the LogECso of lamprey GnRH-I (-8.10 ± 0.150). This significant difference 
in IP activation suggests the presently cloned lamprey GnRH-R is lamprey GnRH-III 
selective. Cells transfected with blank pcDNA3.1 vector showed no response in IP 
accumulation following treatment with either lamprey GnRH-I or lamprey GnRH-III 
(data not shown).
Despite this difference in LogEC50, both lamprey GnRH-I and lamprey GnRH-III 
were shown to stimulate a statistically indistinguishable maximum level of IP 
accumulation when the wild type or mutant lamprey GnRH receptors were treated with a 
high dose (10'6 M) (Figure 20). Serial truncation of the lamprey GnRH receptor resulted 
in an initial decrease in magnitude of IP signaling. The 80aa C-terminal tail resulted in 
an approximately 43% reduction in signal relative to wild type. Further truncation of the
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Figure 18. Transfection Optimization. Transfection was optimized using the lacZ gene. Shown here, 
increasing numbers o f cells were seeded prior to transfection in order to optimize cell density. Percent 
transfection was determined based on the number o f blue cells relative to the number o f total cells (blue 
and clear). Top picture runs in decreasing order from left to right.
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Figure 19. Lamprey GnRH Receptor IP Dose Response. The lamprey GnRH receptor was shown to 
activate the IP signaling system, in a dose dependant manner, in transiently transfected COS7 cells. 
Lamprey GnRH-III stimulated IP accumulation at a significantly lower logEC50 when compared to lamprey 
GnRH-I (P<0.002). LogEC50 shown as mean ± SEM; N=3.
I HP (Control)
C S 1 0 -6M LGnRH-l 
■ 1 1 0 - M  LGnRH-l 11
120aa(WT) 80aa 40aa Oaa 
C-Terminal Tail Length
Figure 20. Efficacy of Lamprey GnRH Receptors with C-Terminal Tail Truncations. The wild-type 
lamprey GnRH receptor and mutants containing intracellular C-terminal tail truncations were expressed in 
COS7 cells and treated with a maximum dose (10-6 M) o f lamprey GnRH-I, lamprey GNRH-III or control 
(IP buffer). Functional analysis was performed based on the fold induction o f IP stimulation relative to 
control within each group. Truncations o f  the lamprey GnRH receptor results in a decrease in IP 
production, which is fully recovered in the tail-less mutant form.
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C-terminal tail to 40aa also showed a decrease in signal relative to wild type (28% 
reduction), however to a lesser extent as compared to the 80aa C-terminal tail. Finally, 
the magnitude of signaling of the tail-less lamprey GnRH receptor mutant was shown to 
fully recover, producing IP levels comparable to wild type.
Discussion
Through the characterization and optimization of cell culture and transfection techniques, 
the cloned lamprey GnRH receptor has been shown to be functional. Optimal 
transfection efficiency was shown to be achieved when performed in 60 millimeter 
culture plates with 5x105 cells using 5 pg vector and 15 pL of Lipofectamine.
Stimulation o f the transfected receptor with either lamprey GnRH-I or lamprey GnRH-III 
led to an accumulation of IP in a dose dependant manner. Lamprey GnRH receptor C- 
terminal tail truncations resulted in an initial decrease in IP production relative to wild 
type, which was fully recovered by the tail-less mutant. These data suggest the cloned 
lamprey GnRH receptor is lamprey GnRH-III selective.
The GnRH receptor family is unique among G protein-coupled receptors because 
a number of its members lack an intracellular C-terminal tail. All of these tailless 
receptors have been identified from mammalian species, and since the first six GnRH 
receptors identified were tailless, it was originally thought that all GnRH receptors lacked 
a C-terminal tail. In 1997, the first GnRH receptor with a C-terminal tail was identified 
in the African catfish (Tensen et al., 1997). The implications of this variation in presence 
or absence of the C-terminal tail remains an important subject of investigation. Various 
studies have shown that the C-terminal tail of GPCRs has an important role in controlling
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expression, membrane cycling, desensitization, and G protein activation (Blomenrohr et 
al., 2002; Sealfon et al., 1997). Progressive truncation of the C-terminal tail of the catfish 
receptor 1 was shown to drastically and progressively reduce surface expression of the 
receptor (Blomenrohr et al., 1999; Bogerd et al., 2002), and addition of the catfish GnRH 
receptor 1 C-terminal tail to the rat GnRH receptor greatly increased the surface 
expression of the receptor construct (Lin and Conn, 1998). The known tailed GnRH 
receptors contain intracellular tails of varying sizes from 40 -  80 amino acids in length. 
The lamprey GnRH receptor includes a C-terminal tail of 120 amino acids; this is the 
longest C-terminal end identified to date in a GnRH receptor. An initial analysis of the 
functional significance of the lamprey GnRH receptor’s lengthy C-terminal tail was 
performed based on the magnitude of IP signaling using mutants of the lamprey GnRH 
receptor containing serial truncations of the intracellular C-terminal tail (120aa (wild 
type), 80aa, 40 aa and Oaa (tail-less)), which were stimulated with a maximal dose (10'6 
M) of either lamprey GnRH-I or lamprey GnRH-III. Partial truncations of the C-terminal 
tail resulted in a decrease in the magnitude of IP accumulation compared to wild type, 
however signaling was fully recovered by the tail-less mutant of the lamprey GnRH 
receptor, as shown in Figure 20. Interpretation of these data can be difficult, however in 
conjunction with previous studies of the function of other GnRH receptor C-terminal tails 
(Blomenrohr et al., 1999; Lin and Conn, 1998; Oh et al., 2005; Pawson et al., 1998) we 
suggest these findings indicate that truncation of the lamprey GnRH receptor C-terminal 
tail may cause a structural alteration which decreases ligand binding affinity and 
therefore decreases IP signaling. Alternatively, this structural alteration could lead to a 
disturbance in G protein binding to the activated receptor, however it may likely be a
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combination of both (Blomenrohr et al., 1999). Interestingly, the magnitude of IP 
signaling of the tail-less lamprey GnRH receptor is equivalent to the wild type, which we 
speculate to be due to a compensation resulting from a reduced level of ligand dependant 
internalization, which is typically seen in tail-less type I GnRH receptors and some tail­
less type II GnRH receptor mutants (Blomenrohr et al., 1999; Lin and Conn, 1998; Oh et 
al., 2005). This suggestion that the tail-less mutant may be subjected to a reduced level 
of ligand dependant internalization is supported by the fact that all of the 
phosphoacceptor sites located within the lamprey GnRH receptor’s C-terminal tail are 
located within the first 40 amino acids, as predicted by the CBS Prediction Server at the 
Technical University of Denmark (Figure 21). Additionally, the long C-terminal tail of 
the lamprey GnRH receptor may function, in part, to produce the high levels of surface 
expression demonstrated in our previous GnRH binding studies (Knox et al., 1994; 
Mateme et al., 1997). This analysis indicates the lamprey GnRH receptor possesses 
several of the conserved structural and functional attributes of both type I and type II 
GnRH receptors, and is therefore likely a representative of the ancestral form. Further 
analysis of the function of the lamprey GnRH receptor’s lengthy C-terminal tail on the 
level of cell surface expression, ligand binding affinity and internalization is the subject 
of ongoing research in our laboratory, which will be necessary to fully describe this 
unique system.
In conclusion, cell culture and transfection techniques were established, which 
were used to show that stimulation of the cloned lamprey GnRH receptor led to a dose 
dependant response in accumulation of IP when treated with either lamprey GnRH-I or 
lamprey GnRH-III. Functional analysis o f the lamprey GnRH receptor C-terminal tail
69
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
N e t P h o s  2 . 0s p r e d i c t e d  p h o s p h o r y 1 a t i o n  s i t e s  i n  S e q u e n c e  
___________I__________ i__________ |__________ i___________l
o
Cl
20 40 60 80
S e q u e n c e  p o s i t i o n
100 1 2 0
Figure 21. Predicted Phosphoacceptor Sites Located W ithin the Lamprey GnRH Receptor C- 
Terminal Tail. The lamprey GnRH receptor C-terminal tail amino acid sequence was used to search for 
predicted phosphoacceptor sites using the NetPhos 2.0 search tool through the Technical University o f  
Denmark’s Center for Biological Sequence Analysis. Sequence position referes to amino acid number 
within the C-terminal tail.
indicates it’s significant role in IP signaling and internalization. In addition to having an 
important role in lamprey reproductive processes, the extensive C-terminal tail of the 
lamprey GnRH receptor has great significance for understanding the evolutionary change 
of this vital structural feature within the GnRH receptor family.
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CHAPTER III
FUNCTIONAL CHARACTERIZATION AND KINETIC STUDIES OF AN 
ANCESTRAL LAMPREY GnRH-III SELECTIVE TYPE II GnRH RECEPTOR FROM 
THE SEA LAMPREY, PETROMYZON MARINUS
Introduction
The vertebrate hypothalamic-pituitary-gonadal (HPG) axis is regulated by the 
gonadotropin-releasing hormone (GnRH), a decapeptide hormone that is produced and 
released from the hypothalamus. At the anterior pituitary, GnRH action is mediated 
through high affinity binding with the GnRH receptor, a class A, or rhodopsin-like seven 
transmembrane G-protein coupled receptor (GPCR) (Millar et al., 2004). The GnRH 
receptor is unique among all GPCRs in that the type I mammalian GnRH receptors lack 
the highly conserved intracellular carboxy-terminal (C-terminal) tail, which has been 
shown to be a vital structural element required for several key functions, such as G- 
protein coupling and second messenger activation, ligand binding, cell surface expression 
and ligand dependant internalization (Blomenrohr et al., 1999; Bockaert et al., 2003; 
Heding et al., 1998; Koenig and Edwardson, 1997; Ronacher et al., 2004). Based simply 
on the presence or absence of a C-terminal tail, the GnRH receptors can be divided into 
two groups; the type I tail-less GnRH receptors, which have only been identified in 
mammals and the C-terminal tail containing type II GnRH receptors, which have been
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identified across the vertebrate lineage (Ikemoto et al., 2004; Okubo et al., 2001; Silver et 
al., 2005).
GnRH receptor signaling has been characterized in several systems, and is 
primarily thought to function through the IP3 second messenger pathway, however type II 
GnRH receptors and in some cases type I GnRH receptors have been shown to also 
activate cAMP signaling (Arora et al., 1998; Grosse et al., 2000; Liu et al., 2002; Oh et 
al., 2005; Stanislaus et al., 1998). The presence or absence of the C-terminal tail in the 
type II and type I GnRH receptors, respectively, could possibly explain the signaling 
disparity between the two groups, where, for example, an HFRK motif in the membrane 
proximal region of the bullfrog type II GnRH receptors was recently shown to be 
required for cAMP signaling (Oh et al., 2005). Rapid, ligand dependant internalization 
resulting in desensitization and/or signal switching is another key functional difference 
between type I and type II GnRH receptors, which has been described and attributed to 
the presence or absence of specific Ser/Thr residues located throughout the C-terminal 
tail (Blomenrohr et al., 1999; Pawson et al., 2003; Ronacher et al., 2004; Willars et al., 
1999).
As an agnathan, the oldest class of vertebrates, the sea lamprey has become a 
model system for the analysis of the evolution o f the neuroendocrine regulation of 
reproduction (Sower, 2003). Lamprey express two forms of GnRH, lamprey GnRH-I and 
lamprey GnRH-III, both of which are produced in the hypothalamus and have been 
shown to regulate the reproductive axis (Deragon and Sower, 1994; Sherwood et al.,
1986; Silver et al., 2004; Sower et al., 1993; Suzuki et al., 2000). Recently, a GnRH 
receptor cDNA was cloned from the sea lamprey, Petromyzon marinus, which contained
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a C-terminal tail of 120 amino acids, the longest of any previously described GnRH 
receptor (Silver et al., 2005). To better describe the lamprey GnRH receptor a series of 
functional and pharmacological assays were performed in the current study. The lamprey 
GnRH receptor was shown to stimulate the cAMP signaling system, in a dose dependant 
manner, which, through mutagenesis studies, was shown to depend on the presence of the 
C-terminal tail. The C-terminal tail was also shown to be required for rapid ligand 
dependant internalization, binding affinity and to some degree, cell surface expression. 
Finally, pharmacological profiling, in conjunction with these and previous efficacy data 
confirms that the lamprey GnRH receptor is lamprey GnRH-III selective. These data 
indicate that the lamprey GnRH receptor shares several characteristics of both type I and 
type II GnRH receptors, and may represent an ancestral form, which provides insight into 
the evolution and function of the GnRH receptor family.
Materials and Methods
Cell Culture, Construct Development and Transfection
COS7 cells (American Type Culture Collection, Manassas, VA) were maintained in 10% 
fetal bovine serum (FBS) in Dulbecco’s Modified Eagle’s Medium (DMEM) at 37°C in 
5% CO2 . The coding regions o f the wild type and mutant lamprey GnRH receptor 
(GenBank Accession Number AF439802) (See Figure 17) were inserted into the 
pcDNA3.1 mammalian expression vector (Invitrogen, Carlsbad, CA). The lamprey 
GnRH receptor open reading frames were amplified via PCR using the Advantage2 PCR 
system (CLONTECH, Mountain View, CA) with the LGnRH-R ORF 5’ (5’-CAC CAT
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GGA ACC CAT CAA CAT GAA CAT GAC-3’) combined with either the LGnRH-R 
ORF 3’ (to produce the wild type ORF: 5’-TCA GAT GCAGCA GCT TTC AGG ACA 
TAC GAG AG-3’), LGnRH-R 80aa 3’ (to produce the lamprey GnRH receptor with an 
80aa C-terminal tail: TCA-TGC-CGC-TCT-GTT-CAC-GGG-GAC), LGnRH-R 40aa 3’ 
(to produce the lamprey GnRH receptor with a 40aa C-terminal tail: TCA-ACT-CCG- 
CAC-GGA-CGA-GGC-CGA), or the LGnRH-R Oaa 3’ (to produce the tail-less lamprey 
GnRH receptor: TCA-CGC-CGC-GAA-CAC-GCC-GTA-GAT). The day prior to 
transfection, 5x10s cells were seeded in 60-millimeter culture plates. Transfection was 
performed using 5 pg of vector and 15 pL of Lipofectamine (Invitrogen) in 2.4 mL total 
volume in Opti-MEM-I (Invitrogen) per culture.
LGnRH Receptor cAMP Assay
The day after transfection, cells were trypsinized and 96-well plates were seeded with 
5xl0 4  cells/well, and cultures were grown overnight. On day 3, cells were stimulated 
with either control (ID buffer - 1.0 mM 3-isobutyl- 1-methylxanthine in DMEM), 
LGnRH-I (American Peptide Company, Sunnyvale, CA) or LGnRH-III (American 
Peptide Company) in ID buffer (concentrations ranging from 10' 5 M to 10" 1 0  M for dose 
response analysis or 10' 5 M for the C-terminal tail functional analysis) for 1 hr at 37°C. 
Treatments were performed in triplicate and cells transfected with blank vector were used 
as negative controls. cAMP assays were performed using the BioTrak 
Enzymeimmunoassay system (Amersham), per the manufacturers instructions. Analyses 
were performed using Prism (GraphPad San Diego, CA).
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Whole Cell LGnRH Receptor Saturation Binding Assay
• * 1 2 5Saturation binding assays were performed using adherent, intact cells with 1-lamprey
GnRH-I. 1 2 5 I-lamprey GnRH-I was iodinated using a modification of the chloramine-T
method, which was purified as described by Stopa et al.(Stopa et al., 1988). As a note,
lamprey GnRH-III was not used as the radioligand since it cannot be iodinated due to the
lack of a Tyr residue. For saturation binding assays, the day after transfecting COS7 cells
with either the wild type of mutant lamprey GnRH receptors, lxlO 5 cells were seeded
into 24 well plates in 500 pL of medium, which were grown for 2 days at 37°C in 5%
CO2 . Cells were then washed one time in 500 pL of assay buffer (25 mM HEPES
modified DMEM with 0.1% BSA), followed by incubation with increasing 
1concentrations of I-lamprey GnRH-I (InM to lOOnM), in 200 pL total volume of assay 
buffer, for 3.5 hrs on ice in the 4°C cold room. Non-specific binding was determined 
using cells incubated with both 1 2 5 I-lamprey GnRH-I and 10 pM cold lamprey GnRH-III. 
After 3.5 hrs, cells were quickly washed two times with 500 pL of ice cold PBS and cells 
were examined using an inverted microscope to insure no cells were lost. Cells were 
solubilized with 300 pL of 0.5 M NaOH, 0.1% BSA, and bound 1 2 5I-lamprey GnRH-I 
was counted using a y-counter. All total binding samples were run in triplicate, while 
NSBs were run in duplicate, and each independent experiment was repeated 2-3 times. 
Data were analyzed using Prism (GraphPad).
Competitive Binding Analysis
Competitive binding properties of lamprey GnRH-I, lamprey GnRH-III, chicken GnRH- 
II (Peninsula Laboratories, San Carlos, CA), mammalian GnRH (Peninsula Laboratories)
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and DAla6 -Pro9-NEt mGnRH (Peninsula Laboratories) were performed using COS7 cells 
transfected with the wild type lamprey GnRH receptor. Cells were prepared as described 
above, however the 1 2 5I-lamprey GnRH-I concentration was held constant at 10 nM, with 
either assay buffer (total binding) or increasing concentrations of cold competing ligand 
in assay buffer (ranging from 10" 1 3 M to 10"6  M) in 200 pL total volume for 3.5 hrs on ice 
in the 4°C incubator. Cells were washed and processed as described above. All samples 
were run in triplicate, in three independent experiments. Data were analyzed using Prism 
(GraphPad).
LGnRH Receptor Internalization Assay
Internalization of I-LGnRH-I was performed based on the acid-wash method, as 
previously described (Hazum et al., 1983; King et al., 2000; Pawson et al., 1998). Briefly, 
COS7 cells transfected with the wild type lamprey GnRH receptor or C-terminal tail 
truncated mutants were seeded ( lx l 05 cells) in 24 well plates in 500 pL of medium, and 
were grown for 48 hours. Cells were incubated with 10 nM 1 2 5 I-LGnRH-I on ice at 4°C 
for 3.5 hours. Cells were then immediately brought to 37°C for increasing periods of 
time. At the end of each time point, cells were placed on ice and were washed two times 
with 500 pL of ice cold PBS. Acid sensitive (surface bound) 1 2 5 I-LGnRH was washed 
away by the addition of 0.3 mL of acid solution (150 mM NaCl, 50 mM acetic acid, pH 
2.8) for 12 min. The acid wash was removed, and acid insensitive (internalized) ligand 
was recovered using solubilizing reagent (0.5 M NaOH with 0.1% SDS). Both acid 
sensitive and insensitive binding was quantified via y-counter, and percent internalization 
was determined based on comparison of internalized ligand to total cell associated ligand
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(internalized + surface bound). NSBs were determined using non-transfected cells. 
Treatments were performed in triplicate, and independent experiments were run 3 times 
for each receptor construct. Data were analyzed using Prism (GraphPad).
Results
Lamprey GnRH receptor cAMP activation
Both lamprey GnRH-I and lamprey GnRH-III stimulated a significant response in cAMP 
accumulation, in a dose dependant manner, in COS7 cells that were transiently 
transfected with the lamprey GnRH receptor (Figure 22). The LogECso (represented as 
mean ± SEM; n=3) of lamprey GnRH-III (-8.29 ± 0.090) was significantly (P < 0.0001) 
lower then the LogECso of lamprey GnRH-I (-6.57 ± 0.150). This approximately 50-fold 
difference suggests that the presently cloned lamprey GnRH-R is lamprey GnRH-III 
selective. Cells transfected with blank pcDNA3.1 vector did not respond to treatment 
with ether lamprey GnRH-I or lamprey GnRH-III (data not shown).
Consistent with this difference in LogECso, lamprey GnRH-III stimulated a larger 
magnitude of cAMP accumulation, compared to lamprey GnRH-I, when the wild type or 
mutant lamprey GnRH receptors were treated with a maximum dose (10'5 M) (Figure 23). 
Stimulation of the wild type lamprey GnRH receptor led to a 1.68 ± 0.073 fold increase 
in response to lamprey GnRH-I and a 2.11 ±0.162 fold increase in response to lamprey 
GnRH-III. Serial truncation of the lamprey GnRH receptor led to a drastic decrease in 
the magnitude of cAMP accumulation, whereas the stimulation of the 80aa C-terminal 
tail resulted in 1.26 ± 0.204 and 1.36 ± 0.117 fold increases in response to lamprey
77
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Figure 22. Lamprey GnRH Receptor cAMP Dose Response. The lamprey GnRH receptor was shown 
to activate the cAMP signaling system in a dose dependant manner. Lamprey GnRH-III (LogEC50 -8.29 ± 
0.090) was a significantly more potent activator o f the lamprey GnRH receptor relative to lamprey GnRH-I 
(LogEC50 -6.57 ± 0.150). Representative curve from 3 independent experiments, LogEC50 shown as mean 
SEM; n=3.
GnRH-I and lamprey GnRH-III, respectively. Further truncation of the C-terminal tail to 
40aa resulted in a recovery of cAMP accumulation (1.77 ± 0.242 fold for lamprey GnRH- 
I and 2.19 ± 0.262 fold increases for lamprey GnRH-III), however the tail-less mutant 
showed a drastic reduction in ability to activate the cAMP system (1.26 ± 0.056 fold 
increase in response to lamprey GnRH-I and 1.30 ± 0.059 fold increase in response to 
lamprey GnRH-III).
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Figure 23. Efficacy of Lamprey GnRH Receptors with C-Terminal Tail Truncations. cAMP 
accumulation assay using Wild type and mutant lamprey GnRH receptors containing C-terminal tail 
truncations treated with a maximum dose ( 10"5 M) o f either lamprey GnRH-I or lamprey GnRH-III are 
shown relative to fold stimulation. Lamprey GnRH-III simulates a greater magnitude o f  cAMP signaling 
compared to lamprey GnRH-I in the wild type receptor. Truncation of the C-terminal tail reduced cAMP 
accumulation, which was not recovered in the tail-less mutant form.
Pharmacological Characterization
Binding of 1 2 5I-lamprey GnRH-I to intact, adherent COS7 cells transfected with the 
lamprey GnRH receptor was saturable with a Bmax of 394.6 fMol/well and a IQ of 31.1 
nM. This relatively high IQ was expected, given that this receptor is likely lamprey
• • • m rGnRH-III selective. Binding of I-lamprey GnRH-I to the C-terminal tail truncated 
mutant lamprey GnRH receptors was also saturable (see Figure 24), whereas the 80aa tail 
mutant had a Bmax of 276 fMol/well and a IQ of 51.7 nM, the 40aa tail mutant had a 
Bmax of 1906 fMol/well and a IQ of 85 nM, while the Oaa tail-less mutant had a Bmax of 
775 fMol/Well and a IQ of 72 nM (See table 2). C-terminal tail truncations resulted in an
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intact Cell Saturation Binding
□ 120aaTail 
a 80aa Tail 
v 40aa Tail 
O Oaa Tail
Figure 24. Saturation Binding Analysis. Saturation binding analysis of " I-lamprey GnRH-I using 
adherent, intact COS7 cells transfected with the wild type lamprey GnRH receptor (□), 80aa tail (A), 40aa 
tail (V), or tail-less (0) mutants. Data shown as mean ± SEM (n=3), representing 2-3 independent 
experiments.
increase in cell surface expression of the 40 aa C-terminal tail (483.0% of wild-type) and 
tail-less mutants (196.4% o f wild-type), while the 80aa C-terminal tail mutant expression 
decreased (69.9% of wild-type). In all cases the truncations resulted in an increase in Kd, 
80aa tail (166.2% of wild-type), 40aa tail (273.3% of wild-type) and tail-less (231.5% of 
wild-type).
COS7 cells transfected with the wild-type lamprey GnRH receptor were used in a 
series of competitive binding assays in order to describe the binding affinity of different 
GnRH isoforms. Assays using intact, adherent cells were performed holding 125I lamprey 
GnRH-I constant at 10 nM with increasing concentrations of cold competitor, ranging
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Lamprey GnRH Receptor C-terminal Tail Truncations: Function and Pharmacology
cAMP Accumulation Binding Kinetics
Construct LGnRH-I LGnRH-III Kd (nM) Bmax (IMol/Well)
Wild Type 1 .6 8 ± 0.073 2 .1 1 ± 0.162 31.1 ± 10.3 394.6 ± 52.1
80aa Tail 1.26 ± 0.204 1.36 ± 0.117 51.7 ± 18.4 276.1 ± 46.9
40aa Tail 1.77 ± 0.242 2.19 ± 0.262 85.4 ± 5.3 1906 ± 67.1
Tail-Less 1.26 ± 0.056 1.30 ± 0.059 72.3 ± 19.8 774.5 ± 140.9
Table 2. Summary o f Lamprey GnRH Receptor C-Terminal Tail Truncation Analysis. Note, 
mGnRHa is DAla6Pro9NEt mammalian GnRH.
lamprey GnRH receptor is lamprey GnRH-III selective (Figure 25), with a 
pharmacological profile of lamprey GnRH-III (Kj = 0.708 ± 0.245 nM) = chicken GnRH- 
II (Kj = 0.765 ± 0.160 nM) > mammalian GnRH (Ki = 12.9 ± 1.96 nM)> DAla6-Pro9 
NEt mammalian GnRH (Kj= 21.6 ± 9.68 nM) > lamprey GnRH-I (118.0 ± 23.6) (see 
table 3).
LGnRH Receptor Competitive Binding
□ LGnRH-III 
a  LGnRH-l 
v mGnRH
o DAIa6P ro 9NEt mGnRH 
o chG nRH -ll
GnRH (LogM)
Figure 25. Lamprey GnRH Receptor Competitive Binding Analysis. Competitive binding analysis of 
125I-lamprey GnRH-I using intact adherent COS7 cells transfected with the wild type lamprey GnRH 
receptor incubated with increasing concentrations o f lamprey GnRH-III (□), lamprey GnRH-I (Z^ , 
mammalian GnRH (V), DAla6Pro9NEt mammalian GnRH (0) or chicken GnRH-II (o). Data shown as 
mean ± SEM (n=3) o f % maximum binding demonstrates a binding preference for lamprey GnRH-III, 
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LamDrev GnRH Recentor Characterization
GnRH Form LoeECSO LoeIC50 Ki (nM)
IGnRH-III -8.29 ± 0.09 -8.99 ± 0.0922 0.708 ± 0.245
IGnRH-I -6.57 ±0.15 -6.81 ± 0 .116 118.0 ±23.6
chGnRH-II — -8.96 ±0.0713 0.765 ±0.16
mGnRH — -7.79 ±0 .147 12.9 ± 1.96
mGnRHa — -7.68 ±0 .116 2 1 . 6 ±9.68
Table 3. Summary of lamprey GnRH receptor efficacy and pharmacological profiling. Note, 
mGnRHa is DAla6Pro9NEt mammalian GnRH.
Lamprey GnRH Receptor Internalization
Internalization of 1 2 5 I-lamprey GnRH-I was used to characterize the effect of C-terminal 
tail length on the rate of ligand dependant internalization, which is described as the 
percent of total cell associated ligand, and fit using a single component exponential 
equation (Y=Ymax(l-ekt); y= % internalized, k = % intemalized/min and t=time in minutes 
(see Figure 26). The wild-type lamprey GnRH receptor was rapidly internalized in 
response to treatment with 10 nM 1 2 5I-lamprey GnRH-I. Within the first 10 min at 37°C, 
approximately 63% of the cell associated radioligand was found in the intracellular 
fraction. Lamprey GnRH receptor mutants with C-terminal tail truncations were used to 
identify regions containing motifs that are required for rapid ligand dependant 
internalization. Truncation of the C-terminal tail to 80aa or 40aa had no effect on either 
the rate or extent of internalization when compared to wild-type. The tail-less lamprey 
GnRH receptor, however, showed a marked reduction in ligand dependent internalization, 
with a Ymax of 28.9%, a drastic reduction compared to the wild-type or other truncated 
mutants.
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Figure 26. Internalization Profiles o f  the Wild-Type and Mutant Lamprey GnRH Receptors. 125I- 
lamprey GnRH-1 mediated internalization o f the wild type lamprey GnRH receptor (□), 80aa tail (A), 40aa 
tail (V), or tail-less (0) mutants in transiently transfected COS7 cells. Treatments were brought to steady 
state on ice and then rapidly brought to 37°C for increasing periods o f time. Percent internalization was 
calculated as a measurement o f  internalized radioligand relative to the total cell associated radioligand. 
Data shown as mean ± SEM (n=3), representing 2-3 independent experiments.
Discussion
The GnRH receptor from the sea lamprey (Petromyzon marinus), a member of the oldest 
class of vertebrates, the agnathans, was used in a series of functional and 
pharmacological experiments in order to investigate and better define how the function of 
the GnRH receptor family has evolved across vertebrates. Stimulation of the lamprey 
GnRH receptor was shown to activate cAMP production, however this activation was 
shown to require the first 40aa of the C-terminal tail. Since the tail-less lamprey GnRH 
receptor mutant was capable of ligand binding we speculate that Gas coupling requires a
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motif within the first 40aa of the C-terminal tail. Pharmacological profiling indicates the 
lamprey GnRH receptor is lamprey GnRH-III selective, with an equal affinity for 
lamprey GnRH-III (Ki = 0.708 ± 0.245nM) and chicken GnRH-II (Ki = 0.765 ±0.16 nM). 
The wild-type, 80aa C-terminal tail and 40aa C-terminal tail lamprey GnRH receptors 
were shown to undergo rapid, ligand dependant internalization, however the tail-less 
mutant was not, indicating a motif within the first 40 amino acids that is required for this 
process. This unique lamprey GnRH receptor, with both high affinity for lamprey GnRH- 
III and chicken GnRH-II and ligand binding activity in the tail-less form may represent 
an important ancestral state which provides insight into the function and evolution of the 
vertebrate GnRH receptor family.
Unique among the approximately 1000 GPCR encoding genes in the human 
genome (Fredriksson et al., 2003), the type I GnRH receptor lacks an intracellular C- 
terminal tail, which is thought to be involved in G protein coupling, cell surface 
expression and internalization (Blomenrohr et al., 1999; Ronacher et al., 2004; Vrecl et 
al., 2000). Interestingly, tail-less, or type I GnRH receptors, have only been identified in 
mammals, while type II GnRH receptors, which contain C-terminal tails, have been 
cloned from species across the vertebrate lineage, suggesting a recent, rapid evolutionary 
history (Millar et al., 2004; Sealfon et al., 1997). A comparative analysis of GnRH 
receptors across the vertebrate lineage can provide significant insight into the molecular 
evolution of this receptor family. In this light, the GnRH receptor from the sea lamprey, 
Petromyzon marinus (Silver et al., 2005), provides an ideal model to analyze basal, or 
ancestral-like functions and functional elements that are involved in ligand binding, 
signaling and internalization.
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Pituitary GnRH receptors are thought to primarily signal through G aq/n, resulting 
in the stimulation of the IP3 second messenger system, however G as activation and 
cAMP signaling has been reported as well (Arora et al., 1998; Grosse et al., 2000; Liu et 
al., 2002; Oh et al., 2005; Stanislaus et al., 1998). G-protein coupling to type I GnRH 
receptors clearly occurs within the intracellular loops, where several motifs have been 
identified that may be involved in G-protein coupling (See table 4). For instance, the 
DRxxxI/VxxPL motif in IL2 and a conserved Ala residue in IL3 have been linked to 
Gaq/11 coupling (Arora et al., 1995; Myburgh et al., 1998), while a BBxxB (where B is 
any basic amino acid) in IL1 was shown the be required for G as coupling (Arora et al., 
1998). Furthermore, the presence or absence of the C-terminal tail in the type II or type I 
GnRH receptors could possibly explain the signaling disparity between the two groups, 
whereas an HFRK motif in the membrane proximal region of the bullfrog type II GnRH 
receptor-1 was recently shown to be required for cAMP signaling, but not for IP 
signaling (Oh et al., 2005). In the present study, lamprey GnRH receptor was shown to 
activate the cAMP signaling system, in a dose dependent manner, in transiently 
transfected COS7 cells. Lamprey GnRH-III (LogECso -8.47 ± 0.046) was a more potent 
activator of this system compared to lamprey GnRH-I (LogECso -6.59 ± 0.082), which 
supports the previous hypothesis, based on IP activation (Silver et al., 2005) that the 
lamprey GnRH receptor is lamprey GnRH-III selective. These data have several 
interesting implications. The lamprey GnRH receptor activates both the cAMP and IP 
signaling systems, however the IP system is activated at an approximately 10 fold lower 
concentration of both lamprey GnRH-I and lamprey GnRH-III, and is also activated to a 
greater magnitude of approximately 4.5 fold, compared to ~1.7 fold (lamprey GnRH-I) or
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Receptor G-Protein Region Involved in G-Protein Coupling Reference
Mouse GnRH-R Gas IL1 (K71LKSR75; L58; L80) Arora et al., 1998
Mouse GnRH-R ffrtq/l l IL2 (L147) Arora et al., 1995 
Kitanovic et al., 2001;
Mouse GnRH-R Grtq/i i IL2 (DRS) Arora et al., 1997
Mouse GnRH-R GOq/u
Gaq/]1*^
EL3 (Leu237) Chung et al., 1999 
Ulloa-Aguirre et al.,
Rat GnRH-R Gas IL3 1998
Rat GnRH-R Gaq/n C-terminus (F325S326L327) Brothers et al., 2002
Human GnRH-R Gaq/i i IL3 (A261) Myburgh et al., 1998
Bullfrog GnRH-Rl Gas C-T (membrane proximal HFRK) Oh et al., 2005
Lamprey GnRH-R Gaq/n IL1, 2 or 3 (Activated by tail-less mutant) Silver et al., 2005
Lamprey GnRH-R Gas C-T (within first 40 amino acids) Presented Here
Table 4. GnRH Receptor Domains Involved in G-Protein Coupling. IL, intracellular loop; C-T, C- 
terminal tail; C-terminus refers to the C-terminal amino acids o f the tail-less type GnRH receptors.
-2.1 fold (lamprey GnRH-III) (Figure 23) accumulation of cAMP. Not unexpectedly, 
truncation of the lamprey GnRH receptor C-terminal tail interfered with cAMP signaling, 
which is partially recovered by the 40aa tail mutant, and lost again in the tail-less mutant 
form. The exact nature of GPCR/G-protein coupling is still in question since no 
conserved motifs that can be generally used to define G-protein specificity have been 
identified, nor has any particular domain been shown to be required. These current data 
indicate that a motif within the first 40aa o f the lamprey GnRH receptor is involved in the 
Gas coupling, which we speculate to be the “HFRK” like motif (HVRR in lamprey) 
located within the membrane proximal region of the C-terminal tail. Furthermore, this 
region contains a BBxxB (B-any basic amino acid), which has been shown to be involved 
in G as coupling in type I GnRH receptors, however in which case this motif is located in 
the first intracellular loop (Arora et al., 1998).
The pharmacological profile of the lamprey GnRH receptor, as shown in Figure
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25 and Table 1, confirms the hypothesis that the lamprey GnRH receptor is lamprey 
GnRH-III selective, and furthermore supports the hypothesis that lamprey express at least 
one additional, lamprey GnRH-I selective receptor, as previously described based on 
quantitative in vitro autoradiography (Knox et al., 1994) and IP signaling efficacy (Silver 
et al., 2005). The equivalent affinity for lamprey GnRH-III and chicken GnRH-II for this 
ancestral vertebrate GnRH receptor implies that perhaps they represent ancestral forms of 
GnRH, as previously suggested (Sherwood et al., 1997; Sower, 1997); nonetheless more 
data would be required to confirm this hypothesis.
Efficacy data on their own can be difficult to interpret and misleading, however in 
conjunction with binding affinity studies they can provide invaluable insight into the 
molecular mechanisms of GPCR function. The effects of lamprey GnRH receptor C- 
terminal tail truncations on binding affinity and cell surface expression showed that 
perturbation of the C-terminal tail increases Kd (reduces binding affinity) and increases 
the level of cell surface expression, except in the case of the 80aa C-terminal tail mutant, 
in which case the level of surface expression decreased . These data may explain the 
drastic decrease in signaling of the 80aa C-terminal tail mutant, which likely results from 
a combination of decreased binding affinity (from 31.1 ± 10.3 nM to51 .7±  18.4 nM) and 
surface expression (from 394.6 ± 52.1 fMol/well to 276.1 ± 46.9 fMol/well). 
Alternatively, the recovery of cAMP accumulation that was seen when the lamprey 
GnRH receptor with 40aa tail was activated may be due to the increase in cell surface 
expression (1906 ± 67.1 fMol/well), which compensates for the reduction in binding 
affinity (85.4 ± 5.3 nM). Lastly, the tail-less mutant was shown to maintain ligand 
binding capability at a diminished binding affinity (72.3 ± 19.8 nM), which, despite an
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increase in surface expression (774.5 ± 140.9 fMol/well), led to the accumulation of near 
basal levels of cAMP (1.26 ± 0.056 fold and 1.30 ± 0.059 fold, when stimulated with 
lamprey GnRH-I or lamprey GnRH-III, respectively). Due to the fact that the tail-less 
lamprey GnRH receptor mutant is known to be active in stimulating IP 3 at an equivalent 
magnitude compared to wild-type type (Silver et al., 2005), these data support the 
hypothesis that Gas coupling occurs within the first 40 amino acids o f the C-terminal tail.
Rapid, ligand dependant GPCR internalization is a well established regulatory 
mechanism that results in receptor desensitization or alternatively facilitates signal 
switching from G-protein mediated second messaging to MAP kinase signaling (McArdle 
et al., 2002). Activation of type II GnRH receptors has been extensively shown to lead to 
rapid internalization that can be P-arrestin dependent or independent, dynamin dependent 
or independent and through either clathrin coated or caveolae (Acharjee et al., 2002; 
Hislop et al., 2005; Pawson et al., 2003; Ronacher et al., 2004). Type I GnRH receptors 
have been shown to be internalized, however at a significantly slower rate and to a lesser 
extent when compared to type II GnRH receptors (Hislop et al., 2005; Pawson et al.,
1998; Willars et al., 1999). Addition of the C-terminal tail from the type II catfish GnRH 
receptor to the rat GnRH receptor was shown to result in several functional aberrations, 
most notably induction of rapid ligand dependant internalization, which was shown to be 
reversible through C-terminal tail truncations (Lin et al., 1998). Furthermore, removal of 
the C-terminal tail from the type II chicken GnRH receptor was shown to result in an 
internalization profile similar to the naturally tail-less human type I GnRH receptor 
(Pawson et al., 1998). These studies provided the impetus to further define the motifs 
involved in this rapid internalization, leading to a series of studies indicating specific
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Ser/Thr moieties located in both the membrane proximal or distal regions of the C- 
terminal tail (Blomenrohr et al., 1999; Millar et al., 2004; Pawson et al., 2003; Ronacher 
et al., 2004). For example, Ser of the catfish GnRH receptor is a major ligand induced 
phosphoaccepter, which, through site directed mutagenesis (S3 63A), was shown to be 
required for rapid internalization (Blomenrohr et al., 1999). Mutation of a Thr doubled 
(Thr Thr ) in the distal region of the chicken GnRH receptor C-terminal tail led to a 
70% reduction in ligand dependent internalization compared to wild-type, which was 
shown to internalize in a fl-arrestin independent, dynamin dependant manner through 
caveolae (Pawson et al., 2003). More recently, Ronacher et al. identified a Ser doublet 
(Ser Ser ) in the membranes proximal region of the human type II GnRH receptor, 
which when mutated to Ala led to a 75% reduction in internalization compared to wild- 
type, which was also shown to require both GRK and dynamin, but not {3-arrestin, and to 
proceed through both clathrin coated pits and caveolae (Ronacher et al., 2004). The 
120aa C-terminal tail of the lamprey GnRH receptor, the longest of any known GnRH 
receptor (Silver et al., 2005), contains several Ser/Thr residues located throughout the 
entire sequence, however they are concentrated within the first 40aa (Figure 27). The 
lamprey GnRH receptor was shown to be rapidly internalized in response to stimulation, 
whereas approximately 60% of the ligand bound receptors were located in the 
intracellular space. Truncation of the C-terminal tail to 80aa or 40aa had no effect on 
internalization (rate or maximum level), however the tail-less mutant showed a drastic 
reduction in internalization, similar to other previously described tail-less receptor 
internalization profiles (Heding et al., 1998; Pawson et al., 1998).
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Figure 27. GnRH Receptor Schematic H: Putative C-Terminal Tail Phosphoacceptor Sites. The
lamprey GnRH receptor C-terminal tail o f  120aa is the longest o f any known GnRH receptor. Several 
putative phosphorylation sites are located within the C-terminal tail, which are shown highlighted in gray. 
Black lines represent cutoff points within the sequence used to develop vectors containing C-terminal tail 
truncations to include the wild type (120aa tail), 80aa tail, 40aa tail or tail-less (Oaa tail) mutants.
In summary, the lamprey GnRH receptor was shown to activate the cAMP 
signaling system, which required the first 40aa of the C-terminal tail. Pharmacological 
profiling, in conjunction with efficacy data, provided evidence that the lamprey GnRH 
receptor is lamprey GnRH-III selective, which supports the hypothesis that lamprey 
express a second, lamprey GnRH-I selective receptor. Truncations of the lamprey GnRH 
receptor’s C-terminal tail were shown to reduce binding affinity, which explains their 
reductions in signaling capacity. Finally, the lamprey GnRH receptor underwent rapid
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ligand dependant internalization, which was drastically reduced in the tail-less mutant 
form, suggesting that putative phosphoacceptor sites located within the first 40aa of the 
C-terminal tail are required for this regulatory mechanism. Since the 40aa C-terminal tail 
lamprey GnRH receptor mutant is capable of stimulating both IP3 and cAMP 
accumulation and undergoes rapid ligand dependant internalization, we speculate that the 
extensive length of the lamprey GnRH receptor C- terminal tail may not have a functional 
significance with these signaling systems. However, the intact lamprey GnRH receptor 
C-terminal tail likely is required for structural stability and therefore efficient ligand 
binding, or possibly for some unknown signaling mechanism. The loss of amino acids in 
the C-terminal tail of GnRH receptors during the subsequent evolution of vertebrates to 
the tail-less form in mammals may reflect the various actions of GnRH in controlling 
pituitary gonadotropins through diverse regulatory mechanisms. These data support the 
evidence that the lamprey GnRH receptor shares several characteristics of both type I and 
type II GnRH receptors, and may represent an ancestral form, which provides insight into 
the evolution and function of the GnRH receptor family.
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CHAPTER IV
CLONING AND ANALYSIS OF THE LAMPREY GnRH-III cDNA FROM EIGHT 
SPECIES OF LAMPREY REPRESENTING THE THREE FAMILIES OF
PETROMYZONIFORMES
Introduction
Gonadotropin-releasing hormone (GnRH) is the central regulator of the hypothalamic- 
pituitary-gonadal axis, and therefore reproductive function, in all vertebrates. To date 
twenty-four isoforms of GnRH have been identified, fourteen from vertebrates and ten 
from invertebrates, two of which were identified in the sea lamprey (Petromyzon 
marinus), lamprey GnRH-I and -III (Sherwood et al., 1986; Sower et al., 1993). In 
addition, the cDNA encoding lamprey GnRH-I has been identified in the sea lamprey 
(Suzuki et al., 2000). Lamprey are the earliest evolved vertebrates for which two forms 
of GnRH have been clearly demonstrated as functional neurohormones mediating the 
pituitary-gonadal axis (Sower and Kawauchi, 2001). Both lamprey GnRH-I and -III 
were shown to be expressed in the preoptic anterior hypothalamus and the posterior 
hypothalamus of the adult sea lamprey (Nozaki et al., 2000). Lamprey GnRH-III is 
considered the most active form during sea lamprey maturation based on the relative 
number of lamprey GnRH-III producing neurons which is larger than lamprey GnRH-I 
producing neurons during the larval and adult stages (Nozaki et al., 2000; Tobet et al.,
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1995) and that lamprey GnRH-III was more potent compared to lamprey GnRH-I in 
inducing spermiation in male sea lamprey (Deragon and Sower, 1994; Sower, 2003). 
Neither lamprey GnRH-I or -III peptides have been isolated from any other species of 
lamprey, although both forms have been detected in the brain and hypothalamus using 
immunocytochemistry and HPLC coupled with radioimmunoassay or 
immunocytochemistry in the pouched lamprey (Geotria australis), Australian lamprey 
(Mordacia mordax), silver lamprey (Ichthyomyzon unicuspis) and western brook lamprey 
(L. richardsoni) (Eisthen and Northcutt, 1996; Sower et al., 2000).
In vertebrates it is now known that two or three forms of GnRH can be expressed 
within the brain of a single species (Dubois et al., 2002; Miyamoto et al., 1984; Wada et 
al., 1998; White and Femald, 1998; White et al., 1994). A proposed relationship of these 
GnRH forms was recently described based on phylogenetic analysis, location of 
expression within the brain and general associated function (Femald and White, 1999).
In this model, the GnRH family was divided into three paralogous lineages, starting with 
GnRH-I (also known as mammalian GnRH and its orthologs), which is expressed in the 
hypothalamus and is the central regulator of the pituitary gonadal axis. GnRH-II (also 
known as chicken GnRH-II) is expressed in the midbrain and is generally considered to 
have a neuromodulatory function (Femald and White, 1999; Parhar, 2002). Finally, 
GnRH-III (also known as salmon GnRH), which is only found in the teleosts, is 
expressed in the telencephalon and is also believed to have a neuromodulatory function 
(Femald and White, 1999; Parhar, 2002). Parhar recently modified this scheme by the 
addition of a fourth family that consists of medaka and seabream GnRH, which formerly 
would have been considered GnRH-I (Parhar, 2002). This modification is supported by
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the fact that the cells producing medaka and seabream GnRH do not share the same 
developmental origin as the other hypothalamic forms, although they do function in a 
similar manner and group together phylogenetically. These models that describe the 
molecular phylogeny of the GnRH family are incomplete since only a limited number of 
the known GnRH sequences were used.
Interest in the evolution of reproductive mechanisms has led researchers to study 
lamprey, which are one of the two extant representatives of the most ancient class of 
vertebrates, the agnathans, which diverged from the main line of vertebrate evolution 
approximately 450 million years ago. The divergence of the lamprey lineage is believed 
to have occurred between two proposed early genome duplications (Ohno, 1970), making 
the lamprey an important model for evolutionary biology (Kuratani et al., 2002). Despite 
this interest in the lamprey, very little is known about the lamprey phylogeny. In the 
1970s a lamprey phylogeny was proposed based primarily on the size, shape and 
distribution of dentition (Hubbs and Potter, 1971; Potter and Hilliard, 1987). Based on 
the morphology of their teeth, the lamprey were divided into three families: the 
Petromyzonidae, which are found in the northern hemisphere, also referred to as the 
holarctic species, and the two southern hemisphere families, Geotriidae and Mordaciidae. 
The Petromyzonidae consists of six genera: Ichthyomyzon, Petromyzon, Caspiomyzon, 
Eudontomyzon, Tetrapleurodon, and Lampetra. Notably the I. unicuspis is believed to be 
the most closely related to the ancestral stock of lamprey due to its simple tooth shape 
and distribution (Hubbs and Potter, 1971). The Geotriidae and Mordaciidae each consist 
of only one genus, Geotria and Mordacia respectively (Hubbs and Potter, 1971). This 
overall division into three families is supported by sequence analysis of the primary
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structure of insulin, where the M. mordax sequence is more similar to that of the holarctic 
sequences than to the G. australis sequence (Conlon, 2001; Conlon et al., 2001). One of 
the divisions of lampreys has since been supported by an analysis o f  mitochondrial genes 
exclusively within the Lampetra, reconfirming the species designation within this family 
(Docker et al., 1999), however, further analysis of other characters is needed to better our 
understanding of the lamprey phylogeny.
To address the question of the molecular relationship within the GnRH family, as 
well as the phylogeny of the lamprey lineage we have isolated the cDNA encoding the 
prepro-lamprey GnRH-III from eight different species of lamprey representing all three 
families of the Petromyzoniformes. These sequences were used in a phylogenetic 
analysis with other known prepro-GnRH sequences published on GenBank, or solely 
with each other to address each question respectively. Our analysis suggests that the 
lamprey GnRH forms are unique as they grouped together, yet separate from the three 
previously described paralogous lineages of GnRH. The analysis within the lamprey 
lineage supports the phylogeny based on dentition at the family level, although ultimately 
additional traits need to be considered.
Materials and Methods
Animal Collection and Handling
Eight species of lamprey were used in this study, which were collected from both North 
America and Australia in accordance to UNHIACUC animal care guidelines. Experts in 
the field, using local fish guides, verified the identity of each species. Species collection 
sites and tissues dissected are described in Table 1. In all cases except one, the dissected
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tissue was immediately frozen in either liquid nitrogen or dry ice, then stored at -80°C. 
The tissues collected from G. australis were immediately submersed in 1 mL of 
RNAlater (Ambion, Austin, TX) at room temperature. Samples were then stored at -  
20°C until used, at which point the RNA/ater was poured off the tissue.
RNA Isolation
Total RNA was isolated using the Tri-Reagent (Molecular Research Center, Inc., 
Cincinnati OH), an isothyocyanate phenol chloroform extraction method, with a glass 
homogenizer. RNA was isolated using 1 mL Tri-Reagent per 100 mg of tissue. Yield 
was determined by spectrophotometry in MilliQ H 20 or phosphate buffer at pH 8.1.
cDNA synthesis
First strand cDNA synthesis was done using the First Strand cDNA Synthesis kit by 
Amersham Pharmacia Biotech (Buckinghamshire, England). First strand synthesis uses 5 
pg of total RNA and is catalyzed using the Moloney Murine Leukemia Virus (M-MuLV) 
reverse transcriptase with a Notl-dTig primer. The RNA was denatured via a 10-minute 
incubation at 65°C before being used. Denatured RNA was then mixed with 1 luL of kit 
reaction mixture (M-MuLV reverse transcriptase, porcine RNAguard, RNase/DNase-free 
BSA, dATP, dCTP, dGTP, and dTTP in buffer), 1 pL of 200mM dithiothreithol (DTT), 
and 1 pi of 5 pg/pl Notl-dTig primer followed by incubation for 1 hour at 37°C. First 
strand cDNA was stored at -20°C. The single strand cDNA can be amplified via the 
polymerase chain reaction (PCR), as described below, or used to make second-strand 
cDNA via the Gubler-Hoffman technique (Gubler and Hoffman, 1983), as done using the
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Species Collection Location Collectors Tissues Collected
P. marimis Cocheco River, NH Sower Lab
Brain, pituitary, testis, ovary, liver, 
kidney, heart, muscle and eye
L. appendix Oyster River, NH Sower Lab Brain
L. tridentatus Washington Craig Robinson (USGS) Brain, testis, ovary, liver and muscle
L. richardsoni Washington Craig Robinson (USGS) Brain, ovary, liver and muscle
I. Unicuspis Great Lakes Region Sid Morkert (US FWLS) Brain and pituitary
/. Fossor Great Lakes Region Paul Sullivan (DFO)
Brain, pituitary, testis, ovary, kidney and 
liver
G. australis Tasmania, Australia Sower and Colleagues
Brain, pituitary, testis, kidney, liver, 
muscle, heart and eye
M. mordax Tasmania, Australia Sower and Colleagues Brain and ovary
Table 5. Summary of Lamprey and Tissue Collection. Tissues were collected from both North America, 
including six species from the Petromyzonidae, and Australia, including one species from both the 
Geotriidae and Mordaciidae. Obtained tissues were subject to availability.
Marathon™ eDNA Amplification Kit (Clontech, Palo Alto, CA, USA). Second-strand 
cDNA was synthesized from single stranded cDNA mixed with 48.4 pi sterile water, 16 
pi 5X second-strand buffer (500 mM KC1, 50 mM ammonium sulfate, 25 mM MgCL2 , 
0.75 mM P-NAD, 100 mM Tris (pH 7.5), and 0.25 mM BSA), 1.6 pi lOmM dNTPs, and 
4 pi of 20X second-strand Enzyme cocktail ( 6  units/pl E. coli DNA polymerase I, 1.2 
units/pl E. coli DNA ligase, and 0.25 units/pl E. coli RNase H) followed by incubation at 
16°C for 1.5 hours. The second-strand cDNA was isolated via rounds of extraction using 
25:24:1 phenol:chloroform:isoamyl alcohol followed by 24:1 chloroform:isoamy 1-alcohol, 
and was finally precipitated using 4 M ammonium acetate and ethanol.
Degenerate PCR
Amplification of the 3’ end of the lamprey GnRH-III cDNA from all eight species was 
performed by PCR using single stranded brain cDNA (ss cDNA) as template with the 
lamprey3-l degenerate primer (GAR-CAY-TGG-TCN-CAC-GAT-TGG) paired with the
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Notl primer. The lamprey3-l primer was designed based on the known decapeptide 
sequence o f lamprey GnRH-III, with consideration of the specific differences to lamprey 
GnRH-I decapeptide. Promega PCR components were used and the cycling was 
performed with an Eppendorf Master Gradient thermal cycler under the following PCR 
parameters: 95°C for 2 min followed by 35 cycles of 95°C 30 sec, 60 °C for 1 min, and 72 
°C for lmin, and finished with a 5 min 72 °C incubation and 4 °C hold. Samples were 
analyzed by electrophoresis using 2% agarose gels stained with ethidium bromide. The 
pGEM-T Easy Vector system (Promega, Madison, WI) was used to clone amplified 
products, which was then sequenced at the Huntsman Cancer Institute DNA Sequencing 
Facility at the University of Utah.
5 ’ Rapid Amplification o f cDNA Ends (RACE)
5’-RACE was performed using the Marathon cDNA Amplification Kit (Clontech). A 
partially double stranded DNA adapter was ligated onto both ends of the synthesized 
double stranded cDNA (see above), to which a specific primer was used in combination 
with a gene specific sense or anti-sense primer [P. marinus:
GGCGCTCTCGAGGAACTTCTCG, I. unicuspis: CGCGTG
CCCT GTT CGT G ACC AAT A A; I. fossor: C AGGGTT CGT GT C ACGT GGCGCTCT; L. 
tridentatus: CCTACACACAGCCACTCTGGGACACGC; L. richardsoni: CGTCAC 
AGACCACAGCGAGGGCATT; L. appendix: GACCCCTGCTGGAGGAGCTTGAGG 
C; G. australis: GGCTCTCGCTGGACGGGTTCG; M. mordax: CTGCGAGAGGTA 
ACTGAGGAGGTC]. All reactions were cycled using the Eppendorf Master Gradient 
thermal cycler under the following parameters: 95°C 2 min followed by 5 cycles of 95 °C
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for 15 sec, 2 °C above primer specific annealing temp 5 min, 5 cycles of 95 °C for 15 sec, 
primer specific annealing temp, 10 cycles of 95 °C for 15 sec, primer specific annealing 
temp less 2 °C for 5 min, 15 cycles of 95 °C for 15 sec, primer specific annealing 
temperature less 4 °C for 5 minutes, and finished with a final 5 minutes 72 °C incubation 
and 4 °C hold. Amplified 5’ ends were cloned and sequenced as described above.
Phylogenetic Analysis
The DNAStar suite by Lasergene was used for sequence analysis (EditSeq) and 
alignments (MegAlign). Two alignments of the GnRH deduced amino acid precursors 
(including the signal peptide, GnRH decapeptide, dibasic cleavage site and GnRH 
associated peptide) were constructed using ClustalW. The first alignment contained the 8 
lamprey GnRH-III precursors (or prepro GnRH) with 64 GnRH precursors representing 
type I, II and III GnRHs as well as the octopus GnRH and 2 tunicate prepro-GnRHs.
This analysis was rooted using the prepro-octopus GnRH protein; the tunicate forms were 
not used as the root due to alignment difficulties. The second alignment contained only 
the 8 lamprey GnRH precursors. Both were analyzed using Phylogenetic Analysis Using 
Parsimony (PAUP) version 4.0betal0 (Swofford, 2001), and trees were constructed using 
the neighbor joining method.
Reverse Transcriptase PCR (RT-PCR)
RNA extracts from all tissues collected were treated with RQl-RNase free-DNase 
(Promega). 50 ng of DNase free RNA was used in each reaction using the AccessQuick 
RT-PCR System (Promega) with a 0.1 pM final primer concentration in a 25.5 pL final
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reaction volume. The primers used were designed to amplify an approximately 400-500 
base pair product [P. marinus 5’: CTG GAATCATCACAGAAGCCACACT, 3’: 
TCTAAGAGACGTCACAGACCACAGC; I. unicuspis 5’: 
GTGTCGCTGACGCACACACAGCAGT, 3’: TCATGTTGACGATAC 
GCTGAGCGGC; I. fossor 5’: C AC ACTCGGCT GCTT GT AG AC AT, 3’: AGCGGC 
GATGAAGAATTAAATAAAC ; L. tridentatus 5’: CGGT GGTTT ATTTT CT C A AC A 
GACC, 3’: TCT A AGAG ACGT C AC A A ACC AG AGC; L. richardsoni 5’: GAAACA 
AACAGATTCCTCTCCGAGC, 3’: CGTT GATT AT CTTCGT CT GC AGCTT ; L. 
appendix 5’: CT GG AAT CAT C AC AGAAGCC AC ACT, 3’: CTGAGCGGCGATGAA 
A AATT A A AT A ; G. australis 5’: ACAACTTTATTCACGGACAACACCC, 3’: AGA 
TT GT GAGCT ACCT CTCGC AG AA; M  mordax 5’: AC ACGT GTT GAG ACGAT G 
GAGAAAT, 3’: GAT AC ACCTT GC AGGA AT CAT C ACC]. Thermal cycling was 
performed using an Eppendorf Master Gradient thermal cycler using the following 
parameters: 48°C for 45 min, 95 °C for 2 min followed by 30 cycles of 95 °C for 15 sec, 
primer specific annealing temperature for 1 min and 72 °C for 1 min, and finishing with a 
5 min 72 °C incubation and 4 °C hold. Samples were analyzed by electrophoresis using 
2% agarose gels stained with ethidium bromide, and were visualized using the Molecular 
Imager FX (BioRad, Hercules, CA).
Results
Cloning o f the Lamprey GnRH-III cDNAs
The initial products amplified by degenerate PCR encoded from the mature GnRH 
decapeptide through the poly-adenylation sequence. These sequences were then used to
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develop the gene specific primers that were used for 5’RACE, which amplified products 
from the 5’ untranslated region (UTR) through the mature GnRH decapeptide. In all, 
eight cDNAs were cloned that encoded the conserved tripartite structure of the prepro- 
GnRH protein, including a signal peptide (Sig), mature lamprey GnRH-III decapeptide 
and dibasic cleavage site, followed by the GnRH associated peptide (GAP), which are 
flanked by untranslated regions on either side.
The 8 lamprey GnRH-III cDNAs were used to construct a percent identity matrix 
(Table 6). This matrix shows the high percent identity (-90%) between the 
Petromyzonidae sequences, and most notably the relatively low percent identity between 
the two southern hemisphere sequences, the G. australis and M. mordax (48.5%), 
highlighted in grey. The encoded precursor proteins were compared by domain, which 
showed a high level o f sequence conservation relative to the P. marinus (Figure. 28).
The signal peptide and GAP region are highly conserved within the Petromyzonidae, but 
are less conserved compared between families.
cDNA Percent Identity Matrix
I f Iu L a L r Lt P m G a Mm
I. Fossor X 88.8 89.5 90.1 88.0 89.0 54.3 49.2
I. Unicuspis X 95.4 90.8 91.6 95.4 59.2 53.9
L. appendix X 92.3 93.1 93.9 57.3 52.6
L. richardsoni X 91.5 90.7 56.3 54.2
L. tridentatns X 92.8 59.2 57.1
P. marinus X 60.9 53.6
G australis X 48.5
M. mordax X
Table 6. Percent Identity Matrix of the Cloned Lamprey GnRH-III cDNAs. The eight lamprey 
GnRH-III cDNAs were used to construct a percent identity matrix. As expected, there is a relatively high 
percent identity between the holarctic sequences (low 90’s). Most notably, the percent identity between the 
sequences from the two southern hemisphere families is relatively low (48.5).
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Figure 28. Lamprey GNRH-III Protein Precursor Domain Conservation. The signal peptide (mid­
grey) and GAP (dark grey) regions o f the lamprey GNRH-III precursors were compared relative to the P. 
marinus. Both regions are highly conserved within the Petromyzonidae, but are less conserved between the 
three families.
The P. marinus lamprey GnRH-III cDNA (AY052628) is 718bp in length and 
includes an open reading frame (ORF), bp ] 0 7 -3 8 8 , which encodes a 93 amino acid (aa) 
peptide (Sig2 4 aa, GAP56aa). The L. appendix lamprey GnRH-III cDNA (AY307176) is 
722bp in length and contains an ORF, bpn 1.3 8 9 , which encodes a 92aa peptide (Sig2 4 aa, 
GAP55aa). The L. tridentatus lamprey GnRH-III cDNA (AY307178) is 732bp in length 
and contains an ORF, bpi2 i-3 9 9 , which encodes a 92aa peptide (Sig2 4 aa, GAP5 5 aa). The L. 
richardsoni lamprey GnRH-III cDNA (AY307177) is 710bp in length and contains an 
ORF, bpi 1 0-3 8 8 , which encodes a 92aa peptide (Sig2 4 aa, GAP55aa). The I. unicuspis 
lamprey GnRH-III cDNA (AY307176) is 723bp in length and contains an ORF, bpi 14-392 ,
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which encodes a 92aa peptide (Sig2 4 aa, GAP5 5 aa). The I. fossor lamprey GnRH-III cDNA 
(AY307175) is 728bp in length and contains an ORF, bpio8-3 8 6 , which encodes a 92aa 
peptide (Sig2 4 aa, GAP5 5 aa). The G. australis lamprey GnRH-III cDNA (AY307172) is 
774bp in length and contains an ORF, bp 12 4 -4 0 8 , which encodes a 94aa peptide (Sig2 5 aa, 
GAP5 6 aa). The M. mordax lamprey GnRH-III cDNA (AY3 07173) is 6 6 6 bp in length and 
contains an ORF, bp8 5 -3 6 3 , which encodes a 92aa peptide (Sig2 4 aa, GAP5 5 aa) (See Figures 
29-32).
Phylogenetic Analysis
The first alignment used included the eight newly discovered deduced amino acid 
lamprey GnRH-III precursor (preproGnRH) sequences with 64 other sequences from 
GenBank. These additional sequences were selected such that representatives from the 
different classes of vertebrates where included for each GnRH type where possible.
Trees were constructed using the neighbor joining method with the prepro-octopus GnRH 
(AB037165) sequence as an out-group (Figure. 33). The produced tree clearly shows the 
lamprey GnRH forms grouping together, yet outside of the other previously described 
groups of GnRH (I, II and III). Phylogenetic analysis of the 8  lamprey GnRH-III cDNAs 
shows the sequences are divided into 3 groups (Figure. 34), which is a neighbor joining 
tree overlaid with bootstrap values (1000 replicates). This analysis, where branch length 
represents sequence distance, clearly shows the sequences are grouped corresponding to 
the Petromyzonidae, Geotriidae or Mordaciidae, and furthermore, the separation of the 
Geotriidae and Mordaciidae into two distinct families is supported as the G. australis and 
M. mordax sequence are approximately equally removed from each other as they are 
from the Petromyzonidae sequences.
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Figure 29 Lamprey GnRH-III cDNA Sequences I. Lamprey GnRH-III cDNA and encoded protein 
from the Petromyzon marinus (A) and Lampetra tridentatus (B).
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Figure 31. Lamprey GnRH-III cDNA Sequences ID. Lamprey GnRH-III cDNA and encoded protein 
from the Ichthyomyzon unicuspis (A) and Ichthyomyzon fossor (B).
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Figure 32. Lamprey GnRH-III cDNA Sequences IV. Lamprey GnRH-III cDNA and encoded protein 
from the Geotria australis (A) and Mordacia mordax (B).
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RT-PCR
Analysis of tissue specific expression of lamprey GnRH-III was limited to the available 
tissues from each species. In all species examined the lamprey GnRH-III amplicon was 
visualized in the brain. Of the 4 pituitary samples, P. marinus, I. fossor, I. unicuspis and 
G. australis, lamprey GnRH-III expression was only visualized in the P. marinus and I. 
unicuspis. Lamprey GnRH-III expression in the gonads was only seen in the ovary of the 
L. tridentatus, which was verified by sequence analysis (Figure. 35). Expression was not 
seen in any of the other tissues examined. Negative controls, which were identical to the 
experimental reactions in setup and cycling but lacked RNA template, did not show any 
bands (data not shown).
Discussion
We have cloned the full-length cDNA encoding the deduced prepro-lamprey GnRH-III 
precursor from eight species of lamprey. Based on our phylogenetic analysis o f 72 GnRH 
precursors, including the lamprey GnRH-III precursor sequences, along with data from 
previous immunocytochemical and functional studies, we propose that the lamprey 
GnRH isoforms constitute a fourth group of the GnRH family of peptides. In addition, 
our data showed that the lamprey GnRH-III precursors of the two southern hemisphere 
species are highly divergent from the lamprey GnRH-III of the holarctic species, and to 
each other, which supports the lamprey phylogeny based on dentition (Hubbs and Potter, 
1971).
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Figure 33. Phylogenetic Analysis o f GnRH Precursors. The neighbor joining method was used to 
construct this phylogenetic tree o f the deduced amino acid prepro-GnRH precursors (Signal peptide, GnRH, 
dibasic cleavage site and GAP), which is rooted with octopus GnRH. The lamprey GnRH forms group 
separately from the previously described type I, II and IH GnRHs, which suggests they form a unique 
lineage o f  the GnRH family. M, mammalian; cat, catfish; h, herring; g, guinea pig; ch, chicken; r, rana; md, 
medaka; sb, seabream; s, salmon; 1, lamprey.
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Figure 34. Phylogenetic Analysis o f the Lamprey GnRH-III Precursors Proteins. The neighbor 
joining method was used to construct this unrooted phylogenetic tree, where branch length represents 
sequence dissimilarity, o f  the eight prepro-lamprey GNRH-III precursors (signal peptide, GnRH, dibasic 
cleavage site and GAP). The topology o f the tree is divided into three groups corresponding to the three 
families o f  lamprey, the Petromyzonidae, Geotriidae and Mordaciidae. The analysis was resampled with 
1000 bootstrap replicates, which were averaged for the Petromyzonidae group for logistical purposes. This 
tree supports the lamprey phylogeny based on dentition at the family level, which is a strong division as the 
bootstrap value o f the internal branch between the three groups is 98.
Although the application of molecular phylogenetic analysis to reconstruct species 
phylogeny is prone to conflicting results, it is widely accepted as an invaluable addition 
to anatomical, physiological, and behavioral analyses (Brocchieri, 2001; Lio andGoldman, 
1998; Slowinski and Page, 1999). In our analysis a molecular phylogenetic approach was 
used to assess the previously proposed phylogeny of Petromyzoniformes (Hubbs and 
Potter, 1971), which was based primarily on the size, shape and distribution of dentition.
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Figure 35. Tissue Specific Expression o f the Lamprey GnRH-III Transcript. Tissue specific 
expression of the lamprey GNRH-III transcript was determined using RT-PCR. Products were analyzed by 
gel electrophoresis using the PGem7 ladder (in lane one o f each gel), which contains molecular weight 
markers o f  3000,1822, 1229, 657, 450 and 300 bp. B, brain; P, pituitary; T, testes; O, ovary; K, kidney; L, 
liver; M, muscle; H, heart; E, eye.
Based on this scheme, it is proposed that the lamprey lineage is divided into three 
families, including the Petromyzonidae, or holarctic species, and the two southern 
hemisphere families, which include the Geotriidae and Mordaciidae. This model has 
been supported by sequence analysis of the primary structure of insulin, which suggested 
that the M. mordax insulin was more closely related to the insulin of the holarctic species 
than to the G. australis insulin, although no molecular phylogenetic analysis has been 
performed to date to reexamine this relationship (Conlon, 2001; Conlon et al., 2001).
Our phylogenetic analysis of the cloned lamprey GnRH-III precursors, using the neighbor
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joining method, in which the tree is divided into 3 groups corresponding to the 
Petromyzonidae, Geotriidae and Mordaciidae, supports the previously described lineage 
based on dentition at the family level. Furthermore, this tree, which shows the distances 
between taxa as a reflection of dissimilarity, confirms the tripartite division of the 
Petromyzoniformes in which M. mordax lamprey GnRH-III and G. australis lamprey 
GnRH-III sequences are approximately equally removed from holarctic clade as they are 
from each other. However, the internal grouping within the Petromyzonidae did not 
match the arrangement of the phylogeny based on dentition, in which the lchthyomyzon 
lamprey GnRH-III sequences and Lampetra lamprey GnRH-III sequences would be 
expected to form groups together, but were rather mismatched in our analysis. 
Nonetheless, our analysis has provided the first supporting evidence of the phylogeny 
based on dentition at the family level. Further analysis on the internal grouping would 
need to be verified using additional traits, such as a more standard molecular marker 
and/or additional anatomical / physiological / behavioral traits. Concerning the bootstrap 
values, although there was an average bootstrap value of 62 within the Petromyzonidae 
sequences, the most critical internal branch, which divides the three groups of sequences 
into Geotriidae, Mordaciidae and Petromyzonidae was 98, and therefore we are only 
drawing conclusions at the family level.
The GnRH family of peptides is a highly conserved group of neurohormones that 
has been subject to intense investigation since the first primary structure of GnRH was 
identified in the early 1970s (Burgus et al., 1972; Matsuo et al., 1971). As more 
sequences have been identified and more species representing different classes of 
vertebrates have been investigated it has become clear that multiple forms of GnRH are
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expressed within the brain of a single species (Dubois et al., 2002; King and Millar, 1995; 
White et al., 1998; White and Femald, 1998). An earlier analysis considering 
phylogenetic analysis of 23 GnRH transcripts, location of expression within the brain, 
and function demonstrated that the GnRH family was composed of 3 paralgous lineages 
(Femald and White, 1999), which included GnRH-I (hypothalamic releasing form: 
mammalian GnRH and orthologs), GnRH-II (midbrain neuromodulatory form: chicken 
GnRH-II in all vertebrates but lamprey) and GnRH-III (telencephalic neuromodulatory 
form: salmon GnRH, found only in teleosts). It was later suggested that a 4th lineage of 
GnRH consisted of medaka and seabream GnRH, which is based exclusively on the 
difference in origin of the cell bodies that produce these forms of GnRH compared to the 
other type I GnRHs (Parhar, 2002). Neither of these analyses considered the lamprey 
GnRH forms of GnRH in their models, and as such we have re-evaluated these groupings 
using the deduced amino acid sequences from the eight cloned lamprey GnRH-III cDNAs, 
the previously described prepro lamprey GnRH-I protein (Suzuki et al., 2000), and the 
known distribution and origin of the GnRH lineages. Our phylogenetic analysis confirms 
Femald and Whites division of the GnRH family, but shows the medaka and seabream 
forms of GnRH grouping with the type I GnRHs, which conflicts with Parhar’s model. 
Additionally the lamprey GnRH forms group together separately from the three 
previously described lineages of GnRH, and as such we suggest that they, and not 
medaka and seabream GnRH, form the 4th lineage of GnRH (Table 7). Our assertion is 
based directly on our phylogenetic analysis which is supported by immunocytochemical 
and functional data on lamprey GnRH. The origin of the cells that produce the lamprey 
GnRH forms, which were shown to arise from cells in the proliferative zones of the
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Mammal GnRH in mouse, primate, human, sheep, pig, eel, 
newt, frog', chicken GnRH-I in chicken, lizard', salmon GnRH in 
goldfish, salmon', catfish GnRH in catfish', dogfish GnRH in 
dogfish
GnRH-H Midbrain/ ventricular 
ependyma
Chicken GnRH-II in primate, human, chicken, lizard, frog, 








Lamprey GnRH-I and lamprey GnRH-III in lamprey
Table 7. The Four Putative Paralogous Lineages of GnRH. The GnRH family is proposed to be 
divided into four paralogous lineages based on phylogenetic analysis, function, neural distribution and 
developmental origin.
diencephalon (Tobet et al., 1993; Tobet et al., 1997), differs from the origin of the type I 
GnRHs, which arise from cells in the olfactory placode (Norgren and Gao, 1994; 
Schwanzel-Fukuda, 1999; Schwanzel-Fukuda et al., 1989; Wray et al., 1989). In addition, 
both lamprey GnRH-I and lamprey GnRH-III differ from the type I GnRH lineage as they 
are both distributed within the pre-optic-neurohypophyseal system of the lamprey as 
demonstrated using immunocytochemistry in the P. marinus (Nozaki et al., 2000), G. 
australis (Sower et al., 2000), 1. unicuspis (Eisthen and Northcutt, 1996), L. richardsoni 
(Crim, 1985) and L. tridentatus (Crim et al., 1979), and both are active in the regulation 
of the reproductive axis in the P. marinus (Deragon and Sower, 1994). In order to 
ultimately understand the molecular evolution of the GnRH family additional sequence 
data, distribution, functional and physiological data are needed across vertebrates and 
invertebrates.
Expression of the lamprey GnRH-III mRNA was detected in the brain of all 8  
species, as well as the pituitary of the P. marinus and I. unicuspis. Expression was also 
detected in the ovary of the L. tridentatus, which is unique among all of the species tested.
114
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The expression pattern of lamprey GnRH-III in the P. marinus differs to that o f the 
previously described lamprey GnRH-I pattern, where expression was only seen in the 
brain and faintly in the testis (Suzuki et al., 2000), although pituitary expression was not 
investigated in this study. GnRH expression in non-neural tissues is typical (Azad et al., 
1991; Dong et al., 1996; White and Femald, 1998; Yoo et al., 2000), although it’s 
function in tissues other than the gonad is unclear. In P. marinus it has been 
demonstrated that both lamprey GnRH-I and -III stimulates steroidogenesis at the level of 
the gonads, suggesting a possible paracrine and/or autocrine regulatory mechanism 
(Gazourian et al., 1997; Gazourian et al., 2000), although there was no lamprey GnRH-III 
expression detected in the P. marinus testis or ovary in this study.
In summary, the cDNA encoding the lamprey GnRH-III was cloned from eight 
species of lamprey, which was used in a series of phylogenetic analyses to address 
questions concerning the molecular phylogeny of the GnRH family and the lineage of the 
Petromyzoniformes. Based on our phylogenetic analysis using the deduced prepro 
lamprey GnRH-III with 64 other GnRH precursors, along with data from previous 
immunocytochemical and functional studies, we propose that the lamprey forms of 
GnRH constitute a unique lineage within the GnRH family. The phylogenetic analysis of 
the lamprey GnRH-III precursors supports the phylogeny based on dentition at the family 
level, dividing into the Petromyzonidae, Geotriidae and Mordaciidae. The information 
derived from this study provides critical information on the molecular evolution of GnRH 
in vertebrates.
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CHAPTER V
SUMMARY
The field of reproductive neuroendocrinology has grown immensely during the past 30 
years, however the ancestral origin of the hypothalamic-pituitary system within 
vertebrates is still in part undefined, although it has been actively studied by Dr. Sower, 
her collaborators and students. Previous studies investigating fish of ancient origin have 
identified many of the components of the HPG axis in lamprey, including the peptide and 
cDNA encoding lamprey GnRH-I (Sherwood et al., 1986; Suzuki et al., 2000) and the 
lamprey GnRH-III peptide (Sower et al., 1993), the cDNA encoding a putative type II 
GnRH receptor, and most recently, a putative gonadotropin (Sower et al., accepted) and 
gonadotropin receptor (unpublished). The functional role of the lamprey GnRHs has 
been established based on many physiological, biochemical and immunological studies, 
in which both lamprey GnRH-I and lamprey GnRH-III have been shown to regulate 
steroidogenesis and gametogenesis (Deragon and Sower, 1994; Sower, 2003). The 
lamprey GnRH receptor was first described using in vitro quantitative autoradiography, 
from which two high affinity binding sites were characterized in the proximal pars 
distalis (Knox et al., 1994). These studies led to the cloning of a type II GnRH receptor 
from the lamprey pituitary followed by phylogenetic analysis and in situ hybridization 
studies by Nathaniel Nucci, a previous graduate student from Dr. Sower’s laboratory.
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These studies provided the impetus for the research presented within this dissertation, 
which contributes to the field of neuroendocrinology through the analysis of the key 
molecular components involved in the regulation of the HPG axis of the sea lamprey.
This dissertation is divided into two major components, the function characterization and 
kinetic studies of the lamprey GnRH receptor (described in chapters II and III), and the 
cloning and analysis of the lamprey GnRH-III cDNA (described in chapter IV). 
Separately, these data have resulted in three first author publications (one in preparation), 
a patent and two additional patent applications (in review). Together, these data provide 
further evidence to support the hypothesis that the HPG axis is highly conserved across 
vertebrates, and that the evolution of the molecular components and mechanisms most 
likely antedated the origin of all known vertebrates.
Interest in GnRH receptors has developed due to its dual significance in both 
medicinal therapy development and the understanding of GPCR molecular evolution. In 
a general sense, approximately 45% of all drugs on the market target GPCRs , while the 
GnRH receptor is a target for several pharmaceuticals, such as Lupron Depot (TAP 
Pharmaceutical Products Inc.), which is the number one prescription for the treatment of 
prostate cancer. The GnRH receptor is unique among the approximately 1000 GPCRs in 
the human genome as it lacks the highly conserved intracellular C-terminal tail, which is 
thought to be critical for G-protein coupling, structural stability, internalization and cell 
surface expression (Blomenrohr et al., 1999; Lin et al., 1998). The GnRH receptor has 
been the focus of many studies investigating reproduction in species ranging from 
mammals to teleosts, however little is known about these receptors in agnathans, the most 
ancient lineage of vertebrates. As mentioned above, GnRH binding sites have been
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characterized in the lamprey pituitary and a type II GnRH receptor has recently been 
cloned. Interestingly, the lamprey GnRH receptor has the longest C-terminal tail o f any 
vertebrate GnRH receptor which opens the question as to the role of this extra long tail.
The aims of the initial studies described in this dissertation were to determine 
whether the lamprey GnRH receptor cDNA encoded a functional protein, and to examine 
the function of the lengthy C-terminal tail. To accomplish these aims, cell culture, 
transfection and second messenger assays first needed to be developed and characterized. 
Analysis of IP3 accumulation was initially chosen for characterization since it was 
thought to be the primary signaling pathway of GnRH receptors. Both lamprey GnRH-I 
and lamprey GnRH-III were found to activate the lamprey GnRH receptor in a dose 
dependant manner, however lamprey GnRH-III was shown to be more potent. Serial 
truncation of the C-terminal tail decreased the magnitude of IP accumulation, however 
the tail-less mutant showed a full recovery compared to wild-type levels, which was 
significant in that it showed that the tail-less mutant retained ligand binding activity and 
that Gciq/1 1  coupling was not dependent on the C-terminal tail. The full recovery in IP 
accumulation of the tail-less mutant receptor also indicated that perhaps a decrease in the 
level of ligand dependant internalization compensated for a decrease in binding affinity. 
Ultimately, further studies were needed for evaluation of the lamprey GnRH receptor 
since efficacy data on their own are difficult to interpret and can be misleading.
Given that the lamprey GnRH receptor was functional and was activated by both 
lamprey GnRH-I and lamprey GnRH-III, a series of experiments were designed to further 
investigate its functional characteristics and ligand binding properties. The lamprey 
GnRH receptor activated cAMP accumulation in response to both lamprey GnRH-I and
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lamprey GnRH-III, where again lamprey GnRH-III was more potent. Serial truncation of 
the C-terminal tail again led to a reduction in efficacy, however cAMP accumulation was 
not recovered by the tail-less mutant. These data suggested that a motif within the first 
40 amino acids of the C-terminal tail is involved in Gas coupling. Pharmacological 
profiling was used to verify that the lamprey GnRH receptor is lamprey GnRH-III 
selective. The Ki of lamprey GnRH-I was 390% higher then lamprey GnRH-III, 
indicating a lower binding affinity. Based on IP accumulation, cAMP accumulation and 
pharmacological profiling, the lamprey GnRH receptor is proposed to be lamprey GnRH- 
III selective. The wild-type and C-terminal tail mutant lamprey GnRH receptors were 
then used in saturation binding assays using intact adherent cells. Truncations of the 
lamprey GnRH receptor’s C-terminal tail were shown to reduce binding affinity, which 
explains their reductions in signaling capacity. Furthermore, the saturation binding 
assays using the wild type and mutant lamprey GnRH receptors revealed that the tail-less 
lamprey GnRH receptor is capable of binding lamprey GnRH-I, and therefore further 
supports the hypothesis that Gas couples to a motif within the first 40aa of the C-terminal 
tail. Finally, the lamprey GnRH receptor was shown to undergo rapid ligand dependant 
internalization, which was greatly diminished in the tail-less mutant form. This unique 
lamprey GnRH receptor, with both high affinity for lamprey GnRH-III and chicken GnRH-II 
and ligand binding activity in the tail-less form may represent an important ancestral state 
which provides insight into the function and evolution of the vertebrate GnRH receptor 
family.
These data indicate that the lamprey GnRH receptor activates IP3 accumulation to 
a greater magnitude compared to cAMP, when stimulated with lower concentrations of 
agonist (Figure 36). These data thus suggest that IP3 may be the predominant mechanism
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of signal transduction associated with the lamprey GnRH receptor. However, it cannot 
be ruled out that in light of the extra length of the C-terminal tail of the GnRH receptor, 
another unknown signal transduction system may be used in lamprey pituitary 
gonadotrope cells in response to GnRH. All functional studies described within this 
dissertation were performed in mammalian cells which typically are tested for cAMP and 
IP3 . C-terminal tail truncations indicate that a motif located within the membrane 
proximal 40 amino acids is involved in Gas coupling, however Gaq/n coupling likely 
takes place within one of the intracellular loops. Furthermore, an additional motif within 
the membrane proximal 40 amino acids is required for rapid ligand induced 
internalization. The C-terminal tail therefore is likely important for structural integrity, 
or rather the truncation or removal of which results in a structural perturbation leading to 
a decreased binding affinity. Since the 40 amino acid C-terminal tail lamprey GnRH 
receptor mutant is capable of stimulating both IP3 and cAMP accumulation and 
undergoes rapid ligand dependant internalization, it is possible that the extensive length 
of the lamprey GnRH receptor C-terminal tail may not have a functional significance for 
these signaling systems. The loss of amino acids in the C-terminal tail of GnRH 
receptors during the subsequent evolution of vertebrates to the tail-less form in mammals 
may reflect the various actions of GnRH in controlling pituitary gonadotropins through 
diverse regulatory mechanisms. One major difference between lampreys and mammals is 
the transport system of neurohormones to the pituitary. In mammals, neurohormones are 
released into the median eminence and travel via the portal system to the anterior 
pituitary gonadotrope cells. In contrast, in lampreys, GnRH travels to the pituitary either
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Figure 36. Lamprey GnRH Receptor Signaling Composite. The lamprey GnRH receptor activates both 
IP (line with filled in icon) and cAMP (dashed with outlined icon) accumulation when stimulated with 
either lamprey GnRH-I (square) or lamprey GnRH-III (triangle). These data are represented here relative 
to fold induction over basal levels. IP accumulation is occurs to a greater magnitude compared to cAMP, 
and is triggered at a lower concentration of agonist.
by diffusion and/or by transport from the third ventricle following release. Lampreys only 
spawn once in their life and die and the molecular mechanisms involved in GnRH- 
GnRH-R interactions likely differ between lampreys and later evolved vertebrates. 
Moreover, the longer transport time of GnRH to the pituitary (Nozaki et al., 1994) and 
higher concentrations of GnRH in lampreys compared to mammals may be reflected in 
some significant differences in the GnRH receptor in its binding and signaling properties.
The future directions o f this project include several different lines of research. 
Most directly, further functional characterization would need to be performed to identify 
specific residues within the C-terminal tail that are involved in both the rapid 
internalization and cAMP signaling. This could be performed using site-directed 
mutagenesis to remove phosphoacceptor sites, one at a time or in multiples, within the 
first 40 amino acids of the C-terminal tail and perform internalization assays.
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Characterization of cAMP signaling could start with mutation of the HFRK-like motif 
located in the membrane proximal region of the lamprey GnRH receptor C-terminal tail. 
Furthermore, characterizing MAPK signaling and the role of p-arrestin dependant 
internalization on this process would be of interest. Notably, all of these studies were 
performed using COS7 cells, a monkey kidney cell line typically used to characterize 
receptor function. It is very possible that the lamprey GnRH receptor may function 
differently within lamprey gonadotropes, and therefore it would be helpful to develop a 
lamprey pituitary cell line. Description of MAPK signaling may be most significant if 
performed using a lamprey gonadotrope cell line.
Cloning all other lamprey GnRH receptors would allow the development of 
specific receptor type agonists and antagonists. These analogs could be used to describe 
receptor specific signaling events in vivo, where for example microarray or proteomic 
analysis could be used to better understand the cellular response to activation of these 
putative receptors. Such analogs could also be applied to the lamprey population control 
initiative within the Great Lakes region, where a non-toxic GnRH receptor subtype 
specific antagonist could be used to induce infertility while not effecting behavior. These 
additional sequences would also contribute to our general understanding of the 
reproductive system within lamprey, and therefore the ancestral vertebrate state.
The second section of this dissertation describes the cloning and analysis of the 
lamprey GnRH-III cDNA from eight species of lamprey, representing the three lineages 
of the Petromyzonidae. The lamprey GnRH-III cDNA was cloned using a PCR based 
strategy, from which the deduced amino acid sequences of the prepro-proteins were used 
in a series o f phylogenetic analyses to address both the molecular evolution of the GnRH
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family and the lineage of the Petromyzonidae. The produced trees were divided into four 
groups, where the lamprey lineage grouped together separately from the three previously 
described groups. Furthermore, the lamprey GnRH-III sequences were used in an un­
rooted phylogenetic analysis, which produced trees that were divided into three groups 
corresponding to the three families of Petromyzonidae. These data support the lamprey 
phylogeny based on dentition at the family level, however the groupings within the 
Petromyzonidae are not well resolved, indicated by the low bootstrap numbers, which 
likely results from the high level of sequence identity within the group. These data 
provide the first molecular analysis to address the lamprey phylogeny.
Further research on this topic is warrented; analysis of additional traits would 
greatly strengthen our understanding of the lamprey phylogeny. For example, analysis of 
the lamprey GnRH-I cDNAs, GnRH receptors or other sequences could be useful.
Indeed, a reconcile tree analysis of several hundred sequences would be a powerful 
approach. Furthermore, a comparative analysis of genomes would be valuable, however 
at this time or in the near future it is unlikely that such information would be available for 
many species of lamprey (the sea lamprey genome is currently being sequence). 
Additionally, analysis of physiological or anatomical traits would be beneficial as well. 
Ultimately, a multi-trait approach is needed. In regard to the GnRH family, more data is 
key. For example, more sequence information from ancient fish, such as hagfish, and 
from the elasmobranches would provide invaluable insight into the molecular evolution 
of the GnRH family. Additionally, a better understanding of the expression and function 
of non-type I GnRHs would help classify novel GnRHs.
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APPENDIX B
A BRIEF HISTORY OF NEUROENDOCRINOLOGY
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The following is based primarily from the following sources:
Guillemin, R., 2005. Hypothalamic hormones a.k.a. hypothalamic releasing factors. J 
Endocrinol, 184(1): 11-28.
Wade, N., 1981. The Nobel Duel. Anchor Press/Doubleday, Garden City, New York.
The classical view of cellular regulation is divided into three isolated systems: neural, 
immune and endocrine; neurologists studied neural networks and transmitters, 
immunologists studied antibodies and lymphocytes, and endocrinologists studied the 
informational molecules released from glands, which traveled via blood to their target 
organ mediating some physiological response. A series of paradigm shifting events 
began in 1928 with Ernst Scharrer’s concept of neurosecretion; the brain producing and 
releasing peptides that had extra-neural regulatory function (Scharrer, 1928). One such 
function of extraordinary interest was the regulation of the pituitary gland, or more 
specifically the hypophyseal portal vessel-chemotransmitter hypothesis of pituitary 
control, which was fully developed by the 1940’s (Green and Harris, 1947). [NOTE- 
Gregory Popa published the first modem description of the portal system, but incorrectly 
postulated that the blood flowed from the anterior pituitary to the hypothalamus (Popa 
and Fielding, 1930), an idea that was corrected by Wislocki and King in 1936 (Wislocki 
and King, 1936). Harris was credited with developing the hypothesis that the portal 
system facilitates the neural regulation of the anterior pituitary]. These two ideas were 
threaded together in 1955 in light of a study of the hormones involved in the stress 
cascade, where it was observed that hypothalamic extracts stimulated the release of the
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pituitary stress hormone adrenocorticotropic hormone (ACTH) (Saffran and Schally, 
1955). These three revolutionary findings solidified the concept of a neuroendocrine 
system and led to the beginning of the race to identify the first neural peptide in the late 
1950’s, which began at the Department of Physiology in the College of Medicine at 
Baylor University in Houston, Texas. The winners of this race ultimately were awarded 
the Nobel Prize (Wade, 1981).
Isolation of a bioactive neuropeptide was the sought after proof of principle, and 
was the intense research focus of many scientists, most notably Roger Guillemin and 
Andrew Schally (there were others, including Sam M. McCann and Geoffrey Harris, who 
will be briefly noted). The paths of Guillemin and Schally were intertwined; both of 
European descent they each received PhDs in Montreal, Canada; however Guillemin left 
for Baylor Medical College one year before Schally’s arrival in 1954. Their training in 
Montreal, Guillemin’s in physiology and Schally’s in biochemistry, led them to strive to 
achieve the same goal: to be the one to prove the neuroendocrine principle. The two first 
became aware of each other while independently seeking to isolate the hypothalamic 
component that they each had shown to stimulate ACTH release in pituitary cultures 
[referred to as corticotrophin releasing factor (CRF)]. Guillimen reported his findings in 
1955 (Guillemin, 1955; Guillemin and Rosenberg, 1955), however he was overshadowed 
by Schally’s publication of similar results (Saffran and Schally, 1955), which were far 
more detailed and received greater attention (Wade, 1981). The two met at a scientific 
conference and decided to join forces, and so it was that Andrew Schally moved to 
Baylor Medical College in 1957 to become part o f the Guillemin team.
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The idea was simple: isolate any hypothalamic releasing factor; any one would do, 
although at the time luteinizing hormone releasing factor (LRF), the hypothalamic 
substance thought to regulate the reproductive system, was considered the gold mine due 
to the potential medical applications in the field of reproductive physiology. Despite this 
interest in LRF, they initially chose CRF as they each had experience in the area, and the 
assay for ACTH was the most developed pituitary response test available. Right from the 
start Schally and Guillemin despised each other, Guillemin saw no one as his equal and 
Schally expected to be just that. In 1960 Guillemin was appointed to a position in Paris, 
and ran both laboratories from France, and had the advantage of being included on all 
projects developed by his team. On the other hand, Schally was exposed to the 
possibility of being left behind if  another person on Guillemin’s team identified CRF. 
After years of floundering, clashing and controversy over the validity and possible 
contamination of their hypothalamic extracts the two split. Schally was offered a position 
at the VA hospital in New Orleans in 1962, and he jumped at the opportunity to improve 
his station. In 1963 Guillemin returned to Houston due to political fall out in Paris. 
Schally and Guillemin, now 350 miles apart, as competitors, rivals and bitter enemies, 
developed similar strategies: build a large interdisciplinary team and to temporarily leave 
CRF behind and begin the hunt for thyrotropin-releasing factor (TRF), the supposed 
hypothalamic component that drives the pituitaries release of thyroid-stimulating 
hormone-which regulates thyroid function (Wade, 1981).
Over the next seven years each team spent millions of dollars, and came under 
intense pressure from the National Institutes of Health (NIH), their funding source, to 
produce or be denied funding. Each had come to the conclusion that TRF was a
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tripeptide, possibly linked to some other non-amino acid component (Guillemin et al., 
1966; Schally et al., 1966), however they were having immense difficulty with 
purification and sequence analyses. By 1969 they each knew the amino acid composition 
to be glutamate (Glu), histadine (His) and proline (Pro), although they didn’t know in 
which order. Each tested six synthetic peptides representing the different possible 
arraignments o f the three amino acids, none of which showed TRF function except for a 
weak response in the Glu-His-Pro sequence (Schally et al., 1969). The key revelation 
came to each team practically simultaneously: the peptides ends were blocked. Both 
teams scrambled to synthesize the tripeptide with a pyro-glutimate on the N-terminal end 
and an amidated C-terminal end (Pyr-Glu-His-Pro-NH2 ), perform their bioassays and 
rush to publication. Andrew Schally’s report of the isolation of the neurohormone TRF 
was published in Biochemical and Biophysical Research Communications on November 
6th, 1969 (Boler et al., 1969), 6 days before Guillemin’s report was published in Comptes 
Rendus (Burgus et al., 1969).
With the structure of TRF solved, the attention was immediately turned to the 
structure o f LRF, which was widely considered the true endgame. With Schally and 
Guillemin’s teams so focused on TRF, the competition, McCann and Harris, were 
drawing close to determining the structure of LRF. Additionally, Schally’s team 
dissolved due to internal strife and Guillemin lost valuable time during his move to the 
Scripps Institute in La Jolla, California in 1970. Having published the structure of TRF 
their NIH funding was secured and they created even larger teams to help them not only 
be the first to describe the structure of LRF, but of most importance to beat the other. 
Both Schally and Guillemin obtained millions of hypothalami (multiple tons) Guillemin
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used sheep brains and Schally used pig brain, from which they had isolated micro-gram 
quantities of LRF. Subsequently both groups had incorrectly concluded that it was a nine 
amino acid peptide in their initial studies (Wade, 1981). Hisayuki Matsuo, the lead 
chemist on Schally’s team, realized the error that was leading to their false results: the 
particular assay they were doing was incompatible with tryptophan, which needed to be 
assayed independently (Wade, 1981). With these results, Schally’s group identified the 
amino acid sequence of LRF, a ten amino acid peptide, which was synthesized and shown 
to be functional via bioassay. At the Endocrine Society’s meeting in San Francisco in 
1971, Andrew Schally presented his results, publicly and unquestionably seized victory 
over Guillemin (Wade, 1981). The chemical structure presented by Schally led 
Guillemin’s group to obtain the sequence of LRF from the sheep, and each group 
reported their findings, however this time Schally’s publication was first by more then six 
months ahead of Guillemin’s publication (Burgus et al., 1972; Matsuo et al., 1971).
In 1977 Andrew Schally and Roger Guillemin split one half of the Nobel Prize in 
Medicine “for their discoveries concerning the peptide hormone production of the brain”. 
The contribution of neither man was particularly intellectual, because the conceptual 
groundwork had been previously established by Geoffrey Harris (who notably was very 
close to discovering the structure of LRF and was thought to potentially have been 
awarded the Nobel Prize for his contributions to the field, however he died in November 
of 1971 (Wade, 1981). Schally and Guillemin placed themselves in a strategic position to 
investigate a topic of extreme importance in a field of excellent researchers. However, 
they differed from their competitors due to their strong commitment; they operated at an 
industrial level in an academic setting, gambling everything they had: their reputation,
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millions of dollars and even their careers. Their genius, in the end, was in the forward 
thinking teambuilding strategy they used, which in combination with their 100% 
commitment to their relentless pursuit won them the ultimate prize in science.
165
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX C
CELL CULTURE (COS7 CELLS)
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The overview of this protocol is as follows: General considerations, supplies, plating 
cells, changing media, and finally splitting cultures.
General Considerations
-The key to successful cell culture is good technique. This means all movements while 
performing cell culture should be deliberate, and much care and patients is needed to 
perform proper aseptic technique.
- While working in the hood never pass your hand over an open container or piece 
of equipment that you wish to remain sterile. The air in the hood flows downward, 
which potentially can carry contaminants from your hand to anything below it.
- Never touch or let anything come in contact with tubes or bottle near the cap.
- When working in a bottle or tube, remove the cap and hold onto it right side up 
until you place it back on, never put it down or invert it.
-Have all of the tubes/bottles that will be used unscrewed, with the caps resting on 
the tube/bottle.
- When opening a sleeve of culture dishes, cut open with a razor blade on the 
bottom of the bag, so the plates come out the right side up, this way there is no 
chance that dirt will fall from your gloves and get into the side of the dish.
- Never work in the front 1/4 of the hood, as it is the least protected.
- When using a pipet, open the pipet just prior to use, and peel back each side of 
the wrapper and don’t touch it. And when mixing by pipetting up and down, 
never go all the way to either extreme, thereby avoiding bubbles. When pipeting 
don’t hold your hand directly above the tube/bottle, always keep it at an angle to 
avoid contamination.
- If there is ever question as to whether a pipet or other container has been 
contaminated discard said item and use a fresh one.
- Always wear gloves, and spray your hands often with 70% EtOH.
- Put all biohaz in biohaz waste, all other trash, like pipet wrappers just through 
on the floor, and pick up later on.
-At least 30 minutes prior to starting the flow hood needs to be sterilized.
- First liberally spray the entire inside of the hood with 70% EtOH and wipe down 
all surfaces with a paper towel. Next, turn on the blower and re-spray the entire 
inside of the hood with 70% EtOH, close the sash of the hood and turn on the 
germicidal (UV) light. After a minimum of 30 minutes the hood will be sterile. 
From this point on, everything that enters the hood should be liberally sprayed 
down with 70% EtOH.
- Also during this time get the media pre-warmed to 37°C.
-There are two viewpoints on using antibiotics/antimycotics in the culture. On one hand 
they are good to use to keep contamination down, although probably not completely out. 
On the other hand, not using any antibiotics/antimycotics you will know if you have 
contamination right away, and a fresh culture can be prepared. Generally it is suggested
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that you start your cultures without any antibiotics/antimycotics to make sure your 
technique is sound, and then use them after a few passages.
-Cells grow optimally at 37°C in 5% CO2  in a humid environment, which is why we used 
the humidified CO2 incubator at 37°C.
Supplies
Dulbecco’s modified Eagles medium (DMEM)
Fetal bovine serum (FBS)
IX trypsin-EDTA 
Antibiotic/antimycotic (Optional)
Phosphate buffered saline, pFI 7.4 (PBS)
(137 mM NaCl, 2.7 mM KC1, 10 mM Na2HP04, 2 mM KH2P04)
Dissolve: 8 g NaCl, 0.2 g KC1, 1.44 g Na2HP04 and 0.24 g of KH2P04 in 800 
mL MQ H20 and adjust pH to 7.4. Fill to 1 L, and I split into 2 500 mL bottles. 
Sterilize by autoclaving for 20 minutes at 15 psi.
5% C 02
100X20 mm culture dishes 
10 mL pipets 
1 mL pipets
9” sterile Pasteur pipets 
50 mL falcon tubes 
Metal tray 
Rubber stopper
Plating Cells (THIS IS A GENERAL DESCRIPTION)
*This will be described based on a culture began 1 mL culture stocks. If the 
starting material is different in any way protocol modifications may be necessary.
Start 1 culture in a T75 culture plate. Note, using one stock to start more then 1 culture 
can result in very low cell densities, which can take a long time to grow. Therefore, 
starting one culture is recommended, which can soon after be split into multiple cultures.
Set up a 50 mL falcon tubes in a tube stand. This tube is used to make DMEM with 
-10% fetal bovine serum (FBS). Pipet 18 mL of DMEM from the DMEM bottle into the 
falcon tube. The FBS, which will separate during the thaw, should be resuspended by 
pipeting up and down gently. Add 2 mL of FBS to tube 1, and mix by pipet.
When dealing with cells it is common practice to freeze them slowly (generally you can 
freeze the cells in a Styrofoam container in a -80°C freezer, then from there put them in 
liquid nitrogen) and to thaw them quickly (to avoid sheering from ice formation).
Remove a tube of cells from the liquid nitrogen and place it in a rack at room temperature 
for just a few minutes (this can be dangerous as tubes can explode during this step, which 
can cause eyes to fall out). When all the nitrogen is gone the thaw the cells in 37°C 
water bath until almost thawed. Centrifuge the tube to pellet the cells, remove media 
(which contains 10% DMSO), and resuspend cells in 1 mL of media. Transfer cells to 
the T75, add 14 mL of medium and put culture in the 5% CO2 incubator, which should be 
set at 37°C.
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At this time put the media away. Each bottle should be closed, and sealed with 70% 
EtOH sprayed aluminum foil, which protects the cap/bottle junction.
To clean up the hood, organize everything, turn off the blower and spray the entire hood 
down with 70% EtOH. Close the sash, and turn off the light.
Changing Media
Liberally spray down the Pasteur pipet container and bring into the hood. Unfold the foil 
carefully, without touching the inside, so it stays sterile.
Turn on the vacuum from the hood, which has a line running into the sterile hood. Using 
your pinky, remove the lid o f the Pasteur pipets, keeping in mind to always keep the cap 
open side down and never moving your hand over an opening that you want to keep 
sterile. Holding the Pasteur pipet container parallel to the bench top, gently shake and 
twist the bottle such that one single pipet will slide out of the bottle, which you should 
grab with your thumb and pointer finger. When the Pasteur pipet is pulled out, the tip 
should be held high.. .as in your hand should be kept lower then the tip of the Pasteur 
pipet. Place the cap back on the container of Pasteur pipets. Fix the Pasteur pipet onto 
the vacuum. With your left hand uncover the culture dish, holding it to the side (correct 
side up), bring the Pasteur pipet to the lowest part of the culture dish to aspirate NOTE 
keep the Pasteur pipet at an angle such that your hand is not directly over the open culture 
dish.
The best way to switch the media is to make up a fresh stock of 10% FBS in DMEM in a 
clean, sterile, 50 mL falcon tube, which would then be used to apply the 15 mL to each 
culture ahead of time.
Put cells in incubator
Trypsinizing Cells
Prep the hood and pre-warm DMEM, FBS and PBS to 37°C. Thaw and warm trypsin at 
the last possible moment.
Prepare appropriate volume of 10% FBS in DMEM ahead of time. You will need -40 
mL for each culture line.
Aspirate cultures described above.
Add 10 mL PBS to wash. Aspirate.
Add 2 mL of IX Trypsin-EDTA to each culture, and swirl to coat. Incubate at 37°C. 
Incubate plates for 10 minutes- 15 max, but never longer. After 10 minutes you can see 
the cells floating around in the culture, and it becomes slightly cloudy.
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Back in the hood, add ~5 mL of 10% FBS in DMEM to each plate and pipet up and down 
a few times to mix. Count cells using a hemocytomoter with trypan blue (dilute to 
achieve appropriate concentration for counting). Add appropriate volume of culture 
(based on cell density and how many cells you wish to seed) to new T75s. Bring to 15 
mL with 10% FBS in DMEM.
Put cells in incubator. Monitor daily.
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APPENDIX D
CELL CULTURE MATERIALS LIST
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General
C0S7 Cells (ATCC Cat# CRL-1651)
Dulbecco’s modified Eagle’s medium (Invitrogen Cat# 11965-092)
Fetal bovine serum-Certified American Origin (Invitrogen Cat# 16000-044) 
Trypan Blue (Sigma Cat# T8154-100mL)
PBS, pH 7.4
lx Trypsin/EDTA (Invitrogen Cat# 25300-054) 
pcDNA3.1 HisTopo Cloning Kit (Invitrogen Cat# K4900-01)
Lipofectamine (Invitrogen Cat# 18324-012)
Opti-MEM-I (Invitrogen Cat# 31985-062)
T75 flasks (Fisher Cat# 10-126-37)
T25 flasks (Fisher Cat# 10-126-28)
100 mM culture plates (VWR Cat# 25382-166)
60 mM culture plates (VWR Cat# 25382-100)
10 mL pipets (VWR Cat# 53300-523)
50 mL falcon tubes (VWR Cat# 21008-178)
15 mL falcon tubes (VWR Cat# 21008-103)
1.5 mL eppendorf tubes (USA Scientific Cat# 1615-5500)
9” Pasture pipets
10 mL sterile pipets
50 mL sterile pipets
C 02 (NorthEast AirGas Cat# CD50)
IP Assay
M199 (Invitrogen Cat# 12350-039)
Dialyzed FBS (Sigma Cat# f0392-100mL)
Myo- [3H]-Inositol (GE Healthcare Cat# TRK317)
HBSS (Invitrogen Cat# 14175-095)
HEPES (Invitrogen Cat# 15630-080)
Phenol Red (Sigma Cat# P3532)
LiCl (Sigma Cat# L9650)
12 well culture plates (VWR Cat# 62406-165)
AG1 Resin (BioRad Cat# 1432445)
PolyPrep chromatography columns (BioRad Cat# 731-1550)
Perchloric Acid (Sigma Cat# 311421)
KOH (Fisher Cat# P250-500)
Formic Acid (Sigma Cat# 39938-8)
Ammonium Formate (Sigma Cat# 516961)
Sodium Tetraborate (AKA Borax) (Sigma Cat# 221732)
RIA Solvell (RPI Cat# 111180)
20 mL Scintillation vials (Fisher Cat# 03-337-7)
7 mL Scintillation vials (VWR Cat# 66022-300)
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cAMP Assay
BioTrak EIA cAMP assay kit (GE Healthcare Cat# RPN225) 
96 well culture plates (VWR Cat# 62406-081)
3-Isobutyl-1-methylxanthine (Sigma Cat# 15879)
Forskolin (Sigma Cat# F3917)
Intact, Whole Cell Binding Assay
HEPEs modified DMEM (Invitrogen 12320-032)
BSA (Sigma Cat# A-2153)
NaOH (Fisher Cat# S318-500)
SDS (Sigma Cat# L4390)
Acetic Acid (Fisher Cat# 95150-03)
NaCl (Sigma Cat# S-3014)
125INa (PE Life Sciences Cat# NEX-1630)
Glass culture tubes (VWR Cat# 47729-570) 
y-tubes (USA Scientific Cat# 1505-7000)
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Transfection with Lipofectamine for IP assays
Transfection and Assay Procedural Overview 
Day 1-Seed 60 mm plates 
Day 2-Transfect
Day 3-Transfer ~1.5xl05 cells to 12 well plate
Day 4-Switch media to 2% dialyzed FBS, 2 pCi/mL Myo-[3H]-inositol in Medium 199 
Day 5-Stimulate cells, extract IPs, isolate IPs, count in liquid scintillation counter (can be 
split into a 6th day)
Specifics 
Day 1
-Trypsinize cells in T75's with 2.5 mL of IX trypsin for 10 minutes at 37°C.
Wash cells off the growing surface with 5 mL of 10% FBS in DMEM, and 
combine cells from each plate in a 50 mL tube (15 mL total volume) and mix well. 
-Count cells with hemocytometer.
-Seed experiment specific number of 60 mm culture plates with 5x105 cells in 5 
mL 10% FBS in DMEM.
-Incubate overnight in humidified CO2 (5%) 37oC incubator.
Day 2
-Set up 2 tubes (sterile eppendorf 1.5mL, 2.0 mL or any other), labeled I and II 
-Tube I: 5 pg of vector in 300 pL Opti-MEM-I 
-Tube II: 15 pL Lipofectamine and 285 pL Opti-MEM-1
-Mix contents of tube I and II, and incubate at room temperature for 30 minutes. 
-Aspirate medium off of cultures and wash one time with 3 mL of Opti-MEM-I 
(and aspirate).
-Add 1.8 mL of Opti-MEM-I to I/II mixture, and pipet 2.4 mL of transfection 
mixture onto cells. Alternatively, a third tube can be set up, which contains the
1.8 mL of Opti-MEM-I, to which you can add the I/II mixture.
-Incubate for 5 hours in humidified CO2 (5%) 37°C incubator.
-Add 2.4 mL of 20% FBS in DMEM to each culture (brining them to 10% FBS in 
an Opti-MEM-I and DMEM mix), gently mix by swirling, and incubate over 
night in humidified CO2  (5%) 37°C incubator.
Day 3
-cut cells with 1 mL of IX trypsin for 10 minutes.
-Transfer cells to a sterile 1.5 mL tube, and centrifuge at 1500 rpm for 5 minutes 
(setting 1.5 on the eppendorf mini centrifuge in Rm 322).
-Remove Supe carefully. Resuspend pellet in appropriate volume of 10% FBS in 
DMEM and combine when necessary (i.e. if you were to seed 9 wells with ~ lx l0 5 
cells/well, resuspending in 10 mL of medium would be wise as you would seed 1 
mL per well (assuming you set up 2-60 mm cultures for transfection and 
recovered 100% of the cells after trypsinizing them). Count cells to be sure.
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-Plate lx l0 5 to 2x105 cells/well (or more) in a total of lmL of 10% FBS in 
DMEM. If set up right you would just seed lmL of resuspended cells.
-Incubate overnight.
Day 4
-Aspirate media off of cells
-Add 1 mL of 2% dialyzed FBS, 2 pCi/mL Myo-[2-3H]-inositol in Medium 199
-Incubate over night
-Prepare Columns for IP isolation:
-Use lg  resin per column (which will pour a lmL column)
-let resin soak in MQ FLO for 30 minutes at room temp(10 mL/gram)
-pour off most of the water
-while PolyPrep column is plugged, pipet resin and let settle until bed 
volume is approximately lmL.
-remove column plug and run 20 mL MQ FLO through each column to 
clean.
-NOTE: resin is in hydroxyl form, and needs to be in Formate form.
-Resin Conversion:
-run 2 mL of IN Formic Acid threw column. This is a harsh treatment; 
some bubbles will form in the bed and the resin will appear lighter. Let 
the acid completely run out of the column (i.e. no more drops)
-Add 1 mL IN Formic Acid to the resin bed and pipet up and down two or 
three time to remove bubbles and to make sure all of the resin is converted. 
Test effluent pH with litmus paper, should be ~2.0 
-Wash column with ~40 mL MQ H2 O, 10 mL at a time. Column is ready 
when effluent ~pH = ~MQ H2 O pH
-Add 5 mL MQ H2 O, cap and plug column. Column can sit overnight at 
room temp.
Day 5
Stimulation and IP Extraction 
-In hood:
-Carefully remove medium from wells (into a 50 mL labeled Falcon)
-Wash wells 2x with lmL IP buffer (20mM HEPES, 20mM LiCl in 
HBSS) (save buffer for proper disposal)
-Pre-Incubation: add 1 mL IP buffer and incubate cells at 37 °C with gentle 
shaking for 15 minutes
Note-NOT in CO2  incubator, HBSS does not have sodium bicarbonate and 
cultures will quickly become extremely acidic 
-Carefully remove medium and save in 50 mL falcon
-Add lmL of stimulant (control and some range of concentrations of stimulant), 
generally using IP buffer, and incubate 1 hour at 37 °C with gentle shaking. 
-Immediately put plates on ice and add 200 pL of pre-chilled (on ice) 20% 
Perchloric Acid. Incubate on ice for 30 min. OPTIONAL this incubation is 
supposed to be at ~4 °C, so ice bucked with plate(s) could be moved into the cold 
room during this time, but it isn’t necessary.
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-During this time set up 1.5 mL tubes (1 for each well), to which add 5 pL of 
EDTA.
-After the 30 minute incubation transfer medium from wells (first mix by pipet 1 
time (just be consistent) to the 1.5 mL tube from the previous step.
-Neutralize. This is where it gets tedious...All sample need to be approximately 
pH 7.4, which is a light pink color (IP has phenol red). All samples need to be as 
close in color as possible, but it doesn’t need to be exact.
-To the first tube, add -155 pL of 5N KOH, close and mix. Check color, 
if it’s light pink (probably not), test with litmus to verify. Otherwise, add 
5N KOH in 5 pL increments until you get there (again, verified by litmus). 
-Use this first tube to 1) determine how much KOH to add to each tube 
(very few of which will come out perfect) and 2) as a color reference. 
-Incubate at 4 °C (cold room) for 1 hour 
-Centrifuge samples at 5000 rpm (40%) at 4 °C
-Carefully transfer 1.2 mL (2x600 pL) of the Supe to a clean 1.5 mL tube.




60 mM Ammonium Formate 
5 mM Sodium Tetraborate (A.K.A. Borax)
-Elution Buffer
100 mM Formic Acid 
1 M Ammonium Formate
-Regeneration Buffer
100 mM Formic Acid 
3 M Ammonium Formate 
-MQ H20
55.5 M MQ H20  
Column Running
-load 1 mL sample to column (in formate form-see above)
-Wash with 10 mL Wash Buffer
-Elute with 3 mL Elution Buffer. Collect sample in a 20 mL Scintillation vial. 
-Regenerate column with 5 mL Regeneration Buffer 
-Rinse with 10 mL MQ H20  
-Repeat with next sample.
-NOTE-Resin bed is very fragile and will be disturbed by essentially every step 
-Resin has a very inconveniently high affinity for phenol red, which will 
accumulate as you load samples. As a result each column can be used 6- 
10 times, and then should be discarded. The Poly Prep column itself can 
be reused numerous times.
-For example, if 36 samples are to be isolated, 6 columns could be used, 
which would each be loaded 6 times, after which the resin is discarded.
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-10 mL pipetman is very useful-set up four big beakers for each solution 
and four small beakers to hold the 10 mL pipetman tips.
-Total run time for 1 cycle, from loading sample to the end o f  the water 
rinse, is about 28 minutes.
-Add 500 pL sample to 5 mL of RIA Solvell (in a 7 mL scint vial), mix and let sit 
in the dark for 2 hours. Count 10 min/sample.
-Analyze data using Excel and/or Prism (GraphPad).
Transfection with Liyofectamine for cAMP assays
Transfection and cAMP Assay Procedural Overview 
Day 1-Seed 60 mm plates 
Day 2-Transfect
Day 3-Transfer cells to 96 well plate 
Day 4-Switch media to 0.5% FBS 
Day 5-Stimulate cells and run cAMP assay 
Specifics 
Day 1
-Cut cells in T75s with 2.5 mL of IX trypsin for 10 minutes at 37°C. Wash cells 
off the growing surface with 5 mL of 10% FBS in DMEM, and combine cells 
from each plate in a 50 mL tube (15 mL total volume) and mix well.
-Count cells with hemocytometer.
-Seed experiment specific number of 60 mm culture plates with 5xl05 cells in 5 
mL 10% FBS in DMEM.
-Incubate overnight in humidified CO2 (5%) 37oC incubator.
Day 2
-Set up 2 tubes, labeled I and II
-Tube I: 5 pg of vector in 300 pL Opti-MEM-I 
-Tube II: 15 pL Lipofectamine and 285 pL Opti-MEM-I 
-Mix contents of tube I and II, and incubate at room temperature for 30 minutes. 
-Aspirate medium off of cultures and wash one time with 3 mL of Opti-MEM-I 
(and aspirate).
-Add 1.8 mL of Opti-MEM-I to I/II mixture, and pipet 2.4 mL of transfection 
mixture onto cells. Alternatively, a third tube can be set up, which contains the
1.8 mL of Opti-MEM-I, to which you can add the I/II mixture.
-Incubate for 5 hours in humidified CO2  (5%) 37°C incubator.
-Add 2.4 mL of 20% FBS in DMEM to each culture (brining them to 10% FBS in 
an Opti-MEM-I and DMEM mix), gently mix by swirling, and incubate over 
night in humidified CO2 (5%) 37°C incubator.
Day 3
-cut cells with 1 mL of IX trypsin for 10 minutes.
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-Transfer cells to a sterile 1.5 mL tube, and centrifuge at 1500 rpm for 5 minutes 
(setting 1.5 on the Eppendorf mini centrifuge in Rm 322).
-Remove Supe carefully. Resuspend pellet in appropriate volume of 10% FBS in 
DMEM (i.e. if you were to seed 9 wells with -5x10 cells/well, resuspending in 1 
mL would be the way to go-as you would have 1 mL of 5xl05 cells/mL which 
would set you up for the next steps). Count cells to be sure.
-Plate -5x104 cells/well in a total of 100 pL of 10% FBS in DMEM. If set up 
right you would just seed 100 pL of resuspended cells. NOTE-the exact number 
of cells seed doesn’t matter, what matters is that the seeding is consistent between 
wells, as ultimately the analysis will be relative to control, and therefore 
fluctuations in seed number between experiments will not matter.
-Incubate overnight.
Day 4
-Aspirate media off of cells 




-Add 100 pL of stimulant (control and some range of concentrations of stimulant), 
generally using ID buffer (lm M  3-isobutyl-1-methylxanthine in DMEM), and a 1 
hour incubation at 37 °C.
-At this point you are into the cAMP assay kit (BioTrak system from GE Health 
Division- Cat # RPN 225). Aspirate medium and lyse cells and continue their 
protocol.
Notes
-Data Analysis is performed using Excel and Prism GraphPad
-Making all the reagents should be done on this morning, generally it’ good to do
it prior to the stimulation.
-Running the standard curve in duplicate is unnecessary.
-The GE protocol should be followed exactly (hence I ’m not going to re-write it), 
however there is one exception: The last step of the cAMP EIA is a colorization 
reaction, which they say to do for 60 minutes and that you should terminate the 
reaction with 1M sulfuric acid. If this protocol is followed the wells will be out of 
range in the spec analysis. So, add the 1M sulfuric acid at 20 minutes into the 
colorization reaction, then immediately read plate.
Transfection with Lipofectamine for Whole flntactl Cell Receptor Binding Assays
Transfection and Assay Procedural Overview 
Day 1-Seed 5xl05 cells in 60 mm culture dishes 
Day 2-Transfect using Lipofectamine 
Day 3-Transfer cells to 24 well plate 
Day 4-Check cells (make sure they look ok)
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0.1% BSA in DMEM with 25 mM HEPES
PBS
IX PBS at pH 7.4 
Solubilizing Reagent
0.5M NaOH /1%  SDS 
Acid Wash Solution





-Cut cells in T75’s with 2.5 mL of IX trypsin for 10 minutes at 37°C. Wash cells 
off the growing surface with 5 mL of 10% FBS in DMEM, and combine cells 
from each plate in a 50 mL tube (15 mL total volume) and mix well.
-Count cells with hemocytometer.
-Seed experiment specific number of 60 mm culture plates with 5xl05 cells in 5 
mL 10% FBS in DMEM.
-Incubate overnight in humidified CO2 (5%) 37oC incubator.
Day 2
-Set up 2 tubes (sterile eppendorf 1.5mL, 2.0 mL or any other), labeled I and II 
-Tube I: 5 pg of vector in 300 pL Opti-MEM-I 
-Tube II: 15 pL Lipofectamine and 285 pL Opti-MEM-I 
-Mix contents of tube I and II, and incubate at room temperature for 30 minutes. 
-Aspirate medium off of cultures and wash one time with 3 mL of Opti-MEM-I 
(and aspirate).
-Add 1.8 mL of Opti-MEM-I to I/II mixture, and pipet 2.4 mL of transfection 
mixture onto cells. Alternatively, a third tube can be set up, which contains the
1.8 mL of Opti-MEM-I, to which you can add the I/II mixture.
-Incubate for 5 hours in humidified CO2 (5%) 37°C incubator.
-Add 2.4 mL of 20% FBS in DMEM to each culture (brining them to 10% FBS in 
an Opti-MEM-I and DMEM mix), gently mix by swirling, and incubate over 
night in humidified CO2  (5%) 37°C incubator.
Day 3
-Cut cells with 1 mL of IX trypsin for 10 minutes.
-Transfer cells to a sterile tube (i.e. 1.5 mL), and centrifuge at 1500 rpm for 5 
minutes (setting 1.5 on the eppendorf mini centrifuge in Rm 322 or 4 clicks using 
the countertop mushroom centrifuge).
-Remove Supe carefully. Resuspend pellet in appropriate volume of 10% FBS in 
DMEM and combine when necessary (i.e. if you were to seed 24 wells with 
~ lx l0 5 cells/well, resuspending in 13 mL of medium would be wise as you would 
seed 1 mL per well (assuming you set up 4-60 mm cultures for transfection and 
recovered 100% of the cells after trypsinizing them). Count cells to be sure.
-Plate lxlO 5 to 1.5xl05 cells/well (or more) in a total of 0.5 mL of 10% FBS in 
DMEM. If set up right you would just seed 0.5 mL of resuspended cells.
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-Plate setup should include 4 wells for each treatment, 2 for specific binding and 2 
for NSB. So if 6 different hot ligand concentrations will be used, the entire 24 
well plate will need to be used.
-Incubate overnight.
Day 4
-Look at cells under scope to make sure they look ok
-The assay could be done this day, but waiting keeps the time line consistent with 
the IP and cAMP assays
Day 5
Saturation Binding Assay
-First thing, make fresh Assay Buffer and get all reagents chilling on ice in the 
cold room except for the Solubilizing Solution
-Make dilutions of 2x hot ligand solutions (i.e. if assay will be done in 1 well with 
200 pL of 10'8M analog, make 100 pL of 2xlO'8M analog, which will be 
combined with 100 pL of assay buffer in the well to give the appropriate volume 
and concentration - this is done so cold ligand can be added to the NSB wells), 
and pre-chill on ice. Enough ligand should be made so that there is enough for 
each well and one extra for determination of “total added”, and a little extra for 
pipetting error.
-In the hood, wash cells lx  with 500 pL of Assay Buffer, and aspirate.
-In the cold room, add 100 pL of Assay Buffer or cold ligand (2xlO'4M) to 
appropriate wells, then carefully add 100 pL hot ligand to each appropriate well. 
Incubate one ice at 4°C for 3.5 hours in order to reach equilibrium (or at least 
steady state).
-Remove medium from each well. Wash each well 2x with 500 pL ice cold PBS. 
-Add 300 pL of Solubilizing Solution and incubate at room temperature for 2-5 
minutes to disrupt cells.
-Transfer cell lysate to y-tube and count (program 16-60 seconds/tube).
-Analyze using Excel and GraphPad to average results and perform non-linear 
regression/Rosenthal plot, respectively.
Competitive Binding Assay
-Starts as described above, from day one through washing cells in the hood with 
500 pL of Assay Buffer.
-Competition is set up between the I-lamprey GnRH-I and cold (non-labeled) 
peptides. In this case, plate is set up in a series of triplicates, one set for total 
binding (only assay buffer) and the rest of the triplicates receive increasing 
concentrations of cold competitor (generally ranging form 10‘14 M to 10'6M, 
depending on the affinity of the ligand). Wells receive 100 pL of 20 nM hot 
ligand (to deliver a final concentration of 10 nM ) along with 100 pL of either 
Assay Buffer of competitor.
-Incubate on ice in the 4°C cold room for 3.5 hours, wash, solubilize and count as 
described above.
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Internalization Assay
-Starts as described above, from day one through washing cells in the hood with 
500 pL of Assay Buffer.
-All treatments set up in triplicate and each time point is set up in a separate 24 
well plate. This is can be wasteful, but if 4 receptors are being assays and blank 
cells are used as control, 15 wells are used for each time point. Plates should be 
set up for a series of times, to include 0 min through 90 min, with the most time 
points during the first 30 minutes o f the assay (i.e. 0 min, 5 min, 15 min, 30 min, 
60 min and 90 min).
-Each well receives 200 pL of 10 nM 1251 lamprey GnRH-I in Assay Buffer. 
Incubate on ice in the 4°C cold room for 3.5 hours.
-Cultures are transferred to 37oC incubator for appropriate period of time. 
-Remove medium from cells, wash 2x with PBS. Add 300 pL of Acid Wash and 
incubate for 12 min on ice in the 4oC cold room.
-At the end of the 12 min collect the acid wash into y-tubes, which represents the 
cell surface associated ligand.
-Add 300 pL of Solubilizing Solution and incubate cells at room temperature for 
2-5 minutes to disrupt cells, and transfer to y-tubes, which represents the 
internalized ligand.
-Repeat for every time point. The timing can be tricky during the first several 
time points, so plan well and be prepared.
-Analysis is performed based on percent internalization, which is calculated as:
% intemalized=(internalized -NSB)/[(intemalized-NSB)+(surface bound-NSB)] X 100 
-Curve is fit using a single component exponential equation:
Y=Ymax(l-eKt)
Where Y is % bound, K is the rate constant (%/min) and t is time in min.
NOTES:
The two most important aspects of these protocols are time and care. That is, everything 
needs to be done quickly yet gently, which can be difficult to balance, however a 
compromise is essential. Why?
-Cells need to be washed rapidly so bound ligand remains bound. Cells need to 
be washed in the first place to remove free ligand, and two washes does the trick; 
in fact, the dpm of the second wash is generally very low (however you don’t 
usually count the washes).
-Cells need to be washed gently to avoid cell loss. If, for example, you do not 
wash gently large patches of cells will be lost, leading to massive amounts of 
error. To avoid this, never pipet directly onto cells, rather hold the culture plate at 
an angle, and slowly and carefully pipet onto the sidewall. It is a good idea to 
look at the cells using the inverted microscope to verify no cells were lost.
125I is not harmless and at the same time it is not terribly dangerous. The most perilous 
time is during the iodination procedure, while at the time of the binding assays the 
amounts used are quite low. Regardless, basic safety precautions should be followed, 
such as using a lab coat, wearing double gloves, wearing dosimeter badges and using 
good sense.
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During large assays, and even small, standing in the cold room can become, well, cold. 
Put on warm cloths under your lab coat, for more then health reasons. After a while 
dexterity can become an issue and fast yet gentle washing can become difficult. Further, 
if you get a little shaky it can be difficult pipet accurately and can lead to contamination 
issues. And finally, after a while it can become easy to lose track of which sample is 
which and how many times a certain culture has been washed.
Be careful not to contaminate anything. At greatest risk will be the ends of the PI 000 
and P200, which should be cleaned with MeOH (for both radioactivity and peptides). 
Swipes must be done after each use, and it should be noted that when dealing with 125I, 
greater then 20 dpm over background is considered contaminated. Items to be swiped 
should include such things that common sense would dictate, such as pipetmen, tube 
racks, door handles (if inter-room travel is required, which it is), bench top, cold 
room.. .etc. All washes should be collected into 50 mL falcon tubes (or some other 
disposable tube), and samples need to be counted in order to determine the activity of the 
generated liquid waste.
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